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P I C O R N AV I R U S E S
The consequences of infection
The picornaviruses are a large family of positive-
sense RNA viruses (+RNA viruses), responsible for a 
diverse range of pathologies in animals and humans. 
Perhaps the most infamous picornavirus is poliovirus, a 
member of the enterovirus genus and causative agent 
of poliomyelitis. Pictorial evidence of the disease is 
believed to date as far back as 2000 BCE, etched into an 
Egyptian stele (3) (Figure 1), suggesting that the virus has 
circulated in human populations for many thousands 
of years. Fortunately, extensive immunisation 
campaigns have seen a dramatic reduction in polio 
cases in more recent decades. This success has been 
in large part thanks to the development of the oral 
polio vaccine (OPV) which confers intestinal immunity, 
inhibiting viral multiplication in subsequent infections 
and limiting the risk of person-to-person spread (4). 
Nonetheless, efforts to eradicate poliovirus have met 
with resistance in some areas, where regional conflicts 
obstruct the distribution of vaccines, and poverty, 
overcrowding and poor sanitation contribute to viral 
spread (5). These challenges are further compounded 
by the reversion of OPV to virulence, which can stimulate new outbreaks in partially vaccinated 
populations (6). 
The success story of poliovirus is a relatively isolated case, as the development and deployment 
of antiviral drugs and vaccines for other enteroviruses is largely wanting. The task of developing 
vaccines against some picornaviruses is complicated by the number of viral serotypes in 
circulation; for instance, rhinovirus serotypes number in the hundreds (7), while for poliovirus only 
three serotypes are known. Vaccines to counter enterovirus EV-A71, a type of enterovirus A and 
causative agent of hand foot and mouth disease, are available in China (8). However, strategies to 
prevent or treat countless other enteroviruses, including the coxsackie A and B viruses, which can 
cause acute febrile illness, meningitis, encephalitis and myocarditis in young children, remain to be 
developed. The challenge of managing outbreaks where vaccines or treatments are not available is 
exemplified by the 2014 epidemic of EV-D68, an enterovirus capable of causing major respiratory 
illness, which developed across the United States, and spread as far as Canada, Europe and Asia (9)
(10). Antiviral strategies to tackle cardioviruses, another genus of picornaviridae, are also limited. 
Diseases resulting from encephalomyocarditis virus (EMCV) infection are largely limited to swine, 
manifesting as acute focal myocarditis and sudden death, or reproductive failure in pregnant sows 
(11, 12). The recently discovered Saffold virus is more closely related to Theiler’s murine encephalitis 
virus (TMEV), which can cause chronic demyelination in the mice it infects (13). Saffold virus has 
Figure 1. Putative evidence for early 
poliovirus.
Egyptian stele depicting a man with an atrophied 
right leg, thought to represent a victim of 
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been linked to disease in humans, and has been found predominantly as a co-infection with other 
viruses. As such the diseases caused by Saffold virus are difficult to untangle, but it may cause or 
contribute to pathologies as varied as non-polio acute flaccid paralysis, encephalitis, myocarditis 
and meningitis.
Picornavirus replication
Picornaviruses utilise receptor-mediated endocytosis as a general mechanism for internalisation 
into cells (14), representing the first step in the viral life-cycle (Figure 2). The viral genome is then 
released from its capsid and must cross the endocytic membrane to enter the cell cytosol. While 
the mechanism underlying this process remains unclear, genome release may be mediated by 
the VP4 capsid protein multimerising to form a pore within the endocytic membrane (15). Like all 
+RNA viral genomes, picornavirus genomic RNA, which resembles cellular mRNA, can be directly 
translated by host-cell ribosomes once within the cell. In the absence of a 5’cap, picornavirus 
genomes include an internal ribosome entry site (IRES) to facilitate translation. The single 
polyprotein produced during translation is subsequently cleaved by viral proteases into a handful 
of viral proteins and stable precursors, while the maturation of some capsid proteins (i.e. VP0) 
Figure 2. Model of the picornavirus life cycle.
(1) A virus particle enters the cell via receptor-mediated endocytosis. (2) The viral genome passes through a pore 
in the capsid and endocytic membrane to enter the cell cytosol. (3) The positive-sense single-stranded genome 
is directly translated into a viral polyprotein, which is cleaved into structural and non-structural proteins. These 
proteins serve numerous functions, including the shut-off of host transcription and translation. (4) Positive and 
negative strand viral RNA are replicated on a membrane platform (ROs). (5) Newly synthesised positive-strand RNA 
is packaged into nascent virions. These virions may reside in the cytosol, or be enwrapped by double-membrane 
vesicles (DMVs) (6) Viral particles exit the cell, either via fusion of virion containing-DMVs with the plasma 
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occurs by autocatalysis (16, 17). The primary role of the four structural proteins (VP1-VP4) that result 
from these events is to form the icosahedral viral capsid, which houses a newly synthesized copy of 
the viral genome. Conversely, the non-structural proteins, which include 2A-C, 3A-D and in some 
genera (e.g. aphthoviruses and cardioviruses (18, 19)) the leader protein, have a remarkably broad 
range of activities. Several important processes are mediated by the 2A (or aphthovirus leader) 
and 3C proteases, which facilitate self-cleavage within the viral polyprotein and subsequent cis-
cleavages of precursor proteins, but are also responsible for the cleavage of host proteins. Cellular 
innate immune sensors, like MDA5 and PKR, are cleaved by 2A and 3C proteases during infection 
to limit a type I interferon-mediated innate immune response (20). Cleavage of eIF4G by the 2A 
protease, which is important for (cap-dependent) cellular mRNA translation, results in the shut-
down of host protein production (21, 22). While lacking obvious protease activity, the cardiovirus 
leader protein is also able to contribute to host translational shut-off (23). A critical step during 
infection, viral RNA synthesis, is mediated by the viral 3D RNA-dependent RNA polymerase, but 
supported by many of the other non-structural proteins and precursors, including 2C, 3AB, 3B 
and 3CD (24). The viral 3B protein, or viral protein genome-linked (VPg), associates with the 5’end 
of the genome and acts as a primer for synthesis first of negative-sense viral RNA, which in turn 
serves as a template for positive-sense RNA synthesis. The 2BC and 3A proteins also contribute to 
another intriguing process during replication; the induction of endomembrane rearrangements 
(25). Genome replication in all eukaryote-infecting +RNA viruses occurs in conjunction with cellular 
endomembranes, whose compositions are necessarily modified by the accumulation of factors 
required for viral RNA synthesis. These changes are accompanied by striking alternations to the 
membrane morphology, resulting in novel membrane architectures that are believed to provide 
dedicated platforms for efficient viral RNA replication. For this reason, these structures can be 
referred to as viral ‘replication organelles’ (ROs).
T H E  R E P L I C AT I O N  O RG A N E L L E S  O F  P O S I T I V E - S E N S E  R N A  V I R U S E S
A spectrum of replication organelle morphologies
While the formation of ROs is highly conserved amongst +RNA viruses, the endomembranes 
targeted and resulting RO morphologies are diverse. Different viruses have been found to generate 
complex and unique membrane rearrangements, but the archetypal morphologies produced are 
often categorised into two forms, spherules and double-membrane vesicle (DMVs), as all +RNA 
viruses characterised to date have been shown to induce either one of these morphologies. 
Spherules are produced via the invagination of otherwise recognisable host endomembranes 
like the ER, mitochondria or endolysosomes, to produce small membrane pockets that remain 
connected to the cytosol. These structures are formed by a number of viruses, including many 
members of the flavivirus family, like Zika virus and dengue virus (26, 27), as well as togaviruses 
and nodaviruses (28-31). For many DMV-inducing viruses, the evidence thus far suggests that ER 
membranes are predominantly utilised for RO biogenesis. DMVs are produced by many members 
of the order Nidoviridae, including the SARS- and MERS-coronaviruses and equine arteritis virus 
(32-34) and HCV (35). While the origins of enterovirus replication organelles are unclear, their 
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Secondary functions of replication organelles
Although supporting RNA synthesis is likely their primary function, additional roles have been 
ascribed to or hypothesised for ROs, which may confer distinct advantages during replication. ROs 
could act as replication hubs in the cell, by compartmentalising or segregating viral products and 
processes. Concentrating viral factors within ROs may serve to increase the efficacy of processes 
like viral RNA synthesis, but could also facilitate the coupling of ostensibly different processes, 
like genome synthesis and genome encapsidation, as has been suggested for enteroviruses (39, 
40). Whether enterovirus RNA synthesis and viral translation are coupled or segregated remains 
uncertain. While both processes are essential for successful infection, translation itself precludes 
viral RNA synthesis (41), and thus, the timing and balance of both processes must be carefully 
controlled. Another proposed role of ROs is to segregate viral replication intermediates from 
sensors of the host innate immune system. These cellular sensors, like RIG-I and MDA-5 present in 
the cytosol, recognise viral dsRNA and trigger the production of type 1 interferons, thus promoting 
an antiviral state in infected and neighbouring cells (42-45). For viruses that induce invaginated 
spherules there is strong evidence to suggest that vRNA replication occurs within the spherule 
lumen, well separated from the remainder of the cytosol (31). Thus, the notion that spherules can 
shield dsRNA from cellular sensors is largely intuitive. For viruses that induce the formation of 
replication membranes with a DMV morphology the site of replication is less clear. While replication 
could also occur within the DMVs, the interior of DMVs often appears to be closed to the remaining 
cytosol. vRNA replication the DMV interior would be limited, and any replication products would be 
effectively trapped within the DMV. If replication happens instead on the DMV surface then, with 
regard to innate immune evasion, the topology of DMVs is less favourable than that of spherules, 
as cytosol-facing positive-curvature vesicles offers no physical barrier to cytosolic proteins. 
Figure 3. The transforming morphologies of picornavirus replication organelles. At early replication stages 
the viral replication complex associates with cellular membranes, like the Golgi apparatus (pictured), upon which 
viral RNA replication occurs. Replication organelles with archetypal morphologies, including single-membrane 
vesicles and tubules, are generated from these cellular endomembranes. Over the course of infection single-
membrane structures have been found to transform form double-membrane vesicles, which may be further 
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Nevertheless, DMVs that form later in infection could serve to enclose and protect excess dsRNA 
or stalled replication complexes from cytosolic sensors.
A  F O C U S  O N  P I CO R N AV I RU S  R E P L I C AT I O N  O R G A N E L L E S
The dual morphologies of picornavirus replication organelles
Picornavirus replication organelles are an unusual case. Enteroviruses, the best-studied genus of 
picornaviridae, have been found to produce ROs with a two-phase morphology. Early in infection 
clusters of single-membrane tubules (SMTs) are found, interspersed with DMVs. Despite an 
abundance of suggestive data, the ultimate origin of these structures remains contentious (46). 
SMTs appear to transform into DMVs over the course of infection via membrane pairing, bending 
and enwrapping (1, 36) (Figure 3). These studies made use of electron tomography, highlighting 
the power of this 3D electron microscopy approach for the characterisation of RO membrane 
topologies, but also the importance of monitoring potentially dynamic structures throughout 
the infectious cycle. Our understanding of RO morphology in other picornavirus genera, like 
aphthoviruses and cardioviruses, is based on more limited thin-section electron microscopy 
analyses. Studies of EMCV infection ultrastructure thus far have reported vesicle clusters (47, 48) 
or vesicle clusters accompanied by DMVs (38). Similar structures are induced by the aphthovirus 
foot-and-mouth disease virus (FMDV), where single-membrane structures interspersed with 
occasional double-membrane structures have been reported (37). While these structures could 
closely reflect the RO morphologies formed in enterovirus infection, confirmation of an equivalent 
3D RO architecture is lacking. Moreover, in the absence of in-depth time courses analyses, or 
reported intermediate structures, it remains unclear whether the transition from SMTs to DMVs 
characteristic of enterovirus infection is more broadly conserved amongst picornaviruses.
The origin of picornavirus replication organelles
Minimal systems to induce the formation of ROs based on the expression of a subset of viral proteins 
have been successfully applied across many virus families, for example, coronaviruses, arteriviruses 
and HCV (49-52). While this approach has yet to be applied to other picornaviruses, expression of 
the enterovirus 2BC and 3A proteins in cells was found to be sufficient to generate structures that, 
in 2D EM cell-sections, are morphologically similar to ROs found in infection (53). 
Determining a membrane donor for picornavirus replication organelles has proven more 
challenging. For cardioviruses the available evidence is limited, but co-localisation between viral 
protein markers and the ER marker calreticulin suggests that the ER is the RO membrane donor (54). 
For enteroviruses the available data is more extensive, but is at times conflicting. In different studies 
the subcellular location of early vRNA synthesis, which could feasibly correspond to RO progenitor 
membranes, has been linked either to membranes of the ER (55) or the Golgi apparatus (56). Other 
indications of enterovirus RO origin have been derived from associations between viral and host 
proteins. One line of evidence suggests that autophagy-derived membranes or components may 
contribute to RO formation (reviewed in (57)). Other studies point to the involvement of either the 
ER (56)(58)(59) or Golgi apparatus (58), (46). The 3A protein, when expressed in isolation, has also 
been found to localise to Golgi membranes (56), while in other cell types or at different time points 
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more suggestive than demonstrative, RO formation is also concomitant with Golgi apparatus 
disassembly during infection (1, 56), a process which could be driven in part by the transformation 
of Golgi membranes into ROs. Similarly, the host factors GBF1 and PI4KB (described below), 
essential for enterovirus replication, are Golgi-resident proteins in uninfected cells, which may 
point to the Golgi as a suitable target organelle for RO formation. Altogether, these studies present 
a somewhat fragmented array of evidence, and interpreting these data is problematic regardless. 
Sites of early vRNA synthesis may not necessarily correspond to sites utilised for RO formation, 
and cellular marker proteins may be actively recruited to novel sites by viral proteins, rendering 
them poor indicators of host-membrane utilisation. Thus, supporting ultrastructural evidence of 
the transition from cellular organelle to RO is still ultimately required. While for spherule-inducing 
viruses and many DMV-inducing viruses, connections between the cellular organelle and RO are 
readily found, direct connections between a cellular organelle and enterovirus ROs have not been 
reported. It may be that the transition between host membrane and enterovirus RO is rapid, or that 
the transition foci are small or rare. While uncertainty remains over the origins of picornavirus ROs, 
it is likely that the specific endomembranes targeted reflect compositional requirements either for 
other viral replication processes, or for RO biogenesis itself.
Essential host factors for picornavirus replication
Viruses are obligate intracellular parasites that usurp the host-cell translational machinery and 
other resources to support their replication. Picornaviruses, and other +RNA viruses, also usurp 
host endomembranes for the formation of their ROs. Viral RO formation, like viral replication, may 
also depend upon other host factors that the virus alone cannot provide. Thus far, a number of 
host factors required for enterovirus infection have been identified that may have a role in RO 
formation. One of these is reticulon 3, which associates with the viral 2C protein (61). Interestingly, 
the unrelated spherule-inducing brome mosaic virus (BMV) also recruits reticulons (62) as well as 
ESCRT proteins (63) for its RO formation. Other key host factors for enterovirus replication include 
the Golgi-localised protein GBF1, a guanine nucleotide exchange factor for Arf1, which mediates 
the formation of COP-I coated retrograde transport vesicles (64). GBF1 associates with the viral 3A 
protein during infection, resulting in its stabilisation on membranes (60)(65). Beyond a potential 
contribution to the shutdown of the host secretory pathway, the role of GBF1 in infection is unclear. 
A second Golgi-resident enterovirus host factor is phosphatidylinositol 4-kinase III-beta (PI4KB), 
which produces the lipid phosphatidylinositol 4-phosphate (PI4P). PI4P appears to influence the 
efficiency of proteolytic cleavage at specific positions in the enterovirus polyprotein, which could 
explain its importance during infection (66, 67). This lipid is critical not only for the replication of 
enteroviruses and other picornaviruses like kobuviruses (68) and cardioviruses (54), but also for the 
replication of a distantly related flavivirus, hepatitis C virus (HCV) (69). For cardioviruses and HCV, 
replication is reliant upon PI4P production via the III-beta isoform of PI4K (PI4KA). Intriguingly, 
a novel role for PI4P has been demonstrated during HCV infection, where it appears to modify 
the development of HCV replication organelles (70, 71). For enteroviruses and cardioviruses, 
oxysterol-binding protein (OSBP) is also critical for replication. In uninfected cells OSPB forms 
ER-Golgi contacts sites that mediate the exchange of cholesterol for PI4P (72). In infected cells, 
this mechanism appears to be hijacked to transfer cholesterol to PI4P-enriched enterovirus or 
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M E T H O D S  A N D  A P ROAC H E S
Correlative light and electron microscopy
The challenge of understanding rare events within cells is best met through an approach that 
combines microscopy modalities with complementary advantages and disadvantages. Information 
about macromolecular complexes in their cellular context is becoming increasingly accessible using 
cryo-transmission electron microscopy (cryo-TEM), as sensitive detectors, rapid data collection 
and streamlined image processing have burst the established limits of structure determination 
by sub-tomogram averaging (74). While cryo-electron tomography (cryo-ET) can also provide 
unparalleled insights into the ultrastructure of cellular features, it is technically highly demanding. 
This renders it unsuitable in practice for addressing ultrastructural questions that require extensive 
sampling of cells and tissues. Room temperature TEM of resin-embedded sections provides a 
practical imaging solution at the level of cellular ultrastructure, particularly when combined with 
advanced sample preparation procedures (i.e. high-pressure freezing and freeze substitution) to 
preserve morphology. While this approach can provide a detailed snapshot of cellular morphology, 
it cannot be used to monitor processes in cells. For capturing dynamic events, light microscopy 
is the method of choice. Proteins of interest can now be routinely tagged using genetically-
encoded fluorophores, or specific lipids 
or organelles stained with fluorophores, 
which can be then be visualised in live 
cells using fluorescence microscopy 
(reviewed in (75) and (76)). In this way 
important cellular or viral processes 
can be monitored, providing a route to 
unravel the functions of proteins and 
structures involved. Correlative light and 
electron microscopy (CLEM) workflows 
couple these approaches, wherein 
features of interest are first imaged by 
(live-cell) light microscopy and then 
electron microscopy (77). Cells can be 
monitored to follow specific processes 
and then immobilised at a critical 
moment by chemical fixation or rapid 
freezing. Foci of interest highlighted by 
light microscopy can then serve further 
as a guide to exploring the sample in 
EM, where structures underlying the 
fluorescent signal and their surrounding 
cellular context are revealed.
Figure 4. Schematic of Serial block-face Scanning Electron 
Microscope chamber.
The SEM beam scans across the sample to acquire an image of the 
surface layer. The knife positioned within the chamber shears the 
surface layer, removing 25 nm or more. The cycle is repeated until 
the required sample volume has been consecutively sectioned 













    1Serial block-face scanning electron microscopy
While CLEM overcomes the hurdle of pinpointing small, rare or transient foci of interest in a 
dynamic and structure-dense cell, further benefits can be gained by considering the electron 
microscopy method utilised. Correlating optical sections from light microscopy and the EM 
sections is challenging, as diffraction-limited light microscopy imaging results in a large z-resolution 
discrepancy in images from the two modalities. This discrepancy typically necessitates laborious 
and error-prone serial sectioning to find the most appropriate EM section. Furthermore, thin-
section TEM provides only limited contextual information, as each section includes <100 nm of 
the cell depth. One approach to resolve more information is to use electron tomography, where 
images of thicker sections are collected at different tilt angles and reconstructed to produce a 
3D volume (78). However, electron tomography is unsuitable for imaging very large volumes, as 
section thickness is limited to a few hundred nanometres.
The alternative to electron tomography is to produce serial thin sections through the entire sample 
volume for conventional 2D imaging. However, visualizing serial sections is laborious, error-prone 
and often impractical. To image complete eukaryotic cells or even larger volumes, a number of 
techniques have recently emerged. Rather than TEM, these approaches utilise scanning electron 
microscopy (SEM), where a focused electron beam scans the sample surface. One of these 
approaches, array tomography, involves the collection of ultrathin sections on glass slides or silicon 
wafers, which can then be repeatedly stained and imaged by LM to gain functional information 
within large cellular volumes. These sections are subsequently scanned in the SEM to obtain high-
resolution ultrastructural information (79). Another approach for volume imaging is focussed ion 
beam SEM (FIB-SEM). FIB-SEM utilises a secondary beam within the SEM column, typically of gallium 
ions, to etch away the sample surface and reveal the material below. Etching and imaging can be 
performed iteratively to gain 3D information about the sample, although this two-step process 
results in long collection times (80). Another approach is serial block-face SEM (SBF-SEM) (81). 
For this, samples are prepared and mounted within an SEM chamber that incorporates a diamond 
knife. Once the sample surface is imaged, the diamond knife slices away a specified thickness to 
reveal the material beneath, and in this way semi-automated imaging of sample volumes can be 
iteratively collected to produce stacks of TEM-like images (Figure 4). While the xy resolution is in 
the nm range (somewhat lower than in TEM), the z-resolution is limited by the minimum sectioning 
thickness (~25-50 nm), and in all cases a compromise between resolution, field of view and data 
collection time must be reached. Nonetheless, SBF-SEM provides more complete contextual 
information than thin section TEM imaging, eliminating the need for extensive serial sectioning 
for CLEM.
T H E S I S  O U T L I N E
This thesis addresses several open questions regarding enterovirus ROs, including the host fac-
tor requirements for their formation, their potential functions, and the on-going uncertainty sur-
rounding their origin. It extends our detailed understanding of enterovirus ROs to a second pi-
cornavirus genus, the cardioviruses, with broader ramifications for the development of antiviral 
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for vRNA synthesis, asking for a re-examination of how we define the ROs of +RNA viruses. Many 
studies utilise fluorescent markers as a means of assessing co-localisations or the sub-cellular loca-
tion of a protein of interest. However, the majority of genetically encoded fluorescent tags require 
large insertions, which may disrupt functions of the target protein. This is particularly problematic 
for small multifunctional proteins, like those of the picornaviruses.
Chapter 2 explores the generation and applications of a genetically-tagged enterovirus, which uti-
lises a split-GFP approach. This system was used to monitor RO formation concomitant with Golgi 
apparatus disassembly during infection by live-cell confocal microscopy, and to visualise the ac-
cumulation of the 3A protein at ROs using CLEM. This latter application was utilised in Chapter 3, 
which examines the functions of PI4P in enterovirus replication. By exploiting a mutant coxsacki-
evirus capable of replication under PI4KB inhibition, we explore the effects of low PI4P conditions 
on RO formation. Using a range of approaches including TEM, CLEM and autoradiography, a role 
for PI4P in expediting RO formation was established. The intriguing ability of this virus to replicate 
extensively in the absence of ROs was further exploited to investigate the functions of enterovirus 
ROs, the results of which cast doubt on the notion that enterovirus ROs are essential for innate 
immune evasion.
In Chapter 2 and Chapter 3, tantalising hints regarding the origin of enterovirus ROs were un-
covered. Accumulation of the 3A protein at the Golgi apparatus was found to result in rapid Golgi 
disintegration and, under low PI4P conditions that slow RO formation, substantial vRNA synthesis 
occurred at a morphologically intact Golgi apparatus. While these data support the hypothesis that 
enterovirus ROs are derived from Golgi membranes, in Chapter 4 this possibility is addressed di-
rectly by visualising nascent ROs. Using the split-GFP system, we pinpoint the early phase of RO for-
mation in live cells for CLEM. Given that RO biogenesis may occur at small foci, CLEM was coupled 
to SBF-SEM to ensure the whole-cell volume was captured. Remarkably, membrane continuities 
were found between both ER and trans-Golgi network and ROs, suggesting that both organelles 
are capable of supporting RO biogenesis, and uniting seemingly conflicting hypotheses regarding 
the origin of enterovirus ROs. SBF-SEM data were probed further, revealing more about the cellular 
context at this time point, and later in infection.
To date, our understanding of ROs in picornaviruses other than enteroviruses is based upon evalu-
ations of 2D EM cell-sections. In Chapter 5 we pursue an in-depth investigation of cardiovirus ROs, 
using electron tomography to probe the 3D morphology across a range of infection time points. 
This investigation reveals striking morphological similarities and differences in the origin of cardio-
virus and enterovirus ROs. Furthermore, we found that any role for PI4P in cardiovirus replication, 
including RO formation, can be bypassed. These data highlight important similarities between the 
ROs of these closely related viruses, which may well constitute hallmarks of picornavirus infection.
Chapter 6 discusses the broader context and implications of the previous chapters, and draws to-
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S U M M A RY
Like all other positive-strand RNA viruses, enteroviruses generate new organelles (“replication 
organelles”, ROs) with a unique protein and lipid composition on which they multiply their viral 
genome. Suitable tools for live-cell imaging of enterovirus ROs are currently unavailable, as 
recombinant enteroviruses that encode RO-anchored viral proteins tagged with fluorescent 
reporters have to date not been reported. To overcome this limitation, we used a split-GFP system, 
comprising a large fragment (S1-10) and a small fragment (S11) of only 16 residues. The GFP(S11) 
fragment was inserted into the 3A protein of the enterovirus coxsackievirus B3 (CVB3), while the 
large fragment was supplied by transient or stable expression in cells. The introduction of GFP(S11) 
did not affect the known functions of 3A when expressed in isolation. Using correlative light electron 
microscopy (CLEM) we showed that GFP fluorescence was detected at ROs, whose morphologies 
are essentially identical to those previously observed for wild-type CVB3, indicating that GFP(S11)-
tagged 3A proteins assemble with GFP(S1-10) to form GFP for illumination of bona fide ROs. It is well 
established that enterovirus infection leads to Golgi disintegration. Through live-cell imaging of 
infected cells expressing an mCherry-tagged Golgi marker, we monitored RO development and 
revealed the dynamics of Golgi disassembly in real time. Having demonstrated the suitability of 
this virus for imaging ROs, we constructed a CVB3 encoding GFP(S1-10) and GFP(S11)-tagged 3A to 
bypass the need to express GFP(S1-10) prior to infection. These tools will have multiple applications 
in future studies on the origin, location, and function of enterovirus ROs.
I N T R O D U C T I O N
The Enterovirus genus of the Picornaviridae family comprises many human pathogens, such 
as poliovirus, coxsackievirus A and B, enterovirus-68, enterovirus-71, and rhinovirus, which can 
cause a wide spectrum of illnesses (1). Being obligate intracellular parasites, enteroviruses rely 
on the machineries of their host cell for propagation. Like all other viruses that carry a positive-
sense, single-stranded RNA genome, enteroviruses redecorate the cell’s interior to form new 
membranous structures that serve as a platform for viral RNA replication (2–6). These structures 
may aid in concentrating as well as in conferring the proper topology of all required components 
for genome replication. Furthermore, it has been suggested that they can shield viral RNA products 
from degradation by cellular RNAses or from detection by sensors of the innate immune system (7, 
8).
The morphology of the enterovirus-induced membrane structures (often termed “replication 
organelles”, ROs) has been a subject of intense investigation. Two-dimensional electron microscopy 
(EM) studies have shown both single-membrane and double-membrane structures, depending on 
the cell type, time point, and experimental procedure (9–16). Recently, two studies with poliovirus 
and coxsackievirus B3 (CVB3) were conducted to reveal the three-dimensional structure of the ROs 
in the course of infection using electron tomography (17, 18). Both studies showed that the first 
structures detected upon infection are single-membrane tubular structures. These tubules appear 
to be formed at the expense of Golgi membranes, since the Golgi is in most cell sections no longer 
detected when the tubules are present. The tubules emerge during the exponential phase of viral 
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synthesis. Later in infection, the tubular ROs morph into double-membrane vesicles (DMVs) and 
multilamellar structures, a phenomenon that is reminiscent of autophagy. For poliovius it was 
shown that newly-synthesized viral RNA localizes not only to the tubular structures, but also to the 
DMVs, implying that the DMVs may also facilitate genome replication (17). In addition, DMVs have 
been proposed to mediate non-lytic release of progeny virions (19–21). 
While EM analyses have provided insight into the structure of the enterovirus ROs, fluorescence 
microscopy studies have focused on unraveling their origin by investigating the presence of 
essential host factors or marker proteins on the ROs. These studies have been performed in cells 
that had been fixed at various time points post-infection, usually at 1 to 2 hour intervals, which gives 
limited insight into the dynamics of RO formation. ROs are mostly visualized by immunolabeling 
using antibodies directed against viral proteins that are anchored in the RO membrane, i.e. 2B, 
2C, or 3A. With this approach, ROs were shown to colocalize with several proteins involved in ER-
to-Golgi transport (22–25) as well as with LC3, a protein involved in the autophagy pathway (11, 13, 
19). However, ROs are not mere remnants of the early secretory pathway or constituents of the 
autophagy pathway. Instead, enteroviruses seem highly selective in hijacking components from 
these pathways to create completely new organelles with a unique protein and lipid composition 
optimized for genome replication (reviewed in (5)).
Although we are learning more and more about the morphology and the origin of enterovirus 
ROs by three-dimensional EM studies and by fluorescence microscopy of fixed cells, it has 
not been possible thus far to directly visualize ROs in living cells. Live-cell imaging can provide 
unprecedented insights into the dynamics of biological processes, including RO formation and viral 
effects on other cellular structures or organelles, and may capture rare or rapid events that may be 
missed in the analysis of fixed cells. Moreover, observations by immunolabeling of fixed cells may 
be compromised by artifacts induced during sample preparation, and should be complemented by 
live-cell imaging (26). To date, enterovirus ROs have only been monitored indirectly in living cells 
that expressed a fluorescently labeled cellular protein, the Golgi-resident Arf1-RFP, as an RO marker 
(22). Yet, the use of a cellular protein as a RO marker may complicate investigations examining the 
transition from Golgi to early enterovirus ROs. A better strategy for direct visualization of ROs in 
living cells is to label a viral protein involved in their formation. The enterovirus genome can accept 
coding sequences of foreign proteins (GFP (27, 28), proLC3 (16), Timer (29), and luciferase (27, 30) 
among others) at the start of the open-reading frame before the capsid coding region. In addition, 
a poliovirus encoding a viral proteinase (i.e. the 2A protein) tagged with dsRed was generated (31). 
However, 2A is not a bona fide RO-marker as it does not localize exclusively to ROs. Attempts to 
generate enteroviruses that encode fluorescently labeled, membrane-anchored viral proteins to 
illuminate ROs have thus far been futile, most likely because fusion of a fluorescent protein to an 
RO-anchored viral protein impaired its function or liberation from the polyprotein. The use of small 
genetically-encoded tags may overcome this limitation, as evidenced by the successful generation 
of recombinant polioviruses that encode small epitope tags (such as HA, FLAG, and c-myc) in their 
3A protein (32) and a recombinant CVB3 encoding an HA-tag in its 2B protein (33). 
In this study, we used a split-GFP system (34) to tag the 3A protein of CVB3, a small protein of 89 
amino acids with a C-terminal hydrophobic domain that inserts into the RO membranes (35). This 
split-GFP system is based on superfolder GFP, a variant of GFP that folds better, matures more rapidly, 
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consisting of eleven beta-strands, which in this system are split into a large fragment (strands 1-10, 
S1-10) and a small fragment (S11) of only 16 amino acids. Separately, these two fragments are non-
fluorescent. Green fluorescence is emitted only when they assemble into superfolder GFP (34). We 
show that tagging 3A with GFP(S11) does not affect its known functions when 3A is expressed alone. 
When introduced into the viral genome of CVB3, GFP(S11)-tagged 3A assembled with GFP(S1-10) to 
illuminate enterovirus ROs as shown by correlative light electron microscopy (CLEM). We illustrate 
the suitability of CVB3 encoding this split-GFP-tagged 3A for live-cell imaging by monitoring the 
development of ROs and the disintegration of the Golgi, as visualized using GM130-mCherry, in 
infected cells in real time. This new tool simplifies the visualization of enterovirus ROs, avoiding 
immunolabeling of viral proteins in fixed cells, and will have multiple applications in future studies 
on the origin, location, and function of enterovirus ROs.
R E S U LT S
3A tagged with GFP(S11) assembles with GFP(S1-10) to yield GFP fluorescence 
In order to visualize the enterovirus ROs in living cells, one of the non-structural proteins that is 
anchored in the membranes of the ROs should be labeled with a fluorescent tag. A transposon-
based insertion mutagenesis study revealed that the N-terminal region of poliovirus 3A tolerates 
small insertions (32, 37). Specifically, viable insertions were found after residues 2, 6, 9, 10, or 11. Since 
the 3A proteins of coxsackievirus B3 (CVB3) and poliovirus are highly homologous, these positions 
were good candidates for introduction of a small tag in CVB3 3A. We chose to insert GFP(S11) after 
amino acid 2 in CVB3 3A without using any linker residues, yielding 3A(S11aa2) (Fig. 1A).
Before introducing GFP(S11) into the viral genome, we first tested whether inserting the tag into 
3A at this position would generate GFP fluorescence upon co-expression with GFP(S1-10). Staining 
with an anti-3A antibody demonstrated that the expression pattern of 3A(S11aa2) resembled 
that of  untagged 3A (i.e. lacking GFP(S11)) in HeLa (Fig. S1A) and in BGM cells (data not shown), 
indicating that the GFP(S11)-tag does not alter the localization of 3A. Co-expression of GFP(S1-10) 
with 3A(S11aa2), but not with untagged 3A, resulted in a GFP signal that greatly overlapped with 
the 3A-pattern generated with the anti-3A antibody (Fig. S1B, HeLa cells not shown). Furthermore, 
3A(S11aa2) was not GFP fluorescent in the absence of GFP(S1-10) (Fig. S1A). Thus, GFP(S1-10) can 
assemble with 3A(S11aa2) to yield GFP fluorescence at the sites where 3A is localized in the cell.
Introduction of GFP(S11) into 3A does not impair its known functions
Next, we investigated whether 3A(S11aa2) is able to perform the same functions as untagged 3A. 
Enteroviruses hijack the Golgi-resident PI4KB (phosphatidylinositol 4-kinase III beta) via their 
3A protein to ROs to enrich these membranes in PI4P (phosphatidylinositol 4-phosphate), an 
essential lipid for viral RNA replication (22). In line with previous observations (22, 38, 39), PI4KB 
was present in a faint Golgi-like pattern in untransfected HeLa cells, whereas in 3A-transfected cells 
an intese PI4KB signal was detected at membranes containing untagged 3A (Fig. 1B). Likewise, in 
cells co-expressing 3A(S11aa2) and GFP(S1-10), PI4KB recruitment was observed to the membranes 
containing fluorescent 3A (Fig. 1B).
The enterovirus 3A protein interacts directly with GBF1, an essential host factor for enterovirus 
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in turn recruits the COP-I complex to Golgi membranes upon activation (40). The COP-I coat 
initiates budding of transport vesicles that ferry cargo at the ER-Golgi interface and in the Golgi 
(41). Expression of 3A in isolation leads to the perturbation of ER to Golgi transport (30, 42–44), as 
demonstrated by the dissociation of COP-I from Golgi membranes in BGM cells (44), presumably as 
a result of the interaction of 3A with GBF1 (30, 44). Similar to untagged 3A, 3A(S11aa2) visualized by 
co-expression of GFP(S1-10) clearly caused COP-I dissociation (Fig. 1C).
 In addition to the interaction with GBF1, enterovirus 3A also directly binds to the host 
factor ACBD3 (acyl-CoA-binding protein domain 3), although the role of this protein in enterovirus 
Figure 1. 3A(S11aa2) recruits PI4KB and dissociates COP-I from Golgi membranes. A) The CVB3-3A(S11aa2) 
protein. The GFP(S11)-tag (bold, underlined) is inserted after amino 2 of 3A without any linker residues. The 
hydrophobic domain, predicted by the Kyte and Doolittle method (67), is indicated as well as the location of the 
helical hairpin predicted by NMR analysis of the truncated poliovirus 3A protein (68). B, C) HeLa R19 (B) or BGM (C) 
cells were co-transfected with the plasmid encoding GFP(S1-10) (i.e. pGFP(S1-10)) and either p3A-myc or p3A(S11aa2)-
myc. The next day, cells were fixed and subjected to immunofluorescence analysis. The 3A protein was visualized with 
an antibody staining for p3A-myc (a primary anti-3A antibody and a secondary Alexa488-labeled antibody), while 
p3A(S11aa2) was visualized by the GFP fluorescence as a result of assembly with GFP(S1-10). PI4KB (A) or COP-I (B) were 
detected with immunofluorescence using a secondary Alexa594-labeled antibody. Untransfected cells are indicated 
with an asterisk. Nuclei were stained with DAPI. Wide-field images were acquired with an Olympus BX60 fluorescence 
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replication is still enigmatic (38, 39, 45–47). We tested whether 3A(S11aa2) could still interact with 
GBF1 and ACBD3 in a mammalian two-hybrid system (38, 39). Similar to untagged 3A, 3A(S11aa2) 
interacted with GBF1 and ACBD3, even in the presence of overexpressed GFP(S1-10) (Fig. S2). 
Collectively, our results demonstrate that introduction of GFP(S11) in CVB3 3A after the second 
residue does not affect the ability of 3A to interact with previously identified host factors or to 
perform its known functions, which prompted us to introduce GFP(S11) into the viral genome of 
CVB3.
Tagging 3A with GFP(S11) results in a replication-competent CVB3 that generates fluorescent 
replication organelles 
Introduction of the GFP(S11)-tag into the infectious clone of CVB3 yielded viable virus, i.e. CVB3-
3A(S11aa2). Sequence analysis of the viral genome confirmed that the tag was retained in the 3A 
protein without mutations. In addition, we generated a replication-competent CVB3 with the 
short affinity tag StrepII of 10 residues in 3A (i.e. CVB3-3A(StrepIIaa2)). Insertion of the StrepII-tag 
also did not affect the known functions of 3A (data not shown), and the tag was retained in 3A 
for five passages (data not shown), further demonstrating that residue 2 is an amenable site for 
introduction of a small tag. 
Subsequently, we tested whether the GFP(S11)-tag in 3A affects the replication kinetics of the 
virus. Since cells that have been transfected with plasmid DNA are less susceptible to picornavirus 
infection (48), we generated single cell clones of HeLa and BGM cells that stably express GFP(S1-10). 
Next, we compared the growth kinetics of CVB3-3A(S11aa2) to wild-type (wt) CVB3 in the presence 
and in the absence of GFP(S1-10). Samples were subjected to endpoint titration to determine the 
production of infectious virus, or quantitative PCR to measure viral RNA levels. Replication of wt 
CVB3 in BGM cells and BGM(GFPS1-10) cells was nearly identical, showing that the presence of 
GFP(S1-10) did not alter CVB3 replication kinetics (Fig. 2A, 2B). The replication kinetics of tagged 
CVB3 in BGM(GFPS1-10) also resembled that of BGM cells, indicating that binding of GFP(S1-10) to 
3A(S11aa2) does not impede replication (Fig. 2A, 2B). Both infectious virus production and viral RNA
levels of the tagged CVB3 were delayed compared to wt CVB3 (Fig. 2B). This delay in replication 
has also been observed for recombinant polioviruses that encode 3A proteins with small epitope 
tags (32). Together, these findings showed that replication of CVB3-3A(S11aa2) is similar to other 
enteroviruses that encoding small tags in a viral protein.
Having produced replication-competent CVB3-3A(S11aa2), we then tested whether this virus 
induced GFP fluorescence in cells expressing GFP(S1-10). Figure 3 (left images) shows that these 
cells do emit GFP fluorescence upon infection with CVB3-3A(S11aa2). To investigate whether the 
GFP fluorescence was restricted to the sites where the 3A(S11aa2) proteins are localized in the 
cell, we first stained cells with an anti-GFP antibody. Figure 3A shows that the anti-GFP antibody 
recognized GFP(S1-10) as demonstrated by the cytoplasmic staining in uninfected cells, whereas 
BGM cells lacking GFP(S1-10) were negative (data not shown). In infected cells, GFP fluorescence 
was not observed throughout the entire cytoplasm, but instead in a pattern that is reminiscent of a 
3A staining pattern. This suggests that assembled, fluorescent GFP is only found at sites that contain 
3A(S11aa2). Interestingly, while anti-GFP antibody staining in infected cells was detected throughout 
the cytoplasm, the signal was more intense at regions corresponding to  GFP fluorescence. This is 





























    2
the anti-GFP antibody has a higher affinity for full-length, assembled GFP.
To ensure that GFP fluorescence is exclusively emitted from 3A(S11aa2)-containing sites, cells from 
the same infection were stained with an anti-3A antibody. Figure 3B shows that GFP fluorescence 
was detected in a pattern that greatly overlapped with 3A visualized by immunofluorescence. 
However, the immunofluorescence with the 3A-antibody generated a slightly more extensive 
3A-pattern, most likely as a consequence of not all 3A(S11aa2) proteins being bound by GFP(S1-10). 
This could be due to partial inaccessibility of 3A(S11aa2) proteins to their GFP(S1-10) counterparts as 
3A proteins localize to densely-packed ROs.
Next, we set out to confirm that the emerging GFP fluorescence is emitted from ROs that contain 
3A(S11aa2). To this end, we applied correlative light electron microscopy (CLEM) (49, 50), which 
provides a direct link between fluorescent signals and the virus-induced structures that underlie 
them at high resolution. The emerging fluorescence signal in BGM (GFPS1-10) cells infected with 
CVB3-3A(S11aa2) and stained with Mitotracker Deep Red FM was monitored by live-cell imaging. 
Cells were imaged and fixed at an intermediate time point in infection. Following sample processing 
and EM imaging, the Mitotracker signal and corresponding mitochondria were used to orient 
fluorescence and EM images with an independent marker. Using this method, 3A(S11aa2) was found 
to localize to ROs, evident as both tubules and clusters of DMVs and multilamellar structures (Fig. 
4). Furthermore, the CLEM results not only show that GFP fluorescence was emitted from bona fide 
ROs, they also demonstrate that the GFP(S11) insertion in 3A does not affect the development of the 
different RO morphologies typically observed during enterovirus infections.
Figure 2. Single-cycle growth curve analysis of CVB3-3A(S11aa2). BGM cells (A) or BGM cells that stably express 
GFP(S1-10) (B) were infected with wt CVB3 or CVB3-3A(S11aa2) for 30 min at MOI 1. At the indicated time points, cells 
were subjected to titration analysis after freeze-thawing cycles to determine the amount of infectious virus particles. 
Alternatively, cells were lysed to determine the amount of viral RNA by quantitative PCR. The results are expressed as 
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Live-cell imaging reveals the dynamics of Golgi disassembly in live infected cells
Enterovirus infections trigger the disassembly of the Golgi apparatus, which coincides with the 
formation of early ROs (18, 22). Here, we used live-cell imaging to visualize this process in living cells. 
To this end, BGM cells stably expressing GFP(S1-10) were transduced with MLV particles encoding 
mCherry-GM130 as a traceable marker for the Golgi. Live-cell confocal imaging was first carried out 
with a narrow pinhole (95.56 µm) to detect the first local changes in Golgi structure during infection. 
As expected, GM130 was observed as a condensed perinuclear signal in uninfected cells (Fig. 5A) 
or early in infection with CVB3-3A(S11aa2) when fluorescent 3A (which will be further referred to 
as 3A-GFP) could not yet be detected (Fig. 5B, Movies S1 and S2). Strikingly, the first 3A-GFP signal 
detected in infected cells was rarely associated with GM130, but could instead be observed as 
distinct cytoplasmic punctae. Localization of 3A-GFP signal to the Golgi region typically occurred 
Figure 3. GFP fluorescence is only emitted from sites where 3A(S11aa2) is localized in cells. A, B) BGM cells 
stably expressing GFP(S1-10) were infected with CVB3-3A(S11aa2). At 5 and 6 h p.i., cells were fixed and subjected to 
immunofluorescence analysis. The detected GFP fluorescence is the result of GFP(S1-10) assembling with 3A(S11aa2). 
Nuclei were visualized with DAPI. Images were acquired with a Leica SPE-II DMI-4000 confocal laser scanning 
microscope. Scale bars equal 10 µm. A) GFP(S1-10) was detected with a primary polyclonal antibody directed against 
GFP and a secondary Alexa594-labeled antibody. The uninfected cell is marked with an asterisk. B) The 3A(S11aa2) 
protein was stained with a primary antibody directed against 3A and a secondary Alexa594-labeled antibody. An 
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within 25 minutes (n=17, range 0-45 minutes) of initial detection. This was followed by a sharp 
increase in the intensity and number of Golgi-adjacent 3A-GFP punctae and a local perturbation 
of Golgi morphology, characterized by the onset of GM130 signal fragmentation (Fig. 5B, asterisk 
GM130 channel). Interestingly, while this rapidly increasing 3A-GFP signal was clearly detected in the 
Golgi region, it rarely co-localized directly with the GM130 marker (Fig. 5B inset, arrowhead), which 
is in agreement with previous observations in fixed cells (22). This suggests that RO membranes 
originate from a compartment of the Golgi not labeled by the cis-Golgi marker GM130, or that 3A 
resides there only transiently before accumulating in the ROs. 
The first signs of disruption of Golgi morphology largely began during or even preceding the 
accumulation of visible 3A signal (Fig. 5B asterisk 3A-GFP channel, Movie S1), suggesting that 
local changes to morphology occur rapidly and may be triggered by 3A accumulation in regions 
of the Golgi outside the imaging plane. To facilitate the detection of the whole Golgi and to 
monitor large scale changes in Golgi morphology, imaging was carried out using a wider confocal 
Figure 4. 3A(S11aa2) localizes to ROs that have tubule and DMV morphologies. A, B) BGM GFP(S1-10) cells were 
infected with CVB3-3A(S11aa2), stained with Mitotracker Deep Red FM and monitored by live cell imaging. Full-depth 
z-stacks of cells emitting GFP fluorescence were taken and cells were processed for EM. LM-EM overlays were made 
using the Mitotracker as an orientation guide, and 3A-GFP signal was aligned to the corresponding EM image in this 
manner first at low magnification (A), and then within individual cells of interest (B, which is the boxed area in A). 
3A-GFP signal was found at the typical structures that develop during CVB3 infection, including single-membrane 
tubules (B, red box, enlargement shown on the right) and double-membrane vesicles (B, black box, enlargement 
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pinhole (600 µm). Global Golgi fragmentation began typically 10-30 minutes after 3A started to 
accumulate in high amounts (Fig. 6) (n=8, range 0-45 min), which presumably reflects the time 
taken for the cumulative local changes to become apparent within the entire structure, and was 
completed 75-105 min after the initial detection of 3A-GFP signal (n=8). Together, these data 
show that 3A accumulation coincides with the local disruption of Golgi morphology, leading to 
Figure 5. Live-cell imaging reveals the association between 3A accumulation and local perturbation to Golgi 
morphology. A, B) BGM GFP(S1-10) cells transduced with mCherry-GM130 MLV particles were mock-infected (A) or 
infected with CVB3-3A(S11aa2) (B), and imaged by live-cell microscopy with images taken at 5 minute intervals. The 
frames given as time ‘0’ represent either an arbitrary time point (A) or the moment of appearance of 3A-GFP signal 
(B). Images are presented at 180 (A) or 10 to 20 (B) min intervals as indicated. The confocal pinhole was adjusted for 
analysis of local effects (95.56 µm confocal pinhole). While Golgi integrity was maintained for the duration of imaging 
in mock cells (A), local fragmentation of GM130 was evident in infected cells (B, asterisk GM130 channel). The onset 
of fragmentation was associated with a marked increase in the intensity and number of 3A-GFP punctae at the Golgi 
(B, asterisk 3A-GFP channel) although, while 3A signal and GM130 were proximal at this stage, there was no clear 
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global fragmentation and eventual disassembly of the Golgi apparatus. After complete Golgi 
fragmentation, the 3A-GFP signal expands throughout the cell and eventually occupies the entire 
cytoplasm before the cell goes into demise, demonstrating that 3A-GFP signals can be imaged to 
the point of cell lysis (Movies S1 and S2). 
Construction of CVB3 encoding both GFP(S1-10) and 3A(S11aa2)
Studying ROs induced by CVB3 encoding split-GFP-tagged 3A in distinct cell types requires the 
cellular expression of GFP(S1-10). To bypass the need for delivering the GFP(S1-10) gene via 
retroviral transduction or by generating stable cell lines, we constructed a CVB3 that encodes not 
Figure 6. Global disruption to Golgi morphology during CVB3 infection visualized by live-cell imaging. Cells 
were treated as described in Figure 5. Imaging conditions were adjusted to better ascertain global Golgi morphology 
(600 µm confocal pinhole) over the course of infection. The frame given as time ‘0’ represents the moment of 
appearance of 3A-GFP signal. Golgi fragmentation (asterisk GM130 channel) was visible following accumulation of 
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only 3A(S11aa2) but also GFP(S1-10) (Fig. 7A). For this, the gene encoding GFP(S1-10) was inserted 
upstream of the capsid coding region (P1) in the infectious clone containing 3A(S11aa2). GFP(S1-10) 
was followed by an artificial 3CD cleavage site to release the protein from the P1 region upon 
translation. Viable virus (i.e. CVB3-GFP(S1-10)-3A(S11aa2) was obtained upon transfection of BGM 
cells with RNA transcripts of the infectious clone. After harvesting CVB3-GFP(S1-10)-3A(S11aa2), we 
compared its replication kinetics in BGM cells to CVB3-3A(S11aa2) in BGM(GFPS1-10), so that in both 
cases the 3A(S11aa2) protein would bind to GFP(S1-10). The level of viral RNA replication was nearly 
identical for both viruses (Fig. 7B), suggesting that the generation of ROs during the course of 
infection occurs similarly. However, the virus encoding both GFP fragments (i.e. CVB3-GFP(S1-10)-
3A(S11aa2)) was delayed in production of infectious progeny in comparison to CVB3-3A(S11aa2) (Fig. 
7B). In line with a previous study  (51), we found that the processing of the artificial 3CD cleavage site 
Figure 7. Construction of CVB3 that encodes both GFP(S1-10) and 3A(S11aa2). A) A schematic diagram of the 
genome organization of CVB3 showing the insertion of GFP(S1-10) before the capsid coding region and GFP(S11) in 
3A after amino acid 2. B) Growth curve analysis of CVB3-GFP(S1-10)-3A(S11aa2) in BGM cells and CVB3-3A(S11aa2) in 
BGM(GFPS1-10) cells. Cells were infected for 30 min at MOI 1. At the indicated time points, cells were subjected to 
titration analysis after freeze-thawing cycles to determine the amount of infectious virus particles. Alternatively, cells 
were lysed to determine the amount of viral RNA with quantitative PCR. The results are expressed as fold induction 
relative to the quantities determined directly after removing the inoculum. C) BGM cells were infected with CVB3 
GFP(S1-10) 3A(S11aa2). At 5 and 6 h p.i., cells were fixed and subjected to immunofluorescence analysis. The detected 
GFP fluorescence resulted from the assembly of GFP(S1-10) with 3A(S11aa2). Nuclei were visualized with DAPI. Images 
were acquired with a Leica SPE-II DMI-4000 confocal laser scanning microscope. Typical examples of cells early in 
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between a foreign protein and P1 is suboptimal (Fig. S3), which may explain the delay in progeny 
virion production. 
Next, we tested whether BGM cells became GFP fluorescent upon infection with CVB3-GFP(S1-10)-
3A(S11aa2). Figure 7C shows that GFP fluorescence colocalized with 3A, visualized with an anti-3A 
antibody, both early (upper panel) and later (lower panel) in infection. Yet, the GFP fluorescence was 
substantially dimmer compared to BGM(GFPS1-10) cells infected with CVB3-3A(S11aa2). It is plausible 
that the dimmer signal is a result of the equimolar ratios of 3A(S11aa2) and GFP(S1-10) generated 
by this virus, while BGM(GFPS1-10) cells produce an excess of GFP(S1-10). Another explanation for 
the dim GFP fluorescence is that not all GFP(S1-10) is released from P1 due to suboptimal cleavage 
of the artificial cleavage site. When GFP(S1-10) is still fused to P1, it might be unable to assemble 
with 3A(S11aa2) and/or become fluorescent. Nevertheless, these findings suggest that the virus 
containing both GFP fragments is suitable for live-cell imaging.
D I S C U S S I O N
Live-cell imaging is a powerful technology to gain insight into the dynamics of biological processes. 
In the field of virology, this method has mostly been applied to visualize the entry and egress 
pathways of viruses by following the fate of fluorescently labeled, individual virus particles in living 
cells and monitoring their interactions with cellular structures (52). Imaging replication structures 
during infection has so far only been reported for a few viruses, including hepatitis C virus (53, 54), 
vaccinia virus (55), turnip mosaic virus (56), mouse hepatitis virus (57, 58) and equine arteritis virus 
(59). In most of these studies, replication structures are illuminated by a viral protein that is fused to 
GFP. Recombinant enteroviruses that encode an RO-anchored viral protein fused to GFP (or another 
fluorescent reporter) have to date not been reported. Small epitope tags on the other hand were 
successfully introduced in the 3A protein of poliovirus (32), which prompted us to test whether 
small tags suitable for fluorescent labeling are accepted in the 3A protein of CVB3. The smallest 
tag for fluorescent labeling of a protein is the tetracysteine tag of 6-20 residues (depending on 
the version), but it requires visualization with biarsenical dyes FlAsH and ReAsH in extra labeling 
steps, and results in fluorescence with a relatively poor quantum yield (60, 61). The split-GFP system 
uses a tag of 16 residues, GFP(S11), which has the advantage that it does not require staining but 
becomes directly fluorescent upon assembly with the large GFP(S1-10) fragment in living cells (34). 
This system has been successfully applied before in the context of a virus to study the intracellular 
trafficking of ribonucleoproteins of Influenza A virus, where the PB2 polymerase subunit was 
tagged with GFP(S11) (62). In our study, we incorporated GFP(S11) into the RO-anchored 3A protein 
of CVB3. We show that the introduction of GFP(S11) after the second residue does not affect the 
localization or function of 3A when it is expressed in isolation. Whether binding of GFP(S1-10) affects 
the function of 3A(S11aa2) proteins remains unknown, as it is possible that not all 3A(S11aa2) proteins 
are bound by the GFP(S1-10) counterparts. Therefore, the subset of unbound 3A(S11aa2) proteins 
could be solely responsible for exerting the 3A functions.
Having found that the 3A protein was not functionally hampered by the introduction of the 
GFP(S11)-tag, we generated a recombinant CVB3 that encodes 3A(S11aa2). Infections of this virus in 
BGM cells stably expressing GFP(S1-10) yielded discrete fluorescent signals. However, confirming 
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of sub-cellular structures, in the context of their surroundings, that EM can provide. Establishing 
this link with ultrastructure is particularly interesting in the case of enteroviruses, since their ROs 
can adopt various morphologies during infection (i.e. tubules, DMVs, and multilamellar structures) 
which, as observed by EM, often co-exist. In this study, CLEM was employed to confirm that the 
GFP fluorescent foci localize to ROs and to establish which subset of enterovirus RO morphologies 
this fluorescence corresponded to. CLEM revealed that the GFP fluorescence was present at 
bona fide ROs, which took the form of both tubular structures and DMVs resembling those 
observed previously with wt CVB3 in Vero cells (18). Split-GFP CLEM thus allows the unambiguous 
identification of RO morphologies underlying the 3A signal, and opens up new possibilities for a 
better understanding of the requirements for their development. This method also circumvents 
limitations inherent in other, similar approaches. For instance, while immuno-gold labeling of 
proteins is a popular technique that couples an electron-dense gold particle to the protein of 
interest, allowing it to be visualized by EM, its success depends largely upon the antibody used and 
the resilience of epitopes during EM sample preparation. In our experience, sample preparation 
procedures for immunolabeling of CVB3 3A that retain RO membranes unfortunately do so at the 
expense of viral epitope integrity, resulting in insufficient labeling of 3A (unpublished data). 
Enterovirus ROs were imaged in living BGM(GFPS1-10) cells upon infection with CVB3-3A(S11aa2). As 
a proof of concept, we also expressed GM130-mCherry in these cells to visualize Golgi disassembly 
in real time. The onset of Golgi fragmentation was found to correspond to a period of rapid 3A 
accumulation in the Golgi region. Under the experimental conditions used, Golgi disruption was 
completed within 75-105 min after the first detection of 3A-GFP. Interestingly, while 3A accumulation 
occurred adjacent to the GM130 signal, 3A rarely co-localized with GM130-mCherry before and 
during Golgi disassembly. While this does not preclude the transient localization of 3A to the cis-
Golgi, our findings suggest that ROs may be generated from another Golgi compartment not 
labeled by GM130, which is in line with previous observations that suggest that RO formation is 
initiated at the trans-Golgi (22). 
Enteroviruses can infect both polarized and non-polarized cells. The use of CVB3 encoding split-
GFP-tagged 3A in distinct cell types relies on the cellular expression of GFP(S1-10). As an alternative 
to delivering the GFP(S1-10) gene via transduction, we introduced the coding sequence of 
GFP(S1-10) into the viral genome together with 3A(S11aa2). This new recombinant CVB3 encoding 
both GFP fragments also induced GFP fluorescent foci that colocalized with 3A. While progeny 
virion production by this virus was delayed, the viral RNA levels were very similar to CVB3-3A(S11aa2) 
infection of BGM(GFPS1-10) cells, implying that the “two-fragment virus” retained its ability to form 
ROs. Hence, this virus would be suitable for studying enterovirus ROs in physiologically more 
relevant cell types, including pancreatic cells (14) and 3D-cultured CaCo-2 cells (63), without the 
need for ectopic expression of GFP(S1-10).
In conclusion, we have presented split-GFP tagged CVB3 as a new tool for the direct visualization 
of enterovirus ROs in living cells, which will allow the study of their dynamics. Furthermore, the 
combination of live-cell imaging with CLEM will enable us to establish a direct link between events 
observed by fluorescence microscopy and morphologically distinct ROs, which could shed light 
onto the possible differentiated roles of these different virus-induced structures in enterovirus 
infection. This system will therefore serve as a valuable tool for future studies on the origin and 
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E X P E R I M E N TA L  P RO C E D U R E S
Cells. HeLa R19, BGM (buffalo green monkey), and COS-1 cells were grown in Dulbecco’s minimal 
essential medium (DMEM, Lonza) supplemented with 10% fetal bovine serum and penicillin and 
streptomycin at 37oC and 5% CO2. 
Plasmids and infectious clones. The expression construct encoding wild-type (wt) 3A, i.e. p3A-
myc, was described elsewhere (64). GFP(S11), i.e. the residues RDHMVLHEYVNAAGIT, were inserted 
after amino acid 2 in CVB3 3A to yield p3A(S11aa2)-myc. For this, a forward primer containing the 
GFP(S11)-tag was used in a PCR reaction with p3A-myc as a template to generate 3A(S11aa2) as a 
PCR product. Wt 3A in p3A-myc was replaced with this PCR product using standard DNA cloning 
techniques. The same strategy was used to introduce GFP(S11) or the StrepII-tag (i.e. residues 
SAWSHPQFEK) in the infectious clone of CVB3 (p53CB3/T7) described elsewhere (64), yielding 
p53CB3-3A(S11aa2)/T7 or p53CB3-3A(StrepIIaa2)/T7. The GFP(S1-10) expression construct pCMV-
mGFP(S1-10) was purchased from Sandia Biotech. For the production of CVB3 encoding both 
GFP(S1-10) and 3A(S11aa2), the GFP(S1-10) gene followed by a 3CD cleavage site was placed directly 
upstream of the capsid coding region P1 in p53CB3-3A(S11aa2)/T7, similar to modifications previously 
described for CVB3 encoding luciferase (27). For the production of MLVs (Murine Leukemia Virus 
particles), our genes of interest were cloned into the retroviral vectors pQCXIP (for GFP(S1-10) 
or mCherry-P4M-SidM) or pRetroQ-mCherry (for GM130), both purchased from Clontech, with 
standard DNA cloning techniques. In the resulting plasmids, the gene of interest is followed by an 
IRES and a puromycin resistance gene for the production of stable cell lines.
Retroviral particles and the production of stable cell lines. For the delivery of genes (i.e. 
GFP(S1-10), mCherry-GM130, or mCherry-SidM-P4M) into cells, we used an MLV-based retroviral 
vector system (Clontech). MLV stocks were produced by co-transfecting HEK293T cells with 
the plasmid pCAGGS-VSV-G encoding vesicular stomatitis virus protein G (VSV-G), the plasmid 
pMLV-Gag/Pol encoding the capsid proteins, reverse transcriptase, and integrase proteins, and 
the plasmid pQCXIP or pRetroQ-mCherry containing the gene of interest. Four to five days post-
transfection, supernatants were harvested and cleared of cell debris by centrifugation and filtration 
through a 0.45 µm pore size filter. Stocks were buffered with 10 mM HEPES, aliquoted, and frozen 
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using a 100 kD-concentrator (Millipore). For the generation of single-cell clones stably expressing 
GFP(S1-10), BGM and HeLa cells were transduced and grown in the presence of puromycin (2 µg/
ml for HeLa; 30 µg/ml for BGM) to generate pools of GFP(S1-10)-expressing cells, which were 
subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP(S1-10) was 
monitored during passaging by immunofluorescence microscopy using the GFP antibody.
Mammalian two-hybrid assay. pACT, pBIND, and pG5Luc vectors were from Promega. pBIND-
GBF1 encoding the N-terminus of GBF1, pACT-3A, and pBIND-3A were described previously (38, 39). 
pACT-ACBD3 was a kind gift from dr. J. Sasaki (Fujita Health University School of Medicine, Aichi, 
Japan) (45). pACT-3A(S11aa2) and pBIND-3A(S11aa2) were cloned with a forward primer containing 
the GFP(S11)-tag using standard DNA cloning techniques. Subconfluent layers of COS-1 cells seeded 
in 24 well plates were transfected with 350 ng of pACT, pBIND, and pG5Luc plasmids using Fugene6 
(Promega) according to the manufacturer’s protocol. At 48 h post-transfection (p.t.) cells were 
lysed and Renilla and Firefly luciferase levels were measured using the Dual-Luciferase assay kit 
(Promega) following the manufacturer’s protocol. Values were converted to Firefly/Renilla signal 
ratios to correct for transfection efficiencies. 
Virus infection. The production of CVB3 from infectious clones was described previously (39). 
Virus titers were determined by endpoint titration according to the method of Reed and Muench 
and expressed as 50% cell culture infective doses (CCID50). BGM or HeLa cells were infected with 
virus for 30 min to 1 hour. Following removal of the inoculum, fresh medium was added to the cells. 
At indicated time points, cells were either fixed for immunolabeling, lysed to measure the amount 
of viral RNA by quantitative PCR, or frozen to determine the amount of infectious virus particles by 
titration analysis. 
Quantitative PCR. RNA was isolated from infected cells using a Nucleospin RNA kit (Machery-
Nagel). cDNA was synthesized using random hexamers as primers with a TaqMan reverse 
transcription reagents kit (Roche). The cDNA was used for quantitative PCR with the forward 
primer 5’-CGTGGGGCTACAATCAAGTT-3’, the reverse primer 5’-TAACAGGAGCTTTGGGCATC-3’, 
and the LightCycler 480 SYBR Green I master kit (Roche) for 45 cycles (5 s at 95°C, 10 s at 60°C, and 
20 s at 72°C) on a LightCycler 480 (Roche).
Western Blot analysis. Proteins were separated with 10% gradient PAGE using the Gradi-Gel™ 
gradient analysis kit (Elpis biotech). Samples were transferred to nitrocellulose membranes (Bio-
Rad). After cutting the membrane in two at the 15 kD band of the marker, one membrane (proteins 
larger than 15 kD) was incubated with primary antibodies against mouse monoclonal anti-β-actin 
(Sigma) and rabbit polyclonal anti-GFP described previously (44), which also recognizes GFP(S1-10). 
The membrane with proteins smaller than 15 kD was incubated with rabbit polyclonal anti-3A 
described previously (44). Secondary antibodies included IRDye 680-conjugated goat anti-mouse 
or IRDye 800-conjugated goat anti-rabbit (LI-COR). Images of blots were acquired with Odyssey 
Imaging System LI-COR.
Immunofluorescence microscopy. BGM or HeLa cells were grown to subconfluency on coverslips 
in 24-well plates. Where indicated, cells were transfected with 200 ng of plasmid DNA using 
Fugene6 according to the manufacturer’s protocol or infected with CVB3-3A(S11aa2) at an MOI of 
1-10. At 24 h p.t. or 5-6 h post-infection (p.i.), cells were fixed with 4% paraformaldehyde for 20 min 
at room temperature, followed by permeabilization with PBS-0.1% Triton X-100 for 10 min. Cells 
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2% normal goat serum. Cellular proteins were detected with primary antibodies against PI4KIIIB 
(Millipore), GBF1 (BD Biosciences), COP-I (provided by F. Wieland, Biochemie-Zentrum, Heidelberg, 
Germany). GFP(S1-10) was detected with a GFP antibody and CVB3 3A proteins with a 3A antibody, 
both described previously (44). Conjugated goat anti-rabbit and goat anti-mouse Alexa Fluor 488 
or Alexa Fluor 594 (Molecular Probes) were used as secondary antibodies. Nuclei were stained 
using DAPI. Coverslips were mounted with FluorSave (Calbiochem). Images were acquired with an 
Olympus BX60 fluorescence microscope with a 40x (0.75 NA) dry objective or a Leica SPE-II DMI-
4000 confocal laser scanning microscope equipped with a 100x (1.4 NA) oil immersion objective, 
and the confocal pinhole adjusted to 1 airy unit (AU).
Live-cell imaging. BGM(GFPS1-10) cells were seeded in glass-bottom 4-chamber 35-mm dishes 
(CELLviewTM) and grown to ~35% confluency before transduction with MLV mCherry-GM130 
particles. Infection with CVB3-3A(S11aa2) was carried out 18-24 hours later. Cells were washed with 
Fluorobrite medium (Thermo Fisher Scientific) supplemented with 8% fetal calf serum (FCS) and 
25 mM HEPES just prior to imaging. Imaging was performed with a Leica SP5 confocal microscope 
equipped with a HyD detector and a 63x (1.4 NA) oil immersion objective, and the confocal pinhole 
adjusted to 95.56 µm as standard, or 600 µm to approximate wide-field imaging. Cells were 
maintained in a live-cell imaging chamber at 37°C and 5% CO2. GFP and mCherry were excited 
using a 488 nm or 561 nm laser respectively and appropriate emission filters, and positions (xyz) 
were marked and imaged sequentially at 5 minute intervals. For the generation of movies, live-cell 
imaging data were processed in ImageJ and aligned using the StackReg plugin.
Correlative light electron microscopy. Asymmetrical guide marks were scratched into 
glass-bottom 8-well chamber µ-slides (Ibidi), upon which BGM(GFPS1-10) cells were grown to 
subconfluency and infected with CVB3-3A(S11aa2). Just prior to imaging, and to later aid in the 
correlation of fluorescent and EM images, cells were incubated with 100 nM Mitotracker® Deep 
Red FM for 30 minutes, then washed several times in Fluorobrite medium supplemented with 
8% FCS and 25 mM HEPES. Imaging was carried out from ~2 hours p.i. with a Leica SP8 confocal 
microscope equipped with a HyD detector, in a live-cell chamber at 37°C and 5% CO2 and using a 
63x (1.4 NA) oil immersion objective. For each position of interest, a low resolution tile-scan was 
taken of the surrounding area, including guide marks, to aid in later re-identification. Z-stacks 
were acquired using a 1 AU pinhole and Nyquist frequency sampling. Cells were then fixed with 4% 
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M Sørenson’s phosphate buffer (PB) and processed 
for electron microscopy. Post-fixation was carried out with 1% osmium tetroxide for 1 hour in PB 
then 1% tannic acid in PB for 30 minutes, after which cells were serially dehydrated in ethanol and 
infiltrated and embedded in LX 112 resin (Ladd Research Industries) before polymerisation at 60°C. 
Positions of interest imaged earlier were identified on the resin block surface through comparison 
with (horizontally flipped) tilescan images, appropriate block-faces were trimmed and serial thin 
sections cut and collected on copper slot grids covered with a carbon-coated formvar layer. After 
post-staining grids with lead citrate and uranyl acetate, image meshes spanning large areas of the 
grid were collected on an FEI Tecnai 20 FEG electron microscope operated at 120 kV with a 4k x4k 
pixel charge-couple device (CCD) camera (US4000, Gatan) with binning 2 and a final image pixel 
size of 1.94nm. These individual images were later combined into composite stitches (65). Cells of 
interest were digitally extracted from their raw image files using ImageJ and Aperio Imagescope 
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images were then overlaid using Adobe Photoshop CS6. The mitochondrial pattern in the EM 
images was compared with the Mitotracker® Deep Red FM signal to find the right transformations 
to correlate both types of data. While the discrepancy in the axial resolution of light and electron 
microscopes limited the precision of the overlay, the use of this secondary marker was critical to 
determine the z-plane in the confocal data the best fit the EM cell section under analysis and for 
xy orientation of both images, thus providing an independent marker for an unbiased localization 
of the 3A signal. 
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S U P P L E M E N TA L  F I G U R E S
Figure S1. Co-expression of 
3A(S11aa2) with GFP(S1-10) yields 
GFP fluorescence. A) Introduction 
of GFP(S11) into 3A does not alter its 
expression pattern. HeLa cells were 
transfected with plasmids encoding 
wild-type (wt) 3A (p3A-myc) or tagged 
3A (p3A(S11aa2)-myc). One day later, 
the 3A protein was stained with an 
antibody directed against 3A and a 
secondary Alexa594-labeled antibody. 
B) GFP fluorescence is only detected 
when GFP(S1-10) is co-expressed 
with 3A(S11aa2). BGM cells were co-
transfected with the plasmid encoding 
GFP(S1-10) (pGFP(S1-10)) and either 
p3A-myc or p3A(S11aa2)-myc. One day 
later, the 3A protein was stained with 
a primary antibody directed against 
3A and a secondary Alexa594-labeled 
antibody. A, B) Nuclei were stained with 
DAPI. Wide-field images were acquired 
with an Olympus BX60 fluorescence 
microscope. Scale bars equal 10 µm.
Figure S2. 3A(S11aa2) 
interacts with host factors 
GBF1 and ACBD3. A, B) A 
mammalian two-hybrid assay 
was used to determine the 
ability of 3A(S11aa2) to interact 
with the N-terminus of GBF1 
(A) or ACBD3 (B). This assay 
was conducted in the absence 
of GFP(S1-10) (left graphs) or 
in the presence of GFP(S1-10) 
(right graphs) using full-
length GFP as a transfection 
control. Bars represent the 
means of three samples 
± standard deviations. 
Significant differences were 
calculated over the highest 
control sample by a paired 
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Figure S3. Processing of the artificial 3CD 
cleavage site between a foreign protein and 
P1 is suboptimal. A) BGM cells were infected 
with different CVB3 and lysates were prepared 
at the indicated time points. Cell lysates were 
subjected to Western Blot analysis using 
antibodies against actin (loading control), 3A 
(infection control), or GFP that also recognizes 
GFP(S1-10). An aspecific band is indicated 
with an asterisk. BGM cells that stably express 
GFP(S1-10) showed a band at around 25 kD, 
which is in accordance with the somewhat 
smaller size than full-length GFP (27 kD). BGM 
cells infected with CVB3-GFP(S1-10)-3A(S11aa2) 
accumulated a clear band at around 60 kD, 
which corresponds to the precursor VP0 (36 
kD) fused to GFP(S1-10). Little, if any, GFP(S1-10) 
was detectable, indicating a defect in 
processing. We also examined CVB3-EGFP (27), 
which also is delayed in replication compared 
to wild-type CVB3, but not as severely as CVB3-
GFP(S1-10)-3A(S11aa2). In these samples, GFP is 
detected as a fusion protein to VP0 as well as 
an individual protein. Both results demonstrate 
that processing of the artificial 3CD cleavage 
site is suboptimal. Why cleavage of full-length 
GFP from VP0 appeared more efficient than 
for CVB3-GFP(S1-10)-3A(S11aa2) remains to be 
determined. Since GFP(S1-10) folds differently 
than full-length EGFP, this may affect 
processing of the cleavage site. Also, EGFP is 
followed by a longer linker sequence upstream 
of the cleavage site (ALFQG, indicated in bold) 
compared to GFP(S1-10) (shown in B) due to 




Movie S1. Golgi disruption and 3A accumulation monitored over the course of CVB3 infection. Cropped view 
showing Golgi fragmentation at higher resolution (images are of cell shown in Figure 8B) from ~2 to 7.5 hours post 
infection. Fragmentation can be observed from approximately 3.5 hours post infection, and complete disassembly 
occurs within 30 minutes as evidenced by the punctate GM130 signal. Scale bar equals 10 µm, frame rate is 4 fps. 
Images were collected at 5 minute intervals.
Movie S2. The split-GFP system allows 3A to be monitored over the full course of CVB3 infection. Overview of 
a typical field of view during live-cell experiments from ~5 to 10 hours post infection (shown first with green, red and 
brightfield channels, then repeated with green and red channels only). Several phases of infection can be observed, 
including the developing 3A-GFP signal and associated disruption of Golgi morphology, and the accumulation of ROs 
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S U M M A RY 
Enteroviruses reorganize cellular endomembranes into replication organelles (ROs) for genome 
replication. Although enterovirus replication depends on phosphatidylinositol 4-kinase type III 
beta (PI4KB), its role, and that of its product PI4P, is only partially understood. Exploiting a mutant 
coxsackievirus resistant to PI4KB inhibition, we uncover that PI4KB activity has distinct functions 
in proteolytic processing of the viral polyprotein and in RO biogenesis. The escape mutation 
rectified a proteolytic processing defect imposed by PI4KB inhibition, pointing to a possible escape 
mechanism. Remarkably, under PI4KB inhibition the mutant virus could replicate its genome in 
the absence of ROs, using instead the Golgi apparatus. This impaired RO biogenesis provided an 
opportunity to investigate the proposed role of ROs in shielding enteroviral RNA from cellular 
sensors. Neither accelerated sensing of viral RNA nor enhanced innate immune responses were 
observed. Together, our findings challenge the notion that ROs are indispensable for enterovirus 
genome replication and immune evasion.
I N T R O D U C T I O N
Positive-strand RNA (+RNA) viruses comprise many human pathogens, such as hepatitis C virus, Zika 
virus, dengue virus, SARS- and MERS-coronavirus, and enteroviruses. Despite substantial genetic 
divergence across virus families, some features of replication are common to all +RNA viruses 
infecting eukaryotes. One of the most striking is the remodelling of host cell endomembranes 
into novel membranous compartments in the cytoplasm of the infected cell. These compartments 
serve as compositionally unique platforms upon which the components of the viral RNA synthesis 
machinery assemble, and whose micro-environments may facilitate efficient genome replication 
(reviewed in (1) and (2)). In addition, they have been postulated to play a role in the evasion of the 
innate antiviral host responses by shielding viral RNA products from cytosolic sensors such as MDA5 
and RIG-I, which signal to activate the type I interferon (IFN-a/b) pathway, and protein kinase R 
(PKR), which activates an integral stress response (3, 4). 
Members of the Enterovirus genus, belonging to the Picornaviridae family, include poliovirus, 
coxsackie A and B viruses, several numbered enteroviruses (e.g. EV-D68, EV-A71), and rhinoviruses, 
which are causative agents of various human diseases. Enteroviruses, like other positive-sense RNA 
viruses, modify host-cell membranes to form structures with novel morphologies. These modified 
membranes serve as platforms for viral replication, which we will refer to as replication organelles 
(ROs). At earlier stages of coxsackievirus B3 (CVB3) or poliovirus (PV) infection, ROs emerge as 
single-membrane tubules that appear to form at the expense of the Golgi apparatus. These tubules 
are interspersed with double-membrane vesicles (DMVs), which are believed to arise as tubules 
deform and enwrap small volumes of cytosol. In this way, most tubules transform into DMVs over 
the course of infection, and DMVs may be further enwrapped to form multilamellar vesicles (5, 
6). Each stage of virus replication, including the transformation of cellular membranes into ROs, 
is dependent upon the interplay between viral proteins and host factors. The small, membrane-
anchored enterovirus 3A protein has a key role in generating ROs (7), and is known to recruit host 
factors that are essential for genome replication. One of these factors is phosphatidylinositol 
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phosphatidylinositol 4-phosphate (PI4P), while during enterovirus infection the viral 3A protein 
recruits PI4KB to ROs, enriching them in PI4P (8, 10). 
The importance of PI4P in viral infections has been the subject of several recent investigations, 
both for the Picornaviridae, such as Aichivirus (genus Kobuviruses) and encephalomyocarditis 
virus (EMCV) (genus Cardiovirus) and for other +RNA viruses, such as hepatitis C virus (HCV) 
(reviewed in (11) and (12)). In uninfected cells, PI4P is involved in a multitude of functions, including 
signalling, membrane trafficking, regulation of Golgi apparatus organisation, and lipid homeostasis 
(reviewed in (13) and (14)). Of particular relevance for viruses that utilise PI4P is the counterflux of 
PI4P and cholesterol between Golgi apparatus and ER, which is mediated by the oxysterol-binding 
protein (OSBP). OSBP acts as a bridge between these two membrane compartments to generate 
a membrane contact site, using PI4P as a Golgi-based anchor and vesicle-associated membrane 
protein-associated protein A (VAP-A) as an ER anchor (15). During enterovirus infection, OSBP is 
diverted to create a novel type of membrane contact site between ROs and the ER. These sites 
mediate the exchange of PI4P for cholesterol, which is another essential lipid for enterovirus 
genome replication (16-18). 
Recruitment of PI4KB by the viral 3A protein is critical for enterovirus genome replication (8, 9), but 
its exact role is unclear. The stage of genome replication in the enterovirus life cycle encompasses 
different processes, including proteolytic processing of the polyprotein, RO biogenesis, and RNA 
synthesis by the viral replication machinery. In this study, we used a CVB3 mutant resistant to PI4KB 
inhibition, i.e. CVB3 3A-H57Y (19), to further dissect the role of PI4KB and the PI4P-rich environment 
it generates during genome replication. We show that PI4KB activity facilitates efficient proteolytic 
processing of the CVB3 polyprotein. The 3A-H57Y substitution compensates for the impairment of 
polyprotein processing caused by PI4KB inhibition, which may represent the escape mechanism of 
this mutant virus. Distinct from its effect on polyprotein processing, we found that PI4KB inhibition 
also delayed RO formation. Remarkably, CVB3 3A-H57Y could replicate its genome in the absence 
of detectable ROs when PI4KB was inhibited. Under these conditions, viral RNA synthesis was 
observed instead at a cellular organelle, the Golgi apparatus, which challenges the notion that 
ROs are essential for the exponential phase of genome replication. Golgi disintegration and RO 
formation did eventually occur under PI4KB inhibition, which suggests that PI4KB activity is not 
fundamentally required for RO biogenesis, but expedites the process. The delay in RO formation 
under PI4KB inhibition was exploited to experimentally test the hypothesis that ROs shield viral RNA 
from cytoplasmic sensors of the innate immune system. Our results suggest that, in addition to 
being dispensable for viral RNA synthesis, enterovirus ROs do not play a pivotal role in suppression 
of the innate antiviral response pathways.
R E S U LT S
CVB3 3A-H57Y RO formation is impaired under PI4KB inhibition
First, we set out to study the morphology of the ROs induced by CVB3 3A-H57Y under conditions 
where PI4KB is not inhibited. Infected BGM cells were prepared for electron microscopy (EM) by 
high-pressure freezing and freeze-substitution at different times post-infection and analysed for 
the presence of membrane modifications. The first ROs induced by CVB3 3A-H57Y were detected 
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interspersed with double-membrane vesicles (DMVs) (Fig. 1A). The emergence of ROs coincides 
with disintegration of the Golgi apparatus in wt infection (5) and, concordantly, the Golgi apparatus 
was not observed in cell sections that contained ROs at any time point in this analysis. Later in 
infection tubules had largely transformed into DMVs (Fig. 1A, 6 hpi) and into multilamellar structures 
(Fig. 1A, 7 hpi). This progression closely reflects observations of wt CVB3 RO development with 
regard to both the specific morphologies induced and the time frame over which they develop 
(5), (Fig. S1A). Together, these results indicate that the 3A-H57Y substitution does not affect RO 
development or their general architecture.
Next, we investigated the effect of PI4KB inhibition on RO development during CVB3 3A-H57Y 
infection. To determine suitable time points for EM analysis of cells infected in the presence of a 
PI4KB inhibitor, we first measured viral replication in the presence of BF738735, a potent and specific 
PI4KB inhibitor without overt cytotoxicity (a.k.a. Compound 1; (9, 20)). Unlike CVB3 wt (Fig. S2A), 
CVB3 3A-H57Y was resistant to BF738735 (Fig. S2B), although its replication was nevertheless delayed 
and impaired in the presence of BF738735 with regard to both viral RNA (vRNA) and infectious 
Figure 1. CVB3 3A-H57Y RO formation is impaired under PI4KB inhibition. A, B) BGM cells infected with 
CVB3 3A-H57Y (MOI 50). A) Cells fixed for EM analysis at early (5 hpi), intermediate (6 hpi) or late (7 hpi) stages of 
infection show the progression in RO development. B) ROs were not observed in EM cell sections (up to 8 hpi, n = 
153) from cells treated with BF738735. (Left) An example of the Golgi apparatus in cells fixed at 7 hpi. (Right) Parallel 
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progeny virus. This is in agreement with observations using other PI4KB inhibitors (e.g. PIK93; (19)). 
To examine whether the impairment of replication upon PI4KB inhibition was the consequence of 
a decrease in the number of infected cells and/or a reduced level of vRNA replication, we collected 
cells infected with EGFP-CVB3 3A-H57Y at different time points post infection and analysed them 
with flow cytometry. PI4KB inhibition reduced the number of CVB3 3A-H57Y-infected cells (by ~3-
fold), delayed replication (by ~1-2 h), and limited viral protein production, as reflected by reduced 
EGFP levels (Fig. S2C). These results indicate that the PI4KB inhibitor imposes a critical barrier to 
CVB3 3A-H57Y replication in a subpopulation of cells, and reduces the efficiency of replication in 
those cells where infection is established. 
Based on the growth curve analysis, cells were fixed and processed for EM between 5 and 8 hpi, 
as this period encompasses the exponential phase of vRNA replication for CVB3 3A-H57Y under 
PI4KB inhibition. Remarkably, while ROs were detected at a frequency of ~50% in EM cell-sections 
from infections in the absence of PI4KB inhibitor (n = 43 cell-sections assessed at 6 hpi), neither 
archetypal enterovirus ROs (i.e. clusters of single-membrane tubules and/or DMVs) nor cellular 
membranes with atypical morphologies were detected in cells infected under PI4KB inhibition 
(n = 153 cell-sections), even at late time points (7-8 hpi, n = 47 cell-sections, example shown in 
Fig. 1B). Seemingly intact Golgi cisternae were apparent in these cells and were detected at a 
frequency similar to that of mock-infected or BF738735-treated cells (Fig. S1B and C respectively). 
Corresponding immunofluorescence microscopy data showed a high percentage of cells positive 
for dsRNA labelling, confirming that the lack of membrane modifications in the EM analysis was not 
simply due to a low number of infected cells (Fig. 1B, right). These data show that RO development 
is impaired by PI4KB inhibition, and suggest that replication may be taking place instead at a cellular 
organelle.
CVB3 3A-H57Y replicates its genome at the Golgi apparatus under PI4KB inhibition
As an initial indicator of the replication site under PI4KB inhibition, we performed 
immunofluorescence microscopy on infected cells (Fig. 2A). Cells were fixed at 5 hpi in the absence 
of inhibitor, and at 6 hpi in the presence of inhibitor given the delay in replication. Similar to findings 
for wt virus (8, 19), both 3A and dsRNA were detected throughout the cytoplasm in cells infected 
with CVB3 3A-H57Y in the absence of PI4KB inhibition (Fig. 2A, left panels). Golgi disassembly 
could be readily visualized through the signal reduction and dispersion of the cis-Golgi marker 
GM130 and the trans-Golgi network marker TGN46, whereas the PI4KB signal overlapped with the 
3A labelling. Upon PI4KB inhibitor treatment however, 3A and dsRNA were primarily confined to 
the perinuclear region (Fig. 2A, right panels). In wide-field images, the strength and distribution 
of GM130 and TGN46 signals were largely maintained and overlapped with the viral 3A signal. 
These results suggested that both the 3A-H57Y protein and dsRNA reside at the Golgi apparatus 
in the presence of inhibitor. To confirm that these observations were due to specific inhibition of 
PI4KB, the localisation of 3A-GFP was assessed using different PI4KB inhibitors. Similar to BF738735, 
enviroxime, GW5074 or PIK93 treatment resulted the accumulation of 3A specifically at the Golgi 
region, although confocal imaging revealed that 3A did not directly co-localise with the cis-Golgi 
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To unambiguously determine the subcellular location of the 3A-H57Y protein under PI4KB inhibitor 
treatment, correlative light and electron microscopy (CLEM) was performed. For this we employed 
the split-GFP system (21) to label the 3A-H57Y protein, in a similar approach to that previously 
reported for wt CVB3 (22). To produce a split-GFP CVB3 3A-H57Y mutant, the final beta sheet of GFP, 
i.e. strand 11, further referred to as GFP(S11), was introduced into the 3A-H57Y protein to produce 
CVB3 3A-H57Y(S11). Upon CVB3 3A-H57Y(S11) infection of BGM cells stably expressing the remaining 
portion of GFP (GFPS1-10), the two fragments of GFP self-assemble to produce GFP-tagged 3A-H57Y. 
GFP-tagged 3A-H57Y was then visualized by confocal microscopy before chemical fixation and 
processing for EM. Overlays of 3A-H57Y-GFP signal with the corresponding EM cell-sections fixed 
at 6 hpi revealed that the 3A protein localised specifically to the Golgi apparatus (Fig. 3A).
The presence of the 3A-H57Y protein at the Golgi apparatus suggested that vRNA replication occurs 
Figure 2.  The 3A protein localises to the Golgi apparatus under PI4KB inhibition. A, B) BGM cells infected with 
CVB3 3A-H57Y (MOI 10). Untreated cells were fixed at 5 hpi ((A) left panels) and drug treated cells were fixed at 6 hpi 
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at this compartment under PI4KB inhibition. To further investigate this, metabolic labelling was 
performed to detect newly synthesized vRNA in situ. Infected cells were pre-treated with 10 µg/ml 
dactinomycin to inhibit cellular transcription, and incubated with tritiated uridine for 45 minutes 
prior to fixation to label newly-synthesised vRNA. As a control, mock-infected cells underwent the 
same treatment. After processing for EM, radiolabelled uridine was detected by autoradiography 
(ARG). In cells infected with CVB3 3A-H57Y without PI4KB inhibition, abundant ARG signal was 
found in regions containing typical ROs (Fig. 3B). Although RO membranes in chemically fixed 
samples appeared somewhat distended in comparison to high-pressure frozen material (see Fig. 1), 
they were recognisable as clusters of single-membrane compartments (Fig. 3B, black arrowhead) 
Figure 3. Replication under PI4KB inhibition occurs at the Golgi apparatus. A) BGM(GFPS1-10) cells infected with 
CVB3 3A-H57Y(S11) (MOI 7) monitored by live-cell LM, fixed at 6 hpi, and processed for CLEM. Overlay of the 3A-GFP 
signal at the time of fixation with the corresponding EM image (left). Inset highlights one of two 3A-GFP foci present 
in the image shown, both of which correspond to Golgi membranes. B, C) BGM cells infected with CVB3 3A-H57Y (MOI 
50), metabolically labelled, fixed at 6 hpi (B) or 7 hpi (C), and processed for EM autoradiography to detect newly-
synthesized vRNA (ARG). ARG signal is apparent as electron-dense grains. B) ROs positive for ARG signal were readily 
observed in the absence of BF738735. C) In cells treated with BF738735 ROs were not observed, and clusters of ARG 
signal were found exclusively at the Golgi apparatus. cis = Golgi apparatus cis face, trans = Golgi apparatus trans face, 
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interspersed with DMVs (Fig. 3B, white arrowhead) that closely resemble the ROs observed in 
chemically fixed PV-infected (6, 23) or wt CVB3-infected cells (22). In CVB3 3A-H57Y-infected cells 
treated with PI4KB inhibitor and fixed at 7 hpi ROs were not observed (n = 148 cell sections), and 
abundant ARG signal was found at the Golgi apparatus (Fig. 3C), with the vast majority of signal 
localising to the trans-side of the Golgi apparatus and trans-Golgi network rather than the Golgi 
cisternae. This demonstrates that, under PI4KB inhibition, CVB3 3A-H57Y can replicate its genome 
Fig. 4. Golgi disintegration during CVB3 3A-H57Y infection is prolonged under PI4KB inhibition, and 
ultimately results in RO formation. BGM(GFPS1-10) cells transduced with MLV mCherry-GM130, infected with CVB3 
3A-H57Y(S11) (MOI 7) and imaged by live-cell confocal microscopy in the absence (A) or presence (B, D) of BF738735. 
Asterisks (A, B) denote completion of Golgi disintegration, evidenced by an entirely punctate mCherry-GM130 
signal. A) Initial 3A-GFP signal was detected primarily at peripheral locations (arrowhead) and Golgi disintegration 
was typically complete within 25 minutes of its onset (C, upper graph n = 23 cells). B) In cells treated with BF738735, 
initial 3A-GFP signal was detected primarily at the Golgi apparatus (arrowhead). The Golgi disintegration duration was 
typically prolonged but highly variable (C, lower graph n = 48 cells). D) Cells were fixed for EM analysis at 9 hpi. The 
LM-EM overlay reveals single-membrane (black arrowhead) and double-membrane (white arrowhead) structures 
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in the absence of ROs on a seemingly intact Golgi apparatus.
Under PI4KB inhibition, ROs form late in CVB3 3A-H57Y-infected cells
Our results thus far show that, under PI4KB inhibition, CVB3 3A-H57Y replication is possible in 
association with an apparently intact cellular organelle. We next set out to establish whether 
PI4KB inhibition precludes Golgi disintegration and RO development entirely, or simply delays the 
process. Confocal microscopy of live cells expressing mCherry-GM130 was performed to monitor 
the Golgi apparatus across the course of CVB3 3A-H57Y(S11) infection, either with or without 
BF738735 treatment (Fig. 4A-C). In the absence of inhibitor, the process of Golgi fragmentation 
following CVB3 3A-H57Y(S11) infection was similar to that of wt split-GFP CVB3 infections (22). 
The onset of Golgi fragmentation occurred in conjunction with or even preceded 3A protein 
accumulation in the Golgi area, and Golgi disintegration was typically complete within 25 min (n = 
23 cells) (Fig. 4A and C, upper graph). While in the absence of PI4KB inhibition early 3A signal was 
often located at peripheral foci (Fig. 4A arrowheads), under PI4KB inhibition the first 3A signal was 
often found in the Golgi region (Fig. 4B, arrowheads). Remarkably, the Golgi apparatus of most 
CVB3 3A-H57Y(S11) infected cells did disassemble during infections under PI4KB inhibition, but with 
markedly different dynamics. The onset of disintegration under these conditions did not coincide 
with 3A protein accumulation at the Golgi, but suffered a relative average delay of 30 minutes (n 
= 48 cells). Additionally, the time needed for Golgi disintegration was highly variable under PI4KB 
inhibition. In a minority of infected cells treated with BF738735 Golgi disassembly was as rapid 
as in untreated cells. However, in most cells the Golgi disintegration process was substantially 
prolonged (by up to 10 hours) under PI4KB inhibition (Fig. 4B and C, lower graph).
To determine whether Golgi disassembly under PI4KB inhibition was associated with the 
development of ROs, CLEM was performed on cells infected with split-GFP 3A-H57Y(S11) virus 
under BF738735 treatment and fixed at 9 hpi. While some cells retained seemingly intact Golgi 
membranes at this late stage in infection, in those cells lacking recognisable Golgi membranes 
the 3A-GFP signal was found at structures resembling typical early ROs (Fig. 4D, see Fig. 3A for 
comparison). As verified by immunofluorescence microscopy, PI4P did not accumulate in cells 
infected under PI4KB inhibition (Fig. S3), suggesting that the ROs that develop during CVB3 
3A-H57Y infection under PI4KB inhibition do so independently of high PI4P levels.
PI4KB activity drives rapid Golgi disassembly and RO formation
RO formation is likely associated with the amount of viral protein produced in the cell, which in 
turn depends upon vRNA replication levels. Therefore, rather than the absence of high PI4P levels, 
the delay in CVB3 3A-H57Y vRNA replication under PI4KB inhibition could be solely responsible 
for impeding RO formation. Previously it was shown that replication-independent expression of 
PV non-structural proteins results in membranous structures reminiscent of ROs produced upon 
infection (24). Here, we engineered a replication-independent CVB3 expression system, which 
produces high amounts of viral proteins in the absence of vRNA replication. Hence, the inhibition 
of vRNA replication caused by PI4KB inhibition will not result in a delay in viral protein production 
in this setup. The system utilizes a CVB3 cDNA placed under the control of the bacteriophage T7 
RNA polymerase, and is rendered replication-incompetent through modifications to the cloverleaf 
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CVB3 polymerase (25). The 3A-H57Y substitution was introduced into this replication-incompetent 
CVB3 cDNA. Transfection of the CVB3 3A-H57Y cDNA plasmid in HuH-7/T7 cells, which stably 
express the T7 RNA polymerase, resulted in the expression of individual viral proteins whose 
amounts were not affected by the addition of PI4KB inhibitor (Fig. S4). Immunofluorescence 
analysis of transfected cells showed that the first 3A signal could be detected as early as 3 h post 
transfection (hpt), but without significant effects on the Golgi apparatus. In the absence of PI4KB 
inhibitor, Golgi disintegration was observed from 4 hpt onwards, as evidenced by the change in 
GM130 signal in transfected cells (Fig. 5A, upper panels). Under PI4KB inhibition Golgi disintegration 
was delayed by ~1 h (Fig. 5A middle and lower panels). While Golgi disintegration in the replication-
independent system is more rapid than during infection (see Fig. 4), most likely because of the 
high protein expression levels generated with this system, these data nevertheless demonstrate 
that in cells with equal levels of viral proteins, PI4KB inhibition delays enterovirus-induced Golgi 
apparatus disassembly. To determine the contribution of the 3A-H57Y substitution to (delayed) 
Golgi disassembly, we examined whether the wt CVB3 cDNA could also induce Golgi disassembly 
under PI4KB inhibition in the replication-independent system. The results closely resembled 
those obtained for CVB3 3A-H57Y cDNA both with and without PI4KB inhibition (Fig. 5B). This 
demonstrates that the 3A-H57Y substitution does not affect Golgi disintegration. 
Altogether, these findings strongly suggest that enterovirus RO biogenesis is driven by PI4KB 
activity.
The 3A-H57Y substitution rectifies a proteolytic polyprotein processing impairment 
induced by PI4KB inhibition 
Another important step in the enterovirus replication cycle that relies on membranes is the 
proteolytic processing of the polyprotein by the viral proteases (26). Proteolytic polyprotein 
processing is a co- and post-translational event mediated by the viral proteinases 2Apro, 3Cpro, and 
3CDpro. These proteinases catalyse a cascade of cleavages in cis and in trans that liberate individual 
capsid proteins, as well as replication proteins and their precursors (e.g. 2BC, 3AB and 3CD). Recent 
studies indicate that alterations to the lipid composition of membranes during PV infection impact 
polyprotein processing efficiency (27-29). Given that wt virus replication is abolished under PI4KB 
inhibition, we used the replication-independent CVB3 expression system to study the effects of 
PI4KB inhibition on polyprotein processing. Cells were lysed at 16 hours post transfection (hpt) and 
processed for Western blot analysis. PI4KB inhibition led to a relative accumulation of 3AB and a 
reduction in 3A for the wt polyprotein (Fig 5C, left). Remarkably, the 3A-H57Y substitution rectified 
this impaired polyprotein processing, as the relative levels of 3AB and 3A were not affected by PI4KB 
inhibition (Fig. 5C, right). PI4KB inhibition did not affect levels of 3CD or 3D. Together, these results 
demonstrate that PI4KB activity is important for proteolytic processing at the 3A-3B junction, but 
not at the 3C-3D junction (nor at the 2C-3A and 3B-3C junctions). The 3A-H57Y substitution restores 
processing to the level detected in the absence of inhibitor, which may point to a potential strategy 
of the mutant virus to escape PI4KB inhibition. 
The delay in RO formation under PI4KB inhibition does not elicit a strong antiviral response
One of the proposed advantages of ROs is that they may shield vRNA products against viral RNA 
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Figure 5. Effect of PI4KB inhibition on enterovirus-induced Golgi disintegration and proteolytic polyprotein 
processing in a replication-independent CVB3 system. HuH-7/T7 cells transfected with CVB3 3A-H57Y or wt 
CVB3 cDNA under the control of a T7 promoter, both rendered replication-incompetent by altering the 5’UTR 
of the genome. Where indicated, cells were treated with BF738735. A, B) Cells fixed at 4 h or 5 h post-transfection 
and labelled for 3A (green) and GM130 (red) alongside a nuclear stain (blue). Representative 3A-positive cells are 
indicated (arrowheads). Scale bars, 20 µm. C) Western blot analysis of lysates from cells at 16 h post-transfection using 
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Fig. 6. Innate antiviral responses during CVB3 3A-H57Y infection. Cells infected and treated with BF738735 where 
indicated. A) HeLa cells infected with CVB3 3A-H57Y (MOI 50) were lysed for Western blot analysis at the indicated time 
points. Band sizes (in kDa), full-length proteins (arrows), and putative cleavage products (arrowheads) are indicated. 
B) HeLa cells infected with CVB3 wt or CVB3 3A-H57Y (MOI 10). Total RNA was isolated from cells and subjected to 
reverse transcription-quantitative PCR for interferon-b (IFN-b). Mengo Zn, whose L protein contains substitutions 
that render it unable to suppress IFN-b induction, was included as a positive control (left graph). Viral RNA levels were 
determined by quantitative RT-PCR (right graph). Data were normalized to actin mRNA levels. Results are expressed 
as fold induction relative to quantities in mock-infected cells. Two independent experiments are shown, ranging 
from 2-8 hpi and 8-12 hpi. C, D) Cells were infected with CVB3-Rluc 3A-H57Y (MOI 0.01) and lysed to determine the 
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able to replicate its genome at the Golgi apparatus under PI4KB inhibition, vRNA products may 
be more accessible and better detected in this situation, thereby triggering an antiviral response 
that might limit or delay replication. To investigate whether viral dsRNA is better sensed under 
PI4KB inhibition, we studied the activation status of the cytoplasmic RNA sensor PKR. Western blot 
analyses were performed on infected cell lysates to assess viral protein levels in parallel with dsRNA-
activated, phosphorylated PKR (p-PKR). The first appearance and the final levels of viral proteins 
were delayed and reduced respectively under PI4KB inhibition, which is in agreement with the 
observed reduction in the proportion of infected cells and the decrease in viral protein per cell (see 
Fig. S2C). Nevertheless, p-PKR emerged concomitantly with the accumulation of viral proteins both 
in the presence and absence of PI4KB inhibitor (Fig. 6A), suggesting that delayed RO formation 
under PI4KB inhibition does not lead to premature activation of PKR.
Another innate antiviral response that is activated upon sensing of vRNA products is the type I 
interferon (IFN-a/b) pathway. Enteroviruses counteract the transcription of IFN-a/b genes by 
cleaving components in the signalling pathways that control their activation, such as MDA5 (30) 
and its downstream adaptor MAVS (30, 31). The altered location of genome replication under PI4KB 
inhibition may influence the ability of the viral proteinases to cleave these components. However, 
we found that the appearance of MAVS degradation products in infected cell lysates coincided 
with the accumulation of viral proteins irrespective of the presence of PI4KB inhibitor (Fig. 6A). 
Furthermore, qPCR analysis showed that no substantial IFN-b response was triggered in infected 
cells in both conditions (Fig. 6B). Together, these results indicate that the delayed formation of ROs 
during infection does not accelerate cellular sensing of viral dsRNA, nor does it affect the ability of 
the viral proteinases to cleave MAVS.
As a complementary approach to investigate whether the delay in replication in the presence 
of PI4KB inhibitor is related to activation of innate antiviral responses, the level of CVB3 3A-H57Y 
replication was determined in cells lacking sensors of these pathways. Knock-out cells for PKR 
or MAVS, generated with CRISPR-Cas9 technology, were infected with CVB3 wt or 3A-H57Y that 
also encode Renilla luciferase as a sensitive measure to quantify the level of viral replication. In the 
absence of inhibitor, CVB3 3A-H57Y replicated to a similar extent in HeLa, HeLa PKR -/-, or HeLa 
MAVS-/- cells (Fig. 6C and S6). In the presence of PI4KB inhibitor, CVB3 3A-H57Y replication was 
delayed not only in HeLa cells, but also in PKR-/- or MAVS-/- cells. Thus, replication under PI4KB 
inhibition was not significantly increased in PKR-/- or MAVS-/- cells compared to parental HeLa 
cells. Similar results were obtained in U2OS cells, another human cell line (Fig. S5A and S6). 
An alternative strategy employed by some eukaryotes, such as plants, worms, and insects, in 
response to viral infections is RNA interference (RNAi), although whether RNAi is an antiviral 
mechanism in mammalian cells remains controversial (32). In the RNAi pathway, the cytoplasmic 
sensor Dicer cleaves viral dsRNA into viral siRNAs, which are loaded by Argonaute-2 (AGO2) into 
the RNA-induced silencing complex (RISC) in order to degrade vRNA (33). Recently, it was reported 
that replication of the picornavirus EMCV was enhanced in mammalian somatic cells that lacked 
AGO2 (34). To investigate whether the delay in CVB3 3A-H57Y replication in the presence of PI4KB 
inhibitor is due to triggering of antiviral RNAi, we studied its replication kinetics in HeLa and 
HEK293T cells that lacked AGO2. Similar to our findings in MAVS and PKR knockout cell lines, the 
delay in replication under PI4KB inhibition was not alleviated in cells lacking AGO2 (Fig. 6D, S5B). 
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is not caused by premature triggering of innate antiviral responses as result of impaired RO 
biogenesis.
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E X P E R I M E N TA L  P RO C E D U R E S
Replication-independent system. HuH-7/T7 cells were seeded in 24-well plates containing 
glass coverslips. The next day, the cells were lipofectamine transfected with CVB3 cDNA rendered 
replication-deficient through modifications to the cloverleaf structure in the 5’ untranslated region 
(UTR) of the viral genome (25). One hour later, the medium was replaced with fresh medium. At 
indicated hours post-transfection, cells were washed and either fixed for immunofluorescence or 
lysed for Western Blot analysis. 
Live cell imaging. BGM(GFPS1-10) cells were grown in glass-bottom 4-chamber 35-mm dishes 
(CELLviewTM) to ~35% confluency and transduced with MLV mCherry-GM130 particles described 
before (see (22)). Infection with CVB3 3A-H57Y(S11) was carried out 18-24 hours later. Prior to 
imaging cells were washed with Fluorobrite medium (Thermo Fisher Scientific) supplemented with 
8% fetal calf serum (FCS) and 25 mM HEPES. Cells were maintained in a live-cell imaging chamber 
at 37°C and 5% CO2. Imaging was carried out from ~2.5 (hpi) using a Leica SP5 confocal microscope. 
Positions of interest (xyz) were marked and imaged sequentially at 5 minute intervals.
High-pressure freezing and freeze substitution. BGM cells were grown on sapphire discs and 
infected with CVB3 or CVB3 3A-H57Y and refreshed at 1 hpi with medium supplemented with 25 
mM HEPES buffer with or without 1 µm BF738735. Cells were high-pressure frozen using a Leica EM 
PACT2 at different time points post infection. The instruments and procedures used for freeze-
substitution, epoxy resin infiltration and polymerisation were identical to those described in (5). 
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acetate and lead citrate. 
Correlative light and electron microscopy (CLEM) preparation. BGM (GFPS1-10) cells were 
cultured in gridded 8-well chamber µ-slides (Ibidi) ahead of infection with CVB3 3A-H57Y(S11). Just 
prior to imaging cells were treated with 100 nM Mitotracker® Deep Red FM for 30 minutes. Live-
cell imaging was carried out to monitor the levels of 3A-H57Y-GFP. High resolution (1024x1024) 
z-stacks were collected of cells of interest just prior to fixation. To aid in the relocation of these 
cells for CLEM, tile scan overviews were taken and the positions of cells relative to nearby grid co-
ordinates were recorded. Following imaging by live-cell light microscopy (LM), cells were prepared 
for electron microscopy as described previously (see (22)). EM images were collected of cells 
previously identified by LM. The EM and LM data for each cell were overlaid using the Mitotracker® 
Deep Red FM signal (LM images) and corresponding mitochondria (EM images) as a guide for 
image transformation.
Metabolic labelling and autoradiography. A subconfluent layer of BGM cells was grown in 35 
mm dishes (Corning) and infected with CVB3 or CVB3 3A-H57Y at MOI 5. Cells were incubated 
with dactinomycin for 1 hour prior to a 45-minute labelling with tritiated uridine ([5-3H], 1 mCi/ml) 
(Perkin Elmer). Cells were processed for EM as described in (22). Sections of 50 nm were collected 
and post stained with lead citrate and uranyl acetate, then prepared for autoradiography (as 
described in (51)). 
Electron microscopy. Images were collected on an FEI Tecnai12 BioTWIN or TWIN electron 
microscope at 120 kV using an Eagle 4k slow-scan CCD camera (FEI) or OneView 4k high frame-rate 
camera (Gatan) respectively. For the collection of larger EM datasets, meshes of overlapping areas 
across the grid were taken that were later stitched into a single composite image (as described in 
(52)).
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S U P P L E M E N TA L  E X P E R I M E N TA L  P RO C E D U R E S
Cells. BGM, BGM(GFPS1-10) stably expressing GFP(S1-10) (described in (1)), HeLa R19, HEK293T, 
U2OS, and HuH-7-Lunet T7-BLR (HuH-7/T7) cells, and a cell pool stably expressing T7 RNA 
polymerase and blasticidin S-deaminase generously provided by R. Bartenschlager (University of 
Heidelberg, Heidelberg, Germany) ((2)), were maintained in Dulbecco’s modified Eagle’s medium 
(Gibco) supplemented with 10% fetal calf serum, penicillin, and streptomycin, and grown at 37°C 
in 5% CO2. The culture medium for HuH-77/T7 cells contained 10 µg/ml blasticidine, while that of 
BGM(GFPS1-10) cells contained 30 µg/ml puromycin. 
Knock-out cells. HeLa PKR-/- cells have been described before (see (3)). U2OS PKR-/- were 
generated using the pCRISPR-hCas9-2xgRNA-Puro plasmid ((4)) with the same gRNAs as 
used for the HeLa PKR-/- cells, which target the kinase domain of PKR. To target human Ago2, 
gRNA encoding oligonucleotides cassettes (gRNA1: 5’-ACCGACCGCGTCTGCAATGTGACC-3’ 
and 5’-AACGGTCACATTGCAGACGCGGTC-3’, gRNA2: 5’-ACCGCCCATGTTTACAAGTCGGAC-3’ 
and 5’-AACGTCCGACTTGTAAACATGGGC-3’) were cloned into the SapI restriction sites of the 
pCRISPR-hCas9-2xgRNA-Puro plasmid. HEK293T Ago2-/- cells were kindly provided by K.W. 
Mulder (Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands) and have 
been described previously (see (5)). To generate HeLa MAVS-/- and U2OS MAVS-/-, cells were co-
transfected with two plasmids containing gRNA1 5’- GAATACCCTTCAGCGGCGGCC-3’ and gRNA2 
5’-GCTGTGAGCTAGTTGATCTCG-3’. Single-cell clones were generated using end-point dilutions. 
The knock-out was verified by sequence analysis of the genomic DNA and by Western Blot analysis 
(Fig. S7; HeLa Ago2-/- will be shown elsewhere by RPvR). 
Viruses. Coxsackievirus B3 (CVB3) WT was obtained by transfecting in vitro-transcribed RNA 
derived from the p53CB3/T7 plasmid, which contains the cDNA of CVB3 strain Nancy driven by a T7 
RNA polymerase promoter. The 3A-H57Y substitution was introduced in the cDNA clones of CVB3, 
Rluc-CVB3 and EGFP-CVB3 encoding Renilla luciferase or EGFP upstream of P1 ((6)), or the split-GFP-
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point titration analysis and expressed as 50% cell culture infectious dose (CCID50). A Mengovirus 
which lost its IFN-suppressing activities due to substitutions in the Zn-finger domain of the leader 
protein (Mengo Zn) has been described previously (see (7)). Virus titers were determined by end-
point titration analysis and expressed as 50% cell culture infectious dose (CCID50).
Reagents. BF738735 (2-fluoro-4-(2-methyl-8-(3-(methylsulfonyl)benzylamino)imidazo[1,2-a]
pyrazin-3-yl)phenol) ((8), (9)) was provided by Galapagos NV, used at a working concentration 
of 1 µM and added in all the experiments 1 hour after infection or mock-infection. Guanidine 
Hydrochloride (GuHCl) and GW5074 were  purchased from Sigma and used at a working 
concentration of 30 µM and 2 mM respectively. Enviroxime has been previously described ((10)) 
and used at a concentration of 0.5 µg/ml (1.4 µM). PIK93 was provided by Dr K Shokat (University of 
California San Francisco, San Francisco, California, USA) and used at a concentration of 1 µM.
Antibodies. The rabbit antiserum and the mouse monoclonal antibody directed against the non-
structural protein 3A were described previously (see (11), (12)). Rabbit antiserum against CVB3 3D 
was generously provided by C.E. Cameron (Pennsylvania State University, USA). Primary mouse 
monoclonal antibodies included anti-β-actin (Sigma Aldrich), anti-GM130 (BD Biosciences), anti-
dsRNA J2 (English & Scientific Consulting), and anti-PKR (Santa-Cruz). Primary rabbit polyclonal 
antibodies included anti-PI4KB (Millipore), anti-TGN46 (Novus Biologicals), anti-phospho-PKR 
(Abcam), and anti-MAVS (Cardif, Enzo Life Sciences). Alexa Fluor 594-conjugated goat-anti-
rabbit IgG and Alexa Fluor 488-conjugated goat-anti-mouse IgG (Molecular Probes) were used as 
secondary antibodies for immunofluorescence microscopy. For Western Blot analysis, secondary 
antibody detection included IRDye goat anti-mouse or goat anti-rabbit (LI-COR).
Quantitative PCR. RNA was isolated from infected cells using a Nucleospin RNA kit (Machery-
Nagel). cDNA was synthesized using random hexamers as primers with a TaqMan reverse 
transcription reagents kit (Roche). The cDNA was used for quantitative PCR with the forward 
primer 5’-CGTGGGGCTACAATCAAGTT-3’, the reverse primer 5’-TAACAGGAGCTTTGGGCATC-3’, 
and the LightCycler 480 SYBR Green I master kit (Roche) for 45 cycles (5 s at 95°C, 10 s at 60°C, and 
20 s at 72°C) on a LightCycler 480 (Roche). Obtained Ct values were expressed as fold increase with 
the value at t = 2 h set as 1.
Flow cytometry. BGM cells were seeded in 24-well plates and infected with EGFP-CVB3 3A-H57Y 
the next day at different MOIs. Cells were released using trypsin, washed once in phosphate 
buffered saline (PBS), and fixed with 1% paraformaldehyde (PFA) in PBS. Cells were analyzed on 
FACS Canto (BD) using BD FACS Diva software.
Western Blot analysis. Virus-infected cells were collected in lysis buffer (50 mM TrisHCl pH 7.4, 150 
mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.05% SDS) and heated for 5 min at 95°C after addition of 
Laemmli sample buffer. Samples were run on polyacrylamide gels and transferred to a nitrocellulose 
membrane (Bio-Rad), which following blocking was incubated with primary antibodies overnight 
at 4˚C and secondary antibodies for 1 h at room temperature. Images of blots were acquired with 
Odyssey Imaging System (LI-COR).
Immunofluorescence microscopy. BGM cells grown on coverslips were infected with CVB3 WT 
or CVB3 3A-H57Y for 30-60 minutes, after which the inoculum was removed and fresh medium 
was added. At indicated time points post-infection, cells were fixed with paraformaldehyde 
and permeabilized with PBS containing 0.1% Triton X-100. Cells were then stained with primary 
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performed using either an Olympus BX60 or Leica DM5500 fluorescent microscope, and confocal 
imaging was performed with a Leica SpeII confocal microscope.
Replication-independent system. HuH-7/T7 cells were seeded in 24-well plates containing 
glass coverslips. The next day, the cells were transfected with cDNA of CVB3 rendered replication-
deficient through modifications to the cloverleaf structure in the 5’ untranslated region (UTR) 
of the viral genome ((4)) using Lipofectamine 2000 (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. One hour later, the medium was replaced with fresh medium. At indicated 
hours post-transfection, cells were washed and either fixed for immunofluorescence or lysed for 
Western Blot analysis.
Live cell imaging. BGM(GFPS1-10) cells were grown in glass-bottom 4-chamber 35-mm dishes 
(CELLviewTM) to ~35% confluency and transduced with MLV mCherry-GM130 particles described 
before ((1)). Infection with CVB3 3A-H57Y(S11) was carried out 18-24 hours later. In samples to be 
studied under PI4KB inhibition, infections were maintained in medium containing 1 µm BF735738 
from 1 hpi and for the duration of imaging. Prior to imaging cells were washed with Fluorobrite 
medium (Thermo Fisher Scientific) supplemented with 8% fetal calf serum (FCS) and 25 mM HEPES. 
Imaging was carried out from ~2.5 (hpi) using a Leica SP5 confocal microscope equipped with a HyD 
detector and a 63x (1.4 NA) oil immersion objective, with the confocal pinhole adjusted to 1 airy unit 
for GFP emission (95.56 µm pinhole). Cells were maintained in a live-cell imaging chamber at 37°C 
and 5% CO2. Positions of interest (xyz) were marked and imaged sequentially at 5 minute intervals. 
Live-cell imaging data were processed in ImageJ and aligned using the StackReg plugin.
High-pressure freezing and freeze substitution. BGM cells were grown on sapphire discs and 
infected with CVB3 or CVB3 3A-H57Y and refreshed at 1 hpi with medium supplemented with 25 mM 
HEPES buffer. Cells were high-pressure frozen using a Leica EM PACT2 at different time points post 
infection. The instruments and procedures used for freeze-substitution, epoxy resin infiltration 
and polymerisation were identical to those described in (13). Briefly, samples were maintained in 
a Leica AFS2 at -90°C for 44h in a freeze substitution medium containing 10% H20, 2% osmium 
tetroxide and 1% anhydrous glutaraldehyde. The temperature was then raised to 0°C over a period 
of 22 hours through a series of controlled warming phases. Samples were washed with acetone, 
infiltrated with epoxy resin LX-112 (Ladd Research) and polymerised at 60°C. Sections of 70 nm were 
then prepared for electron microscopy and post-stained with uranyl acetate and lead citrate. 
Correlative light and electron microscopy (CLEM). BGM(GFPS1-10) cells were cultured in 
gridded 8-well chamber µ-slides (Ibidi) ahead of infection with CVB3 3A-H57Y(S11). Cells were 
maintained in 1 µm BF735738 from 1 hpi in all incubation steps and for the duration of imaging. Just 
prior to imaging cells were treated with 100 nM Mitotracker® Deep Red FM for 30 minutes, then 
washed several times in Fluorobrite medium supplemented with 8% FCS and 25 mM HEPES. Images 
were collected using a Leica SP8 confocal microscope equipped with a HyD detector and using 
a 63x (1.4 NA) oil immersion objective, while cells were maintained in a live-cell chamber at 37°C 
and 5% CO2. High resolution (1024x1024) z-stacks were collected of cells of interest. To aid in the 
relocation of these cells for CLEM, tile scan ((14)) overviews were taken and the positions of cells 
relative to nearby grid co-ordinates were recorded. Following imaging by live-cell light microscopy 
(LM), cells were prepared for electron microscopy as described in (1). EM images were collected 
of cells previously identified by LM. To assess the correlation the EM and LM data for each cell 
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corresponding mitochondria (EM images) as a guide for image transformation.
Metabolic labelling and autoradiography. Subconfluent layers of BGM cells were grown in 35 
mm dishes (Corning) and infected with CVB3 3A-H57Y at MOI 5 for 1 hour, after which time the 
incubation medium was replaced with fresh culture medium. Cells were incubated with 10 µg/
ml dactinomycin for 1 hour prior to a 45-minute labelling with tritiated uridine ([5-3H], 1 mCi/ml) 
(Perkin Elmer), after which cells were washed several times to remove unincorporated label and 
fixed for 1 hour in 1.5% glutaraldehyde in 0.1M cacodylate buffer.. Control samples consisting of 
uninfected BGM cells pre-treated with dactinomycin and incubated with tritiated uridine were 
also prepared. Cells were then post-fixed with 1% osmium tetroxide for 1 hour in 0.1M cacodylate 
buffer followed by a 30 minute incubation with 1% tannic acid in 0.1M cacodylate buffer, after which 
they were dehydrated in ethanol and infiltrated and embedded in LX 112 resin (Ladd Research 
Industries) before polymerisation at 60°C. Sections of 50 nm were collected on formvar-coated 
EM grids and post stained with lead citrate and uranyl acetate, then prepared for autoradiography. 
For the addition of the layer of photographic emulsion (ILFORD L4), grids were first attached to 
microscope slides by gently pressing the grid edge against a line of double sided sticky tape applied 
down the length of the slide, taking care to avoid contact between the tape and the formvar layer. A 
layer of carbon (~12 nm thick) was then evaporated onto the grids to prevent any direct interaction 
between the stained epon sections and photographic emulsion, which was subsequently placed on 
the grids with the help of a wire loop. Samples were developed for autoradiography as described 
in (15).
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S U P P L E M E N TA L  F I G U R E S
 
Figure S1. The morphologies of WT CVB3 and CVB3 3A-H57Y ROs in BGM cells are indistinguishable.  BF738735 
treatment  does not affect Golgi apparatus architecture. A) BGM cells infected with WT CVB3 and prepared for EM 
by HPF-FS reveal typical enterovirus ROs, including single-membrane tubules, DMVs and multilamellar vesicles (left 
to right). B, C). BGM cells either untreated (B) or treated with BF738735 for 7 hours (C) were fixed for EM analysis. 
Representative images are shown illustrating that the morphology of the Golgi apparatus was unaffected by 
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Figure S2. Replication kinetics of CVB3 3A-H57Y differ in the presence or absence of PI4KB inhibitor. A, B) 
Growth curve analysis. BGM cells were infected with CVB3 WT (A) or CVB3 3A-H57Y (B) and treated with compounds 
where specified. At the indicated time points, cells were either lysed to determine the intracellular level of viral 
RNA with quantitative RT-PCR (left graphs), or frozen to titrate the total amount of infectious virus produced (right 
graphs). Results are expressed as fold increase relative to the quantities at 2 hpi. C) Flow cytometry analysis. BGM cells 
were infected with EGFP-CVB3 3A-H57Y at different MOIs in the presence or absence of BF738735. At the indicated 
time points, cells were collected and fixed for flow cytometry analysis to determine the percentage of EGFP-positive 
cells (left graph) and the mean fluorescence intensity of the EGFP-positive cells (right graph) as an indicator of the 
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Figure S3. PI4P accumulation 
is not detected in cells 
infected with CVB3 3A-H57Y 
in the presence of PI4KB 
inhibitor. BGM cells were 
infected with CVB3 3A-H57Y 
at MOI 10 and treated with 
BF738735 where indicated. At 
the specified time points, cells 
were fixed and labelled with 
antibodies against 3A (green) 
or PI4P (red) alongside a nuclear 
stain (blue). Confocal images 
were acquired with a Leica 
SpeII confocal microscope. 
Without inhibitor, the level of 
PI4P signal was considerably 
elevated (saturated relative to 
background) in infected cells. 
In the presence of inhibitor no 
increase in PI4P was detected in 
infected cells, even at late time 
points (9 hpi). Scale bars, 10 µm
Figure S4. Viral protein production by the replication-independent expression system is not affected by 
PI4KB inhibition. HuH-7/T7 cells were mock-transfected or transfected with CVB3 3A-H57Y cDNA, which is under 
the control of a T7 promoter sequence and rendered replication-incompetent by altering the 5’UTR of the genome. 
cDNA used in (A) additionally encoded Renilla luciferase upstream of the P1 region as a sensitive measure for viral 
protein production. Cells were treated with BF738735 where indicated. A) At 6 h post transfection, cells were lysed 
to determine the intracellular luciferase amount. Guanidine Hydrochloride (GuHCl) (2 mM) was used as a positive 
control for protein production independent of viral RNA synthesis. Values represent mean values of triplicates ± 
standard error of the means. B) At 7 h post-transfection, cells were lysed and subjected to Western Blot analysis using 
an antibody against 3D. A lysate of CVB3-infected cells was used as a positive control. Marker bands of the indicated 
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Figure S5. Innate 
antiviral responses 
during CVB3 3A-H57Y 
infection. U2OS or 
HEK293T cells (KO 
for PKR, MAVS and 
AGO where indicated) 
were infected with 
CVB3-Rluc 3A-H57Y at 
MOI 0.01. Following 
infection, the inoculum 
was removed and 
fresh medium with 
or without BF738735 
inhibitor was added 
to the cells. Cells were 
lysed to determine the 
intracellular amounts 
of luciferase as a 
measure of genome 
replication. Values 
represent mean values 
of triplicates ± standard 
error of the means.
Figure S6. Generation of 
MAVS-/- and PKR-/- cells 
using the CRISPR-Cas9 
system.
Single-cell clones of 
HeLa or U2OS cells were 
characterized by isolation 
of genomic DNA and PCR 
with gene-specific primers 
for PKR or MAVS, followed 
by sequence analysis (upper 
panels). All alleles contain a 
deletion resulting in a frame-
shift event and a premature 
stop codon. The knock-out 
was confirmed by Western 
blot analysis of cell lysates 
(lower panels; marker bands 
of the indicated size in kDa 
are indicated on the left). 
U2OS MAVS-/- cells were 
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S U M M A RY
Enterovirus genome replication occurs at virus-induced structures derived from cellular 
membranes and lipids. However, the origin of these replication organelles (ROs) remains shrouded 
in uncertainty. Direct ultrastructural evidence of the membrane donor is lacking, suggesting that 
the sites of its transition into ROs are rare or fleeting. To overcome this challenge, we combined live-
cell imaging and serial block-face scanning electron microscopy of whole cells to capture emerging 
enterovirus ROs. The first foci of fluorescently-labelled viral protein correlated with ROs connected 
to the endoplasmic reticulum (ER) and preceded the appearance of ROs stemming from the trans-
Golgi network. Whole-cell datasets further revealed striking contact regions between ROs and lipid 
droplets that may represent a route for lipid shuttling to facilitate RO proliferation and genome 
replication. Our data provide direct evidence that enteroviruses use ER then Golgi membranes 
to initiate RO formation, demonstrating the remarkable flexibility with which enteroviruses usurp 
cellular organelles.
I N T R O D U C T I O N
The production of novel membrane structures is an intriguing and highly conserved feature of 
positive-sense RNA (+RNA) virus infections. These modified host-cell membranes are increasingly 
referred to as viral replication organelles (ROs); distinct membrane structures that have been 
suggested to serve as platforms for viral RNA synthesis, by co-ordinating different stages of the 
viral replicative cycle and/or shielding viral products from innate immune sensors (1-3).
While the formation of ROs during infection is a hallmark of +RNA virus replication, the specific 
morphologies produced vary by virus. Some viruses (e.g. dengue virus (4) and Zika virus (5)) 
produce membrane invaginations, or ‘spherules’, in the membranes of cellular organelles. Other 
viruses (e.g. hepatitis C virus (6) and SARS coronavirus (7)) produce double-membrane vesicles 
(DMVs), which can be found in isolation or with outer-membrane connections to the endoplasmic 
reticulum (ER), from which they are derived. Identifying the cellular donor organelle for +RNA 
virus ROs provides important clues about the host factor requirements underlying viral replication. 
However, determining the donor is problematic when ultrastructural analyses fail to capture direct 
connections between cellular organelles and ROs. This is the case for the enteroviruses, a large genus 
of the Picornavirus family that includes important human pathogens like poliovirus, coxsackie-A 
and -B viruses, several numbered enteroviruses (e.g. EV-71 and EV-D68), and rhinoviruses. 
Enterovirus ROs represent a compositionally and morphologically unique structure in the cells 
they infect. Their proliferation and utility as replication membranes are dependent on lipids 
like cholesterol and phosphatidylcholine, which are recruited to ROs via co-opted cellular lipid 
transport mechanisms, and whose levels are sustained by upregulated import, the lipolysis of lipid 
droplets (LDs) and lipid biosynthesis (8-11). During the earlier stages of infection, enteroviruses 
produce ROs with a single-membrane tubule (SMT) morphology, which transform into double-
membrane vesicles (DMVs) and multi-lamellar vesicles as infection progresses (12, 13). These 
membrane morphologies parallel those found in cells infected with cardioviruses, another 
genus of Picornaviridae. Ultrastructural studies suggest that cardiovirus ROs are ER-derived, as 
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For enteroviruses, however, ROs have thus far been observed only as separate compartments that 
lack direct connections to any cellular organelle. 
Establishing the cellular donor organelle for enterovirus RO formation by other means has proven 
challenging, as different studies and experimental approaches support different candidates (15). 
One of these candidates is the Golgi apparatus, which appears to be a suitable platform for early viral 
RNA (vRNA) synthesis. Under conditions where RO formation is arrested, sustained replication of a 
mutant enterovirus takes place at trans-Golgi membranes with a typical morphology (16). This aligns 
with fluorescence in-situ hybridisation studies of wt enterovirus infection, which have revealed 
colocalisation between a Golgi/trans-Golgi marker and early vRNA (17). In contrast, another study 
monitoring RNA incorporation found newly synthesised vRNA proximal to ER membranes early in 
infection (18), with no apparent involvement of the Golgi apparatus. Furthermore, co-localisation 
studies in cells, and biochemical analyses of isolated enterovirus-induced membrane structures, 
have revealed associations between putative ROs and numerous Golgi, ER and autophagy proteins 
(including PI4KB, GBF1, Arf1, Rab1, TGN46, GM130, PDI, P63, Sec31 and LC3 (17), (19), (20)). Rather 
than implicating the host membranes to which they localise in RO biosynthesis, host proteins may 
be recruited to ROs independently and differentially, according to infection stage, host cell or viral 
species studied.
While directly visualising membrane connections between donor organelle and nascent enterovirus 
ROs would help clarify whether the ER, Golgi apparatus or other membranes are utilised for 
RO formation, the lack of such connections in ultrastructural studies to date suggests that they 
are rare or transient and thus difficult to capture. We here utilise correlative light and electron 
microscopy (CLEM) and serial block-face scanning electron microscopy (SBF-SEM) to overcome 
this problem and explore the development of ROs at early and advanced stages of enterovirus 
infection. SBF-SEM is a recently developed technique that facilitates the reconstruction of large 
volumes (whole cells and tissues) but at the expense of resolution when compared to conventional 
TEM (21). First, we explored the resolving power of this technique on enterovirus-infected cells 
and extracted quantitative information about the abundance and volumes of RO clusters. We next 
set out to pinpoint the subcellular location of RO biogenesis. For this, we monitored infection 
until the emergence of the first ROs in live cells, exploiting a split-GFP-tagged coxsackievirus that 
illuminates the viral 3A protein (22). These emerging 3A foci correlated with nascent ROs in SBF-
SEM reconstructions, which were further assessed for any association between cellular organelles 
and ROs. A close physical association was found between ROs and LDs, whose volumes decreased 
over the course of infection, suggesting that  RO proliferation is supported by the formation of 
tight LD-RO contacts that facilitate lipid transfer. Importantly, we were able to locate and resolve 
membrane continuities between putative donor organelles and ROs. Our data provide a timeline 
that unites apparently disparate observations related to the origins of enterovirus ROs, revealing 
that RO formation starts at the ER, followed by biogenesis at the trans-Golgi network. These findings 
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R E S U LT S
Cellular ultrastructure during enterovirus infection explored by large volume electron 
microscopy
To assess the resolving power of SBF-SEM on enterovirus-infected cell ultrastructure, Vero E6 cells 
were infected with CVB3 and fixed at 6 hours post infection (hpi). Our previous studies with electron 
tomography showed that enterovirus ROs with different morphologies (i.e. single-membrane 
tubules, double-membrane vesicles, and multi-lamellar vesicles) are present at this time point. 
After fixation, cells were prepared and imaged by SBF-SEM along with mock-infected cells for 
comparison. These data revealed expansive fields of ROs in infected cells, which dominated a large 
volume of the cell cytoplasm (Fig. 1 and Movie 1). Although the individual membranes of
single- and double-membrane ROs were not resolvable by SBF-SEM under the imaging conditions 
used, single-membrane ROs (white arrowheads) were distinguishable from double-membrane 
(hatched arrowheads) or multi-lamellar (black arrowheads) ROs by their apparent thicknesses (Fig 
1, left). To support this interpretation, SBF-SEM images were compared with higher resolution TEM 
images collected from the same type of samples (Fig. S1A), confirming that enterovirus ROs were 
discernible in the SBF-SEM data. Cellular organelles like the ER, lipid droplets, cis-Golgi cisternae 
and trans-Golgi network could be unambiguously identified in SBF-SEM reconstructions of mock-
infected cells through comparisons with TEM images (Fig. S1B). In infected cells, prominent cellular 
organelles like the nucleus, ER and mitochondria were also identified (highlighted in Fig 1, right), 
while Golgi cisternae were absent throughout these cell volumes. This whole-cell visualisation 
confirms that Golgi apparatus cisternae disintegrate completely during enterovirus infection, as 
was previously inferred from live cell imaging studies monitoring Golgi markers, and 2D EM cell-
sections (12, 16, 17, 23).
In order to obtain quantitative insights into the abundance and volumes of enterovirus ROs at this 
stage of infection, the 3D distribution of the viral ROs was highlighted by manual segmentation of 
the RO regions, nucleus and the cytoplasm in two reconstructed cells: Cell A (Figs. 1 and 2) and Cell 
B (Fig. 2). CVB3-induced RO clusters accounted for large parts of the cytoplasmic volume: 16% of in 
Figure 1. SBF-SEM imaging of CVB3-infected cells resolves ROs in their whole-cell context. Vero E6 cells were 
infected with CVB3 and fixed at 6 hours post-infection for SBF-SEM imaging. Left: a single slice from the SBF-SEM 
reconstruction of an infected cell. The cytosol is populated by clusters of ROs (example in boxed area) including 
single-membrane (white arrowhead), double-membrane (hatched arrowhead) and multi-lamellar ROs (black 
arrowhead). Right: cellular organelles, including mitochondria (red), the ER (yellow) and the nucleus (blue) can be 
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cell A (104 µm3), and 6% in cell B (37 µm3). The difference likely reflects a more advanced infection 
stage in cell A, which is also supported by the large dilation of its ER (Fig. 1) that is associated with 
later stages of enterovirus infection (12, 24). The nanometer resolution achievable by SBF-SEM 
allowed RO clusters in close proximity to be segmented apart to analyse their size distribution (Fig. 
2). For both cells, most of the ROs accumulated in a single large cluster (bright green segmented 
volumes, 98 µm3 in cell A, 27 µm3 in cell B), proximal to the nucleus. Most of the remaining RO 
clusters (coloured) were comparatively small, with more than 90% of the RO clusters smaller than 
0.1 µm3 in both cells (Fig. 2, graph). The presence of numerous smaller RO foci at this late stage 
of infection could suggest that novel RO clusters emerge continuously throughout infection, 
which may eventually fuse with and contribute to the large perinuclear cluster. Alternatively, these 
small clusters may represent sites of early RO formation that fail to expand or fuse with the larger 
perinuclear cluster.
Enterovirus RO biogenesis occurs at distinct ER- or trans-Golgi network-derived foci
Our previous live-cell imaging data demonstrated that the onset of Golgi apparatus disintegration 
in CVB3 infection is concomitant with the accumulation of viral protein (e.g. 3A) in the Golgi 
region (16, 22). Intriguingly, the first foci of 3A protein arise in the cell periphery, often ahead of 
the dramatic 3A accumulation in the Golgi region that expands to dominate the cell cytoplasm as 
infection progresses (Movie 2, white and black arrowheads respectively). It is unknown whether 
both the peripheral and Golgi-proximal 3A foci that emerge during this phase represent developing 
ROs. One intriguing possibility is that the small peripheral 3A foci that form early in infection are 
replication-independent, and that these 3A accumulations are merely the result of translation of the 
incoming vRNA delivered by uncoating of virus particles. To test this, we inhibited vRNA synthesis 
Figure 2. 3D analyses reveal the distribution of RO foci. Vero E6 cells were infected with CVB3 and fixed at 6 hours 
post-infection for SBF-SEM imaging. Segmentations of two infected cells (Cell A and Cell B) highlight the positions 
of individual ROs clusters (multi-coloured) and the nucleus (blue) within the cell volumes (beige, semi-transparent). 
The number of RO clusters and their respective volumes were quantified in these cells (graph), and the histogram of 
RO cluster sizes revealed a similar binary distribution in each cell, where the majority of RO volume in each cells falls 
within a single perinuclear cluster, while the majority of all other RO clusters are two orders of magnitude smaller. Cell 
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by treating infected cells with guanidine hydrochloride (GuHCl) and monitored these cells by live-
cell imaging. The CVB3 3A was visualized by utilizing a split-GFP system (22). Neither peripheral nor 
any other 3A-GFP signal emerged under GuHCl inhibition, demonstrating that their formation is 
not a product of translation of only incoming vRNA, but depends upon vRNA replication (Fig S2).
Next, we investigated whether virus-induced membrane structures could be detected at both 
peripheral and Golgi-associated 3A foci. To do so, we imaged living cells expressing mCherry-
Figure 3. Correlative SBF-SEM and LM highlights the appearance of ROs connected to the ER early in infection. 
BGM(S1-10) cell transduced with mCherry-GM130 and infected with CVB3 3A(S11) and monitored by live-cell imaging 
until the first 3A-GFP puncta emerged. A final confocal z-stack of mCherry-G130 (red) and 3A-GFP (green) signals was 
taken prior to chemical fixation for SBF-SEM A) (Left) Volume rendering of the final confocal z-stacks prior to fixation 
and processing for SBF-SEM, (middle) 3D rendering of the ROs (green) and Golgi cisternae (red) segmented from the 
corresponding SBF-SEM volume, and (right) a representative SBF-SEM slice. The intense GM130 signal in confocal 
data corresponds to recognisable Golgi apparatus cisternae in SBF-SEM data. A good overall correspondence can 
also be established between 3A-GFP puncta and RO foci (e.g. white arrowheads), despite small discrepancies in their 
relative position that suggest limited migration of ROs in the delay between LM imaging and fixation. B) Membrane 
continuities (hatched arrowheads) between all the RO clusters in the cell (white arrowheads) and ER membranes 
(black arrowheads) could be observed. C) Continuities between the ER and ROs could also be found in high resolution 
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GM130, a cis-Golgi marker, and infected them with CVB3 encoding split-GFP-tagged 3A (22). 
Confocal z-stacks were collected of cells with emerging 3A-GFP signal but at different stages of 
Golgi disassembly (~ 4.5 hpi), which were then fixed and prepared for SBF-SEM. Acquired SBF-SEM 
volumes were manually segmented to highlight Golgi cisternae and RO clusters based solely on 
morphological features, which could then be compared with 3D reconstructions of corresponding 
confocal data (Fig. 3A, workflow illustrated in Movie 3). A striking correspondence was found 
between 3A-GFP foci in the confocal data and the location of ROs highlighted by the SBF-SEM 
segmentation, although in some cases a shift in the relative positions of 3A-GFP foci and RO clusters 
was apparent (e.g. hatched arrowheads, Fig. 3A). This may be explained by migration of RO clusters 
in the delay between confocal z-stack acquisition and fixation (ca. 10 min for CLEM datasets), as 
peripheral 3A-GFP foci are often dynamic (Movie 2, hatched arrowheads).
 The cell presented in Fig. 3 represents an early stage of infection encompassing the emergence 
of the first peripheral 3A-GFP foci. These foci are largely distal to the Golgi region, where 
minimal 3A-GFP signal is apparent. The Golgi apparatus appears relatively intact at this stage of 
infection, as recognisable Golgi cisternae could be detected. All RO clusters at this stage (Fig. 3B, 
white arrowheads) were observed in close contact with the ER (Fig. 3B, black arrowheads), with 
Figure 4. Correlative SBF-SEM and LM exposes RO clusters connected to the Golgi apparatus. BGM(S1-10) cell 
transduced with mCherry-GM130 and infected with CVB3 3A(S11) and monitored by live-cell imaging until 3A-GFP 
signal emerged in the Golgi region. A) (Left) Volume rendering of the confocal z-stacks (left) acquired prior to fixation 
and processing for SBF-SEM, (middle) 3D rendering of the ROs (green) and Golgi cisternae (red) segmented from the 
corresponding SBF-SEM volume, and (right) a representative SBF-SEM slice. The mCherry-GM130 and 3A-GFP signals 
correlated well with recognizable Golgi apparatus cisternae and RO clusters, respectively. B) Assessment of a region 
(boxed area in A) containing Golgi-proximal RO foci reveals a membranous region (hatched arrowhead) bridging 
ROs (white arrowhead) and the Golgi apparatus (black arrowhead). C) A similar region imaged using TEM reveals 
membrane continuities between RO clusters (white arrowhead) and the Golgi apparatus (black arrowhead). These 
continuities comprise tubules of the trans-Golgi network (hatched arrowhead) and single-membrane RO tubules 
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apparent membrane continuities between them (Fig. 3B, hatched arrowheads). The existence of 
membrane connections between peripheral RO clusters and ER was confirmed in higher resolution 
TEM images of parallel samples (Fig. 3C). These data suggest that 3A foci that emerge in the cell 
periphery correspond with ROs that are derived from ER membranes. 
Following the emergence of peripheral 3A signal, 3A-GFP accumulates in the Golgi region (Movie 
2, white and black arrowheads respectively). An example of a cell fixed at this stage of infection 
is shown in Fig. 4A. The 3D confocal model reveals 3A-GFP signal in close proximity to mCherry-
GM130 signal, which corresponded to ROs and Golgi cisternae respectively in SBF-SEM data (Fig. 
4A). ROs in the Golgi region (e.g. Fig 4B, boxed region in 4A) were connected to membranous 
regions that bridged the trans-Golgi network (Fig. 4B, hatched arrowheads) and RO clusters (Fig. 
4B, black arrowhead). ER-associated RO clusters were also found in the cell periphery (Fig. S3), 
demonstrating that both ER- and Golgi-associated ROs can coexist in infected cells and suggesting 
that ER-RO interactions persist at later stages of infection. To examine Golgi-associated ROs at 
Figure 5. SBF-SEM and TEM data reveal extensive contact between ROs and LDs. Serial SBF-SEM sections from 
two regions of interest in the cell shown in Fig. 4 (boxed areas in the segmentation models; red, Golgi cisternae, green, 
ROs, yellow, lipid droplets) are presented, highlighting the association between RO tubules (white arrowheads) and 
lipid droplets (LD). Frame numbers (top left) indicate the relative depth from frame 0 through the SBF-SEM volume. 
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higher resolution, samples prepared for SBF-SEM were imaged in parallel by TEM (Fig 4C). In 
addition to Golgi cisternae (Fig. 4C, white arrowhead) and ROs (Fig. 4C, black arrowhead), TEM 
images revealed continuities between trans-Golgi network tubules and single-membrane ROs (Fig. 
4C, hatched arrowhead). Altogether, these data suggest that early RO biogenesis occurs at seed 
points distributed across the ER, followed by RO formation at trans-Golgi membranes. 
Beyond the ER- and Golgi-associated RO foci highlighted by the 3A-GFP signal, significant spatial 
relationships between ROs and other cellular organelles, including endosomes, lysosomes, 
autophagosomes and mitochondria, were not clearly apparent in any cells analysed. However, 
extensive contact regions could be found between RO clusters and lipid droplets (LDs), which in 
some cases appeared to be surrounded by ROs (Fig. 5, arrowheads). Interestingly, a qualitative 
analysis of the number of LDs in SBF-SEM cell reconstructions of cells fixed at late infection 
stages (n=6) hinted at a possible inverse correlation between the infection stage (assessed by RO 
abundance) and the LD content. A quantitative analysis of LDs, visualized with Oil Red O stain by 
light microscopy, confirmed that LDs were depleted across CVB3 infection in our experimental 
setup, and showed a particularly rapid drop early in infection (between 0 and 4 hpi) both in LD 
counts and total LD area per cell (Fig. S4). This result is in line with previous immunofluorescence 
data obtained during enterovirus infection (9, 25) Together, our results suggest that the extensive 
contact regions between ROs and LDs could be utilised for the transfer of critical lipids to ROs, 
supporting their formation and proliferation.
D I S C U S S I O N
Establishing the origin of viral ROs reveals important clues about the host cell requirements for 
their formation. For enteroviruses, existing data suggest that components of the Golgi apparatus, 
ER, ER exit sites (ERES), autophagy pathway, endolysosomal compartments or any combination 
thereof may contribute to the development of ROs (17-19). Ultrastructural evidence of continuities 
between cellular organelles and ROs that would shed light on the membrane donor organelle 
has been lacking, however, suggesting that connections between enterovirus ROs and cellular 
organelles are rare, or that the association of ROs with their donor organelle is short-lived. To 
capture these events, we employed live-cell imaging to monitor the emergence of viral 3A protein 
using a split-GFP system. The resulting 3A-GFP signal was utilised as a correlative marker to highlight 
potential sites of interest in SBF-SEM cell volumes, which were further assessed for any association 
between cellular membranes and ROs.
Intriguingly, RO clusters were found both in the cell periphery and in the perinuclear region at 
early infection time-points. Close examination of SEM volumes revealed connections between 
peripheral RO clusters and ER membranes, and membranous regions that bridged perinuclear RO 
clusters and the trans-Golgi network. Higher resolution TEM images of similar regions confirmed 
the existence of membrane continuities between trans-Golgi tubules and ROs. Peripheral 3A-GFP 
foci, which were found to correspond to ER-derived ROs, largely emerge prior to those found in the 
Golgi region (22) (Movie 2). Thus, the ER in most cells is the initial site of enterovirus RO formation, 
followed by the appearance of Golgi-derived ROs. This chronological separation between ER 
and Golgi-associated ROs could account to some extent for disparate observations of Golgi- or 




































        4
spatiotemporal organisation of enterovirus infection. Our data demonstrate that ER- and Golgi-
associated enterovirus ROs are morphologically similar, require vRNA synthesis for their formation, 
and accumulate viral protein. While these sites may be utilised at different infection stages, this 
could suggest that both are suitable for viral replication, which aligns with existing data suggesting 
that enterovirus replication can occur at the Golgi or ER (17, 18).
Further analyses of SEM volumes did not highlight membrane connections between other 
cellular structures and ROs, but revealed a striking physical association between RO clusters and 
lipid droplets (LDs) (Fig. 5). While previous LM data showed that LDs are located in the vicinity 
of rhinovirus ROs (25), our high-resolution data revealed that ROs are not only often close to 
enterovirus LDs, but they also establish extensive contacts with them. In light of a recent study 
demonstrating the importance of LD-derived lipids for enterovirus replication and RO formation 
(11), it is tempting to speculate that ROs and LDs can form bona fide membrane contact sites (MCS) 
containing tethers and lipid transfer machinery. These MCSs could underlie an important route for 
the recruitment of critical lipids for enterovirus RO formation, like fatty acids and cholesterol (8, 
26), which may contribute to LD depletion as ROs proliferate over the course of infection (Fig S4). 
Despite differences in the lipid and protein composition of the ER and trans-Golgi network (27), 
these data demonstrate that apparently morphologically identical enterovirus ROs can be derived 
from both sites. This indicates that any core cellular components required for enterovirus RO 
formation are common to both the ER and Golgi apparatus or readily recruited by viral proteins. 
The enterovirus host factor phosphatidylinositol 4-phosphate (PI4P), which was recently shown 
to expedite the formation of ROs (16), may represent one example of this. While the beta isoform 
of phosphatidylinositol 4-kinase, PI4KB, is primarily responsible for PI4P production at the Golgi 
apparatus, the alpha isoform PI4KA produces PI4P at the ER, with particularly high levels of PI4P 
present at ERES (28). Together with the observed associations between viral proteins and ERES 
markers (17, 19), this could nominate PI4P-rich ERES as candidate nucleation points for developing 
ER-RO foci. However, PI4KA inhibition does not affect the final replication yield during enterovirus 
infection (29, 30) (31), suggesting that ER-derived ROs may confer a small benefit early in infection, 
but are ultimately expendable for replication. Another possibility is that the PI4P utilised for ER-
derived RO formation is supplied by PI4KB, recruited by the enterovirus 3A protein (17). While 
peripheral 3A protein also accumulated early in the replication of a mutant enterovirus, this 
accumulation was abolished under PI4KB inhibition (16), which could support the notion that ER-
derived ROs require PI4KB. In this way, the compositional requirements for RO formation and viral 
replication would be met by supplementing suitable but diverse donor membranes with recruited 
host factors. Altogether, these data extend the growing body of evidence suggesting that +RNA 
viruses are not constrained to utilising membranes from a single cellular source for their replication, 
which, in some cases, can even be redirected to membranes of a different cellular organelle (32). 
Flexible recruitment of membranes for replication would confer a remarkable level of adaptability 
to different conditions, providing +RNA viruses with an important evolutionary advantage.
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E X P E R I M E N TA L  P RO C E D U R E S
Cell lines and reagents. Vero E6 or BGM cells were cultured using Dulbecco’s modified Eagle’s 
medium (Gibco) supplemented with 10% fetal calf serum, penicillin, and streptomycin, and 
maintained at 37°C in 5% CO2. BGM(S1-10) cells, which express GFP(S1-10) and the puromycin 
resistance gene (Pac), have been described in (22). BGM(S1-10) cell culture medium was 
supplemented with an additional 30 µg/ml puromycin as a selection agent.
Viruses and infection. CVB3 3A(S11aa2), which encodes a 3A with the S11 region of GFP inserted 
after amino acid position 2, has been described in (22). CVB3 wt (strain Nancy) was generated as 
described in (16). For infection, cells were inoculated for 1 hour with CVB3 wt or CVB3 3A(S11) at 
MOI 50 and 5 respectively, after which the inoculum was removed and fresh medium was added. 
At specified time-points after infection cells were imaged by light microscopy and/or prepared for 
electron microscopy by chemical fixation or high-pressure freezing and freeze substitution.
Live cell imaging. BGM(S1-10) cells were grown to ~35% confluency in glass-bottom 4-chamber 
35-mm dishes (CELLviewTM) and transduced with MLV mCherry-GM130 particles (described in 
(22)). Transduced cells were infected with CVB3 3A(S11) 18-24 hours later. Cells were washed with 
Fluorobrite medium (Thermo Fisher Scientific) supplemented with 8% fetal calf serum (FCS) and 
25 mM HEPES just prior to imaging. LM data were collected using a Leica SP5 confocal microscope 
equipped with a HyD detector and a 63x (1.4 NA) oil immersion objective, with the confocal pinhole 
adjusted to 1 airy unit for GFP emission (95.56 µm pinhole). For time-series imaging, positions of 
interest (xyz) were marked and imaged sequentially at 5 minute intervals. For the duration of all 
imaging, cells were maintained at 37°C and 5% CO2 in a live-cell chamber. For correlative light and 
electron microscopy, cells were grown in glass-bottom MatTek dishes with an etched alphanumeric 
co-ordinate system (MatTek Corporation) to facilitate the relocation of the regions identified 
during light microscopy. Cells were monitored until the point of interest, at which time a confocal 
z-stack was acquired, after which samples were immediately fixed for electron microscopy. To 
minimise the time between the first image acquisition of each z-stack and fixation (ca. 10 minutes 
total), one field of view was imaged per sample.
Lipid droplet visualization and quantification. Vero E6 cells grown on coverslips were infected 
with CVB3 wt (MOI 100) and fixed with 3% paraformaldehyde for 1 hour at different infection 
times. Mock-infected cells were also fixed as a control. After washing with PBS, the coverslips 
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(0.5 % w/v in isopropanol) and double-distilled water (6:10) to stain LDs, washed with PBS and 
incubated with the nuclear stain Hoechst. The samples were then imaged in a Leica DM6 wide-
field microscope with a 40x oil immersion objective using both differential interference contrast 
(DIC) and fluorescence imaging modes. LDs appeared as darkly stained circular profiles in the DIC 
images that were absent in unstained samples and could be also detected in fluorescent images 
using a Texas red excitation filter (540-580 nm) (33). A total of 25 cells per condition were randomly 
selected from the DIC images, and the LDs contained in those cells were counted and manually 
segmented from the fluorescent images using Amira 6.0.1 (Thermo Fisher), which was further used 
to compute the LD area per cell. 
Electron microscopy
Preparation of chemically-fixed samples. Sample fixation, staining and embedding procedures 
were adapted from (34). Cells were fixed with 2.5% gluteraldehyde and 4% formaldehyde in 0.15 M 
cacodylate buffer for 60 minutes at room temperature. Initial post-fixation was carried out using 
a solution of 2% osmium tetroxide and 1.5% potassium ferricyanide in 0.15 M cacodylate for 60 
minutes on ice. Samples were then treated with 1% aqueous thiocarbohydrazide for 20 minutes, 
followed by 2% aqueous osmium tetroxide for 30 minutes, and were finally incubated overnight at 
4°C in 1% aqueous uranyl acetate. Samples were then stained using Walton’s lead aspartate at 60°C 
for 30 minutes ahead of stepwise dehydration in ethanol. Samples were infiltrated with resin initially 
using a 50:50 mixture of propylene oxide and Durcupan ACM resin (Ladd research) for 60 minutes. 
Where MatTek dishes were used, coverslips were excised from the surrounding culture dish using 
a razor blade and removed to a container resistant to propylene oxide ahead of this step. Samples 
were then infiltrated with fresh undiluted Durcupan for 90 minutes, before covering regions of 
interest with inverted resin-filled BEEM capsules (Ted Pella) and polymerisation for 48 hours at 
60°C. For TEM, sections of 70 nm were cut from the sample block for imaging and post-stained 
with uranyl acetate and lead citrate. For SEM, sample blocks were prepared as described in (35). 
Briefly, small portions of the cell monolayers were mounted on pins using conductive epoxy resin 
(Circuitworks CW2400), trimmed to form an approximately 400 x 400 x 150 µm pillar, ensuring that 
regions of interest were retained in the block-face for correlative samples, and coated with a 2 nm 
layer of platinum ahead of imaging. 
Electron microscopy imaging. TEM images were collected in an FEI Tecnai12 BioTWIN using an 
Eagle 4k slow-scan CCD camera (FEI) or an FEI TWIN at 120 kV with OneView 4k high frame-rate 
camera (Gatan), both in binning mode 2. Serial block-face scanning electron microscopy (SBF SEM) 
data was collected using a 3View2XP (Gatan, Pleasanton, CA) attached to a Sigma VP SEM (Zeiss, 
Cambridge). Backscattered electron images were acquired using the 3VBSED detector. The SEM 
was operated at a chamber pressure of 5 pascals, with high current mode inactive. Variable pressure 
imaging conditions, which reduce the final resolution, aided in the suppression of charging resulting 
from the large regions of bare resin surrounding single cells. For CLEM data the 30 µm aperture was 
used with an accelerating voltage of 2 kV, a dwell time of 3 µs (10 nm reported pixel size, horizontal 
frame width of 81.9 µm) and 40 nm slice thickness. Two collection setups were used for samples 
fixed at 6 hpi infection, using either the 30 or 20 µm aperture and an accelerating voltage of 2 or 3 
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20.5 µm) or 10 µs (6 nm reported pixel size; horizontal frame width of 24.6 µm), with a slice thickness 
of 50 or 30 nm. 
SBF-SEM image processing and segmentation. SBF-SEM image stacks were acquired as dm3 files 
and converted to 32 bit TIFs for initial batch processing. Images were Gaussian filtered (1 pixel), 
followed by two rounds of unsharp mask and grey level normalisation (Adobe Photoshop). Image 
stacks were then converted to 8 bit TIFs and aligned using the virtual align slices plugin (Fiji). 
Segmentation of features within SBF-SEM data was carried out in a semi-automatic threshold-based 
way for the cell cytoplasm and manually for the viral ROs, nuclei and LDs using or Segmentation 
Editor (Fiji) or Amira 6.0.1 (Thermo-Fisher), which was then also employed to extract volume 
information on the different RO clusters.
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S U P P L E M E N TA L  F I G U R E S
Figure S1. Comparisons of cell ultrastructure in SBF-
SEM and TEM images facilitate the identification 
of ROs and cellular organelles. CVB3-infected or 
mock-infected Vero E6 cells, chemically fixed for EM 
and visualized either by SBF-SEM or TEM A) Single-
membrane, double-membrane, and multi-lamellar ROs 
can be distinguished in SBF-SEM data of infected cells by 
the apparent thickness of the membrane profile. Similar 
regions imaged by TEM resolve the individual membranes 
of these structures supporting the interpretation of SBF-
SEM images. Single-membrane ROs; white arrowheads, 
double-membrane ROs; hatched arrowheads, multi-
lamellar ROs; black arrowheads. (Right panel) Line 
density profiles of the indicated single-, double- or multi-
membrane ROs, as measured along the arrow directions 
(x-axis scale in nm).  B) Cellular organelles, clearly distinct 
in TEM images, can also be resolved in SBF-SEM data in 
uninfected cells. These organelles include Golgi cisternae 
(white arrowheads, top) and trans-Golgi network (hatched 
arrowheads, top), ER membranes (arrowheads, middle) 
and lipid droplets (arrowheads, bottom). Scale bars are 2 
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Figure S2. The appearance of 3A-GFP 
foci in the cell periphery requires 
viral replication. BGM(S1-10) cells 
were infected or mock-infected with 
CVB3 3A(S11). The addition of guanidine 
hydrochloride from 1 hpi, which blocks 
viral replication, prevented the formation 
of both peripheral and Golgi-associated 
3A-GFP puncta.
Figure. S3. Both ER-connected and Golgi-derived ROs co-exist in CVB3-infected cells. Analysis of the peripheral 
RO clusters detected in the SBF-SEM reconstruction of the cell shown in Fig. 4, which was fixed at an early stage of 
CVB3 infection. The analysis shows that these clusters (boxed regions) correspond to ER-associated ROs that can be 
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Figure. S4. Both ER-connected and Golgi-derived ROs co-exist in CVB3-infected cells. Analysis of the peripheral 
RO clusters detected in the SBF-SEM reconstruction of the cell shown in Fig. 4, which was fixed at an early stage of 
CVB3 infection. The analysis shows that these clusters (boxed regions) correspond to ER-associated ROs that can be 
formed in addition to the Golgi-derived ROs (see Fig. 4) observed in the same cell. Scale bars are 500 nm.
Movie S1. Large volume 3D reconstruction of CVB3-infected cells by SBF-SEM. Consecutive slices 
through SBF-SEM and segmentation volumes of a Vero E6 cell infected with CVB3 (cell shown in 
figure 1 and as cell A in figure 2, 6 hpi), highlighting the distribution of RO clusters (green) in their 
cellular context (nucleus, blue and cytoplasm, beige). Total reconstructed volume: 3404 µm3.
Movie S2. Live-cell imaging of CVB3-infected cells highlights peripheral and Golgi-associated 
viral 3A foci. BGM(S1-10) cells were transduced with mCherry-GM130 and infected with CVB3 
3A(S11) (system described in (22)). As it is typically the case, the first 3A-GFP foci appear in the cell 
periphery (e.g., white arrowhead, ~4 hpi), shortly before 3A-GFP signal starts accumulating in the 
Golgi region (e.g. black arrowhead, ~4.5 hpi). The disintegration of the Golgi apparatus, apparent 
by the dispersion and loss of mCherry-GM130 signal, occurred from ~4.5 hpi through to ~5.5 hpi. 
Hatched arrowheads illustrate 3A-GFP foci migration between ~ 5 hpi and ~6 hpi. Scale bar is 10 µm.
Movie S3. The correlative light and serial block-face scanning electron microscopy workflow. 
BGM(S1-10) cells were transduced with mCherry-GM130 and infected with CVB3 3A(S11). Confocal 
z-stacks encompassing the volume of cells of interest were collected, followed by chemical fixation 
for EM processing and SBF-SEM. ROs, Golgi cisternae, and lipid droplets were manually segmented 
from the SBF-SEM volume and rendered in green, red and yellow respectively. Comparing both 3D 
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S U M M A RY
Picornaviruses induce dramatic rearrangements of endomembranes in the cells that they infect to 
produce dedicated platforms for viral replication. These structures, termed replication organelles 
(ROs), have been well characterized for the Enterovirus genus of the Picornaviridae. However, 
it is unknown whether the diverse RO morphologies associated with enterovirus infection are 
conserved among other picornaviruses. Here, we use serial electron tomography at different stages 
of infection to assess the three-dimensional architecture of ROs induced by encephalomyocarditis 
virus (EMCV), a member of the Cardiovirus genus of the family of picornaviruses that is distantly 
related. Ultrastructural analyses revealed connections between early single-membrane EMCV 
ROs and the endoplasmic reticulum (ER), establishing the ER as a likely donor organelle for their 
formation. These early single-membrane ROs appear to transform into double-membrane vesicles 
(DMVs) as infection progresses. Both single- and double-membrane structures were found to 
support viral RNA synthesis, and progeny viruses accumulated in close proximity, suggesting a 
spatial association between RNA synthesis and virus assembly. Further, we explored the role of 
phosphatidylinositol 4-phosphate (PI4P), a critical host factor for both enterovirus and cardiovirus 
replication that has been recently found to expedite enterovirus RO formation rather than being 
strictly required. By exploiting an EMCV escape mutant, we found that low-PI4P conditions 
could also be overcome for the formation of cardiovirus ROs. Collectively, our data show that 
despite differences in the membrane source, there are striking similarities in the biogenesis, 
morphology, and transformation of cardiovirus and enterovirus ROs, which may well extend to 
other picornaviruses. 
I M P O RTA N C E
Like all positive-sense RNA viruses, picornaviruses induce the rearrangement of host cell membranes 
to form unique structures, or replication organelles (ROs), that support viral RNA synthesis. Here, 
we investigate the architecture and biogenesis of cardiovirus ROs and compare them with those 
induced by enteroviruses, members of the well-characterized picornavirus genus Enterovirus. The 
origins and dynamic morphologies of cardiovirus ROs are revealed using electron tomography, 
which points to the endoplasmic reticulum as the donor organelle usurped to produce single-
membrane tubules and vesicles that transform into double-membrane vesicles. We show that PI4P, 
a critical lipid for cardiovirus and enterovirus replication, is not strictly required for the formation of 
cardiovirus ROs, as functional ROs with typical morphologies are formed under phosphatidylinositol 
4-kinase type III alpha (PI4KA) inhibition in cells infected with an escape mutant. Our data show that 
the transformation from single-membrane structures to double-membrane vesicles is a conserved 
feature of cardiovirus and enterovirus infections that likely extends to other picornavirus genera.
I N T R O D U C T I O N
The cardioviruses comprise an important genus of the Picornaviridae family of positive-sense RNA 
(+RNA) viruses. The type species Cardiovirus A, or encephalomyocarditis virus (EMCV), ostensibly 
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wild or farm animals occurs primarily in swine (1, 2), but concerns for human safety have followed 
from studies demonstrating the potential for pig to human EMCV transmission during organ 
xenotransplantation (3, 4), which will become more imminent as the technique matures. The 
Cardiovirus B species is represented by Theiler’s murine encephalomyocarditis virus (TMEV), the 
study of which has led to critical contributions to our understanding of demyelinating diseases 
(reviewed in (5)). Unlike TMEV, the closely related Saffold virus is capable of infecting humans. Saffold 
virus was discovered only recently in a patient with a fever of unknown origin (6), but appears to 
be widespread and commonly found in co-infections with other viruses. Among these co-infected 
viruses are the enteroviruses (7, 8), another genus of picornaviruses that includes poliovirus, the 
coxsackieviruses, rhinoviruses, and enteroviruses A71 and D68. Although the consequences of 
enterovirus and Saffold virus infections in co-infected patients are entwined, there are suggestions 
that Saffold virus could cause or contribute to diseases as diverse as gastroenteritis, encephalitis, 
myocarditis and non-polio acute flaccid paralysis (reviewed in (9)), which are typically associated 
with enterovirus infections.
Understanding the conserved requirements for picornavirus replication is an important strategy for 
developing broadly acting antiviral therapies. Currently, vaccines are available to prevent infections 
with  hepatitis A virus,  poliovirus, and EV71 (only available in China), but there are no approved 
antiviral therapies to treat picornavirus infections. Substantial efforts have been invested in 
developing directly-acting antivirals that target viral proteins, but the spectrum of antiviral activity 
of these agents is limited (10-12). Another strategy, for which interest has been growing in recent 
years, is the development of inhibitors targeting host factors that are conserved amongst different 
genera (13). One host factor required for the replication of both enteroviruses and cardioviruses 
is the lipid phosphatidylinositol-4 phosphate PI4P. Cellular production of PI4P is orchestrated by 
phosphatidylinositol-4 kinases (PI4Ks), which reside in various subcellular compartments and 
generate local pools of PI4P (reviewed in (14) and (15)). Enteroviruses rely upon the III beta class 
of PI4K (PI4KB) (16, 17), which predominantly localises to the Golgi apparatus, while cardioviruses 
require the largely ER-based III alpha class of PI4K (PI4KA) (18). Interestingly, like for cardioviruses 
and enteroviruses, PI4P is also required by the more distantly-related hepatitis C virus (HCV), which 
depends upon PI4KA for its replication (19).
A role for PI4P in expediting the formation of enterovirus replication organelles (ROs) has recently 
been described (20), which could in part explain its importance during viral replication. ROs are 
virus-induced membrane rearrangements formed during infections of all eukaryote-infecting 
+RNA viruses. These structures serve as a hub for viral replication in the cell, and their unique 
properties are believed to confer intrinsic benefits to the viruses that generate them. The expansion 
of membranes that support the viral RNA synthesis machinery may increase replication efficiency, 
while the unique morphology of some ROs could serve to compartmentalise this process or its 
products, and limit host innate immune sensing. The 3D morphology of enterovirus ROs is well 
characterised. Early in infection enteroviruses induce the formation of single-membrane tubular 
ROs that gradually transform into double-membrane vesicles and multilamellar vesicles over the 
course of infection (21, 22). Our understanding of cardiovirus ROs, however, is more limited. Different 
studies have identified single- or double-membrane structures using 2D electron microscopy (EM) 
of chemically fixed samples (23-25), and it is unclear whether these disparate observations reflect 
























































        5
of infection. It remains to be established how membrane modifications arise and develop across 
cardiovirus infection, what their 3D morphology is, which structures are capable of supporting RNA 
synthesis and, furthermore, whether PI4KA plays a role in cardiovirus RO formation. 
Here, we use serial electron tomography (ET) to unravel the 3D morphology of EMCV ROs across an 
extensive time course that encompasses their formation and development. Samples were prepared 
using high-pressure freezing and freeze substitution (HPF-FS) as an alternative to chemical fixation, 
which better preserves structures sensitive to artefacts. We provide evidence that early EMCV ROs 
consist of single-membrane tubules and vesicles that emerge from the ER. These single-membrane 
structures, which emerge during the exponential phase of viral RNA synthesis, appear to serve as 
the primary platform for genome replication. However, double-membrane vesicles (DMVs), which 
largely emerge later in infection, were also capable of supporting RNA synthesis. Remarkably, 
putative transition states between single-membrane tubules and DMVs were found that mirror the 
transformation intermediates observed for enterovirus ROs (21). This chronological progression 
of RO morphology contextualises the previous observations of single- or double-membrane 
EMCV ROs, and represents a striking parallel between cardiovirus and enterovirus DMV formation 
that may represent a conserved mechanism amongst picornaviruses. Given this cohesion in RO 
morphology between enteroviruses and EMCV, we then investigated whether PI4KA plays a role in 
the formation of EMCV ROs, like PI4KB does for enterovirus ROs (20). To this end, we studied the 
effects of PI4KA inhibition on an EMCV mutant that harbours a single substitution in its 3A protein 
(3A-A32V), which confers resistance to PI4KA inhibitors (26). Intriguingly, PI4KA inhibition neither 
affected RO morphology nor significantly delayed RO formation.  This indicates that, similarly to 
enteroviruses, a lack of high PI4P levels does not pose an unsurmountable barrier for cardiovirus 
RO formation.
R E S U LT S
EMCV-induced membrane rearrangements with different morphologies arise over the 
course of infection
We first set out to determine the relationship between EMCV replication and the emergence of 
ROs. Samples for qPCR, viral titer determination, immunofluorescence analysis and electron 
microscopy (chemical fixation) were generated within a single experiment. HeLa cells infected 
with EMCV (strain Mengovirus) at MOI 50 were processed every hour up to 9 hours post-infection 
(hpi) for quantitative PCR (qPCR) of viral RNA and for the determination of viral titer. Samples for 
immunofluorescence and electron microscopy (EM) analyses were fixed between 3 and 9 hpi. 
While data from these chemically fixed EM samples were assessed to quantify the emergence 
of ROs, representative images are presented from a subsequent experiment using an improved 
sample preparation method (high-pressure freezing and freeze substitution) that more faithfully 
preserves RO morphology. The exponential phase of RNA synthesis spanned 3 to 6 hpi, while the 
increase in viral titer lagged by ~2 hours (Fig. 1A). These RNA replication dynamics aligned well 
with increasing dsRNA immunofluorescence signal, which provides a secondary indication of viral 
replication. The first fluorescent signal was detected at 4 hpi and levels increased steadily each 
hour before reaching a plateau at 7 hpi. Between 4 and 5 hpi, dsRNA signal was found at small 
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progressed (Fig. 1B). 
The first virus-induced membrane modifications were detected in EM cell-sections of cells fixed 
at 5 hpi, revealing a complex but sparse assortment of virus-induced single-membrane structures 
(Fig. 2A, arrowheads) and, very occasionally, double-membrane structures (Fig. 2A, asterisk). From 
6 hpi membrane modifications became increasingly clustered into large regions that dominated 
the cytosol, and the abundance of double-membrane structures increased (Fig. 2B, asterisks), 
although single-membrane structures persisted (Fig. 2B, arrowheads). Late in infection double-
membrane vesicles became more dominant (Fig. 2C, white asterisks), and multi-lamellar structures 
were also found (Fig. 2C, black asterisks and inset). Between 5 and 8 hpi, the RO density in the 
cytoplasm greatly increased (from 0.11 to 0.63 ROs per µm2), and the proportion of DMVs (as 
a percentage of total ROs) grew from less than 1% to an average of 35%, although in some cells 
DMVs rather than single-membrane structures were the predominant RO morphology (Fig. 2D). 
A number of cells with evident signs of lysis (e.g. disrupted plasma membrane, extracted cytosolic 
content) could also be found later in infection, which may explain the lack of immunofluorescence 
labelling in some cells by 7 hpi.
Figure 1. The kinetics of EMCV replication and progeny virus production. HeLa cells were infected or mock-
infected with EMCV. A) Cells were lysed every hour between 1 and 9 hpi to determine viral RNA levels by qPCR or to 
determine viral titer by titration. Values, converted to fold increase, represent the mean of triplicates (± std. error). B) 
The subcellular distribution of dsRNA (green) relative to the cell nucleus (blue) was assessed by immunofluorescence 
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Electron tomography reveals the 3D architecture and transformation of ROs
One drawback of 2D EM cell-section analysis is the similarity in cross-section between vesicles 
and tubules running perpendicular to the section plane. Additionally, features like membrane 
connections or small openings may be obscured by the superposition of structures in a 2D 
projection image. To more unambiguously characterise the morphology of EMCV ROs, cells at 
early and late stages of infection were prepared for electron tomography (ET). Tomograms from 
serial cell-sections of the same region of interest were combined to form large 3D volumes for 
analysis.
Figure 2. 2D EM reveals single-, double-membrane and multilamellar structures. An initial 2D EM analysis to 
assess the emergence and development of EMCV ROs was performed using chemically fixed HeLa cells processed 
in parallel with samples described in Fig. 1 (Fig. 2D). Corresponding structures in high-pressure frozen and freeze-
substituted samples are shown (Fig. 2A-C). Single-membrane structures are indicated with arrowheads. Double-
membrane structures are marked with a white asterisk. A) Membrane rearrangements found at early infection 
time points (~5 hpi) were primarily single-membrane structures, but some double-membrane structures were also 
observed. B) Later in infection (~6 hpi) the membrane rearrangements became more clustered and the relative 
abundance of double-membrane structures increased. C) At late infection time points (~7 hpi) double-membrane 
structures were predominant and multilammellar membrane structures were found (black asterisks). D) The relative 
abundance of double-membrane vesicles in EMCV-infected chemically-fixed cells was analysed between 5-8 hpi 
(left). Increase in total ROs over this period expressed as RO counts per µm2 of cytoplasm (right). Total RO count from 
5-8 hpi = 4365, 5 cell sections randomly selected and analysed per time point. The bars represent standard deviations. 
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Single-membrane structures identified in the 2D analysis at early times post-infection were found 
to comprise a mixed population of single-membrane vesicles (SMVs) and single-membrane 
tubules (SMTs) (Fig. 3A, red and blue respectively, Movie S1). Unlike the tubules formed during 
enterovirus infections, EMCV SMTs did not form tightly packed clusters. Both SMVs and SMTs were 
smooth-membrane structures, and were frequently found connected to rough ER (green) by neck-
like membrane connections (Fig. 3B and C, arrowheads), like the ER-derived ROs of nidoviruses (27-
29) and HCV (30). In contrast, DMVs, which were predominantly found at late stages of infection, 
appeared in all instances to be separate compartments, with no membrane connections to other 
structures (Fig. 4A, yellow, Movie S2). Some DMVs appear to be partially enwrapped by additional 
cisternae late in infection (Fig. 4B, purple), to form multilamellar structures. Virus particles were 
also detectable in the EM data as dense hexagonal profiles of ~25 nm (Fig. 4C, arrowhead), which 
were frequently found in the cytosol within 30 nm of ROs (Fig. S1). These particles (Fig. 4D, black 
arrowhead) were distinguishable from ribosomes (Fig. 4D, white arrowhead) by their symmetry 
and well-defined edges.  A closer spatial association was found between virus particles and RO 
membranes (SMVs, SMTs or DMVs) than between randomly generated co-ordinates and RO 
membranes (Fig S1, p < 0.001). This could reflect localised clustering of virions following their 
formation, or a spatial connection between RNA synthesis and virion assembly.
Ultrastructural investigations of enterovirus ROs have revealed putative transition structures that 
may represent the transformation of SMTs into DMVs. This process appears to involve the pairing 
of membrane tubules to form flattened cisternae, which curve to enwrap a small volume of cytosol, 
Figure 3. Tomography of EMCV infected cells at 5 hpi reveals connections between single-membrane ROs and 
ER. HeLa cells were infected with EMCV and high-pressure frozen at 5 hpi for EM processing and serial tomography. 
Shown are different features observed in a serial tomogram comprising five consecutive sections of 200 nm thickness 
from a representative cell. A) Section through the tomogram volume showing SMVs in red, SMTs in blue and ER 
in green, recognisable by the membrane-associated ribosomes (arrowheads), with a segmentation of a sub-region 
of the volume superimposed (left) and in isolation (right). B, C) Sections through the tomogram alongside their 
corresponding 3D model cutaway reveal connections between SMVs (red) and ER (green) (B), and SMTs (blue) and 
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ultimately forming an open DMV in a vase-like configuration. The opening then seals to form a 
complete, closed DMV (21, 22). Similar structures were found in tomograms of EMCV infected 
cells, including paired and highly curved tubules (Fig. 5A i. and ii., white arrowheads), which could 
represent an early stage of DMV formation from SMTs, and DMVs with small openings (Fig. 5A iii., 
arrowhead). Tubular extensions of the outer membranes of DMVs were also found (Fig. 5B, indicated 
by white arrowheads in consecutive sections) that could represent the partial transformation of 
SMTs to DMVs. Supporting this idea, similar electron-dense material was observed both in the 
lumen of single-membrane structures (Fig. 5A black arrowheads), and within the inter-membrane 
space created by these tubular extensions (Fig. 5B, black arrowhead). To further examine the 
possibility of a single- to double-membrane structure transformation, the surface areas of SMVs, 
SMTs and DMVs were estimated using the measured average diameter for each structure (Fig. 5C, 
top). These figures provide a guide as to whether SMTs or SMVs are likely candidate precursor 
structures for DMVs (as described in (21)) as, unless other lipid sources contribute to DMV 
membranes, any precursor structure should have at least the same surface area than the DMV that 
forms from it. The estimated surface areas generated allow for a scenario where DMVs are formed 
by SMTs (Fig. 5C, bottom), and are compatible with the possibility that some (smaller) DMVs could 
also be derived from SMVs. In this scenario, the multilamellar vesicles seen at late time points may 
arise from SMTs that enwrap or partially enwrap existing DMVs, rather than enwrapping the cytosol 
Fig. 4. Tomography of EMCV infected cells at 7 hpi highlights virions proximal to DMVs and multilamellar 
vesicles. HeLa cells were infected with EMCV and high-pressure frozen at 7 hpi for EM processing and tomography. 
Shown are structures observed in a serial tomogram comprising two consecutive sections of 200 nm thickness from 
a representative cell at this time point. A) Section through the tomogram and corresponding model showing SMTs 
in blue, SMVs in red, ER in green, DMVs in yellow and cisternae enwrapping DMVs in purple, with a segmentation of 
a sub-region of the volume superimposed (left) and in isolation (right) highlighting SMTs and DMVs. B, C) Sections 
through tomograms and corresponding models showing a multilamellar vesicle, which consists of a closed DMV 
(yellow) enwrapped by a flattened cisterna (purple) (B), and highlighting the proximity of viral particles (black) in 
the cytosol to ROs (yellow and blue) (C). Virus particles are indicated with an arrowhead. D) Comparison of ribosome 
(white arrowheads) and virus particle (black arrowhead) morphology in a single tomogram section. Scale bars, 500 
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to form a new DMV. DMVs were occasionally found to contain virions in samples analysed at 7 
hpi (pooled data from four tomograms, example shown in Fig. 5D), but at a low frequency (7% of 
68 DMVs), and particles within DMVs represented a small fraction of total virus particles detected 
(2% of 339 particles). An enwrapping mechanism of SMT-to-DMV transformation could explain the 
presence of virus particles within a subset of DMVs, as virions may be enclosed by chance during 
their formation.
RNA synthesis occurs at virus-induced single- and double-membrane structures
To investigate whether all or some of these virus-induced membrane modifications support RNA 
synthesis, metabolic labelling and EM autoradiography (31) was performed. Cells were infected 
with EMCV and fixed at 5 or 7 hpi. During the 2 hours prior to fixation, cells were incubated with 
10 µg/ml dactinomycin to limit cellular transcription. During the 45 minutes prior to fixation, cells 
were additionally treated with tritiated uridine to label newly-synthesised RNA. After chemical 
fixation and preparation for EM, sections were prepared for autoradiography.
While only larger clusters of electron-dense grains are good indicators of underlying viral RNA 
Fig. 5. Intermediate structures suggest that single-membrane structures transform into DMVs. Intermediate 
structures found in EMCV-infected HeLa cells at 7 hpi. The slice thickness is 1.24 nm, and the slice spacing (A, B) 
is indicated in the lower right corner of consecutive images. Black arrowheads indicate electron-dense material 
present in the lumen of SMTs and between the inner and outer membranes of DMVs. A) Membrane curving and 
pairing of single membrane structures (white arrowheads, i. and ii.), and a DMV with an opening to the cytosol (white 
arrowhead, iii.). B) DMV with a tubular extension of its outer membrane (indicated by white arrowheads). C) Tukey 
plots showing the distribution of diameters (left) and surface areas (right) of ROs. Median diameter values (nm) are 115 
(SMV, n = 90), 62 (SMT width, n = 90), 368 (SMT length, n = 90) and 132 (DMV, n = 130). D) Example of a virus particle 
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synthesis given the limited resolution of EM autoradiography (32), substantial autoradiography 
signal could be found clustered around areas containing exclusively single-membrane tubules and 
vesicles (Fig. 6A). This demonstrates their ability to support viral RNA synthesis. Newly-synthesised 
RNA was also evident at RO foci comprised predominantly of DMVs at later stages of infection (Fig. 
Fig. 6. RNA synthesis occurs at single- and double-membrane structures. HeLa cells were infected with EMCV, 
metabolically labelled with tritiated uridine in the presence of dactinomycin, chemically fixed at 7 hpi and processed 
for EM-autoradiography to detect the subcellular location of newly-synthesised viral RNA in 2D EM cell-sections. A) 
Cells at early stages of infection revealed autoradiography signal (electron-dense grains) clustered around areas with 
single-membrane structures. B) In cells at late stages of infection autoradiography signal was found at RO clusters 
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6B), indicating that the transformation from single-membrane structure to DMV does not impede 
continued genome replication.
PI4KA inhibition of a PI4K-resistant EMCV mutant does not alter RO development or 
morphology
While there may be divergence in the origins of enterovirus and cardiovirus ROs, the development 
of SMTs that transform into DMVs appears to be a common feature of both. We next investigated 
whether common requirements for RO biogenesis might also exist between enteroviruses and 
cardioviruses. Specific roles for the enterovirus host factor PI4KB, a PI4P-generating kinase, have 
recently been identified. In addition to facilitating efficient polyprotein processing (20, 33-35), PI4KB 
Fig. 7. RO development during EMCV 3A-A32V infection under PI4KA inhibition. HeLa cells were infected 
with wt EMCV or EMCV 3A-A32V and chemically fixed at 5 or 7 hpi. A) Immunofluorescence labelling reveals a 
dense perinuclear distribution of dsRNA in cells infected with EMCV 3A-A32V and treated with a PI4KA inhibitor A1, 
compared to wt EMCV or EMCV 3A-A32V infections without inhibition. Cells were fixed at 7 hpi. Nuclei (blue) and 
dsRNA distributions (green) are shown. B) Single membrane structures (white arrowheads) and double-membrane 
structures (asterisk) could be found in infections of EMCV 3A-A32V under PI4KA inhibition that resembled those of wt 
EMCV (left, 7 hpi). Connections between single-membrane ROs and the ER (arrowheads) could also be found (right, 5 
hpi). C) Cells were infected with EMCV 3A-A32V, treated with PI4KA inhibitor, metabolically labelled, chemically fixed 
at 7 hpi and processed for EM-autoradiography to detect the subcellular location of newly-synthesised viral RNA in 2D 
EM cell-sections. Autoradiography signal (electron-dense grains) accumulated at RO clusters, similar to observations 
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accelerates the formation of enterovirus ROs (20). To investigate possible roles during EMCV RO 
formation of PI4KA, an essential PI4P-generating kinase for cardiovirus replication, we utilised the 
3A-A32V mutant (26). This mutant, generated through serial passaging of wt EMCV in cells with a 
stable knock down of PI4KA, is capable of establishing replication even in the presence of the PI4KA 
inhibitor A1. At a concentration of 10 nM this compound potently inhibits wt EMCV replication in 
HeLa cells, with no effect on cell viability (26).
In the absence of A1 treatment, infections of the EMCV 3A-A32V mutant in HeLa cells produced 
ROs whose morphology was indistinguishable from those of wt EMCV (Fig. S2). SMTs and SMVs 
predominated at earlier time points, while DMVs were found only occasionally (Fig. S2A, asterisk). 
Later in infection, DMVs proliferated and ROs became more clustered (Fig. S2B, DMVs indicated 
by asterisks). Together, these results indicate that the 3A-A32V substitution does not affect RO 
development or their general architecture. PI4KA inhibition under A1 treatment led to a more 
clustered, perinuclear dsRNA signal compared to uninhibited infections of EMCV 3A-A32V or wt 
EMCV (Fig. 7A) (26). Despite this different staining pattern under PI4KA inhibition, the morphology 
of ROs and time post-infection at which ROs were first detected were not affected. EMCV 
3A-A32V infection under PI4KA inhibition produced single- and double-membrane cardiovirus 
ROs (Fig. 7B, left, white arrowheads and asterisks respectively), typically in proximity to the ER 
(black arrowheads). Importantly, while the clustered dsRNA signal found under inhibition partially 
localized in the perinuclear Golgi region (Fig S3), connections between single-membrane ROs and 
the ER were still found (Fig. 7B, right, white arrowheads), and ROs produced under PI4KA inhibition 
also retained their ability to support RNA synthesis (Fig. 7C). Taken together, our data demonstrate 
that, while PI4KA/PI4P availability may govern the subcellular location of EMCV ROs, it does not 
significantly affect their emergence, morphology, or ability to serve as platforms for viral RNA 
synthesis.
D I S C U S S I O N
Here we reveal the 3D morphology of cardiovirus ROs, and present a comprehensive overview of 
their formation and development throughout infection. At early stages of EMCV infection virus-
induced SMTs and SMVs were found, which appear to transform into DMVs over the course of 
infection. This progression bears a striking resemblance to that of enterovirus ROs, suggesting 
a universal mechanism for DMV formation in picornaviruses. Despite differences in the cellular 
origins of enterovirus and cardiovirus ROs, our data establish that escape mutants from both 
genera are able to bypass any role of PI4P in RO formation.
 Single-membrane ROs predominated at early stages of EMCV infection, which were 
capable of supporting viral RNA synthesis. Interestingly, while enteroviruses invariably produce 
SMTs early in infection (21, 22), also in HeLa cells (22), EMCV produced both SMTs and SMVs. These 
structures were of different sizes, and did not form packed clusters like the SMTs of enteroviruses. 
Many of the SMTs and SMVs visualised at early stages of infection were also found connected to the 
ER, providing compelling evidence that cardiovirus ROs are ER-derived. This finding is supported by 
the reported reliance of cardioviruses on ER-associated proteins like PI4KA, and the observed co-
localisation of calreticulin and RO-associated viral proteins (18). Unlike cardioviruses, enteroviruses 
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the Golgi apparatus to generate their ROs. Interestingly, membrane connections between donor 
organelle and enterovirus ROs were not detected in the tomographic characterisation studies 
(21, 22), suggesting that the process of initial enterovirus RO budding and release from the donor 
organelle is rapid compared to that of cardioviruses.
Despite these divergences in origin and morphology, our findings suggest that the transformation 
of single-membrane ROs into DMVs is conserved amongst enteroviruses and cardioviruses. For 
both genera, DMV formation appears to occur via membrane pairing of single-membrane ROs 
to form curved cisternae that ultimately enwrap small volumes of cytosol (21, 22). Given that 
transport from the DMV interior to the cell cytosol across the double membrane of a closed DMV 
is problematic, these structures may represent a means of sequestering viral products at late 
stages of infection. Interestingly, a small population of DMVs were also found with openings to the 
cytosol. While these open DMVs could reflect an intermediate step in their transformation from 
single-membrane structures to closed DMVs, it is also possible that a small population of DMVs 
retain openings to the cytosol for the duration of infection. Given that viral replication is likely to 
occur on the cytosolic face of early single-membrane ROs (37, 38), the interior of open DMVs could 
represent a shielded environment for replication at later stages of infection, with access to the 
cytosol for virion packing and/or export. A similar mechanism could also underlie the formation of 
the sparse double-membrane structures among abundant single-membrane structures identified 
in 2D EM investigations of foot and mouth disease virus infection (genus Apthovirus) (39), and 
may represent the means by which DMVs form during infections of Picornaviridae more broadly. 
Evidence for a similar mechanism for DMV biogenesis has been presented for the arterivirus equine 
arteritis virus and MERS coronavirus (order Nidovirales), which in this case would not occur through 
single-membrane intermediate ROs but by direct pairing and curving of the ER membranes (40, 
41). While this enwrapping mechanism could represent a general route for DMV RO formation in 
+RNA viruses, it is intriguing that DMV formation is possible both via enwrapping of Golgi- or ER-
derived single-membrane ROs in the case of picornaviruses, or via direct enwrapping of cytosol by 
ER membranes in the case of nidoviruses. The formation of DMVs from these diverse progenitor 
membranes could suggest that their development depends primarily on viral machinery or 
recruited host factors. The cellular functions of these host factors may also provide clues about 
their functions during infection. For instance, LC3 has been found in conjunction with enterovirus 
ROs (42, 43). In uninfected cells, lipidated LC3 is hypothesised to induce the membrane curvature 
underlying omegasome formation during autophagy (44), and its recruitment to enterovirus ROs 
could suggest a similar role in the formation of DMVs, whose development appears to resemble 
that of autophagosomes.
While direct actors have yet to be established, it is likely that cardiovirus RO formation is dependent 
upon specific, membrane-associated host factors. PI4P is an essential lipid for the replication of 
picornaviruses (16, 18, 45) and is generated at the ER or the Golgi apparatus by PI4KA and PI4KB 
respectively. Interestingly, PI4Ks are also important for HCV replication, where they appear to play 
a role in RO formation (19, 46). Expression of a mutated HCV NS5A, whose ability to recruit PI4KA is 
impaired, has been shown to produce ROs with irregular morphologies (19). A role for PI4Ks during 
RO biogenesis has also been demonstrated for enteroviruses, as RO formation was delayed under 
PI4KB inhibition during infections of the PI4KB inhibitor-resistant virus CVB3 3A-H57Y. Under these 
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instead on apparently intact Golgi membranes (20). In our study, PI4KA inhibition shifted the 
subcellular distribution of EMCV dsRNA, but did not affect the time post-infection at which ROs 
were first detected or alter their observed morphology, connectivity with the ER or competence 
to support viral RNA synthesis. These different observations in the two genera could arise from 
differences in the efficiency of the escape mechanism conferred by the specific resistance 
mutations, or alternatively suggest that, unlike for enteroviruses, PI4P does not play a significant 
role in cardiovirus RO formation. In either case, both mutants were able to (ultimately) produce 
ROs with normal morphology under PI4K inhibition, showing that any role of high PI4P levels in 
RO formation can be circumvented by members of both picornavirus genera. PI4P is also required 
for efficient polyprotein processing in enteroviruses, although this requirement is circumvented in 
PI4KB inhibitor escape mutants (20, 33, 34). Whether EMCV requires PI4P for polyprotein processing 
remains to be established.
ROs are believed to confer inherent advantages to the viruses that generate them, but it is unclear 
whether the different morphologies generated provide specific benefits. Although both single- 
and double-membrane ROs were found to support cardiovirus RNA synthesis, single-membrane 
structures predominated during the peak hours of genome replication. While this suggests that 
DMVs are largely superfluous for RNA synthesis, they may provide other benefits during infection. 
DMVs could selectively sequester viral products to prevent their detection by cellular innate 
immune sensors. In the case of enteroviruses, it has been suggested that DMVs may also be utilised 
for the non-lytic release of viral progeny (47). However, virions were only rarely detected within 
EMCV DMVs, which likely reflects random incorporation of virus particles and other cytosolic 
material when DMVs arise by enwrapping. Intriguingly, we found a large proportion of EMCV 
virions adjacent to ROs, suggesting close spatial coordination between RNA synthesis and capsid 
assembly. In enteroviruses, viral RNA synthesis and capsid assembly have been shown to be directly 
coupled, likely through interactions between the RNA replication machinery and the viral structural 
proteins (48, 49).
Collectively, our data reveal striking similarities between the ROs produced by enteroviruses and 
cardioviruses, and raise the possibility of a conserved mechanism of picornavirus RO biogenesis 
to form single-membrane structures that can transform into DMVs. In this regard picornaviruses 
appear to be unique, as other DMV-forming viruses, like coronaviruses or HCV, generate DMVs 
directly from the cellular donor membrane. Given that all +RNA viruses to date have been found 
to produce spherules or DMVs, viruses tend to be classified as producing one or the other RO 
type. However, while picornaviruses do produce DMVs, RNA synthesis transpires predominantly 
on the early single-membrane structures. Thus, in addition to the negative curvature spherules of 
alphaviruses and flaviviruses, and the DMVs formed by coronaviruses and hepaciviruses, positive 
curvature single membrane structures appear to represent a third major form of RO.
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E X P E R I M E N TA L  P RO C E D U R E S
Cell lines and reagents. HeLa R19 cells were maintained in Dulbecco’s modified Eagle’s medium 
(Gibco) supplemented with 10% fetal calf serum, penicillin, and streptomycin, and grown at 37°C 
in 5% CO2. The PI4KA inhibitor A1 (50) was kindly provided by T. Balla (National Institutes of Child 
Health and Human Development, National Institutes of Health, Bethesda, MD, USA) and used at a 
concentration of 10 nM.
Virus infections. Cells were inoculated for 1 hour with EMCV wt (strain Mengo) or EMCV 3A-A32V 
(described in (26)) at an MOI of 50, after which the inoculum was removed and fresh medium (with 
drug A1 where indicated) was added. At specified time-points after infection cells were prepared 
for qPCR, viral titer determination, immunofluorescence or electron microscopy.
Quantitative PCR. A Nucleospin RNA kit (Machery-Nagel) was used to isolate RNA from lysed cells. 
Random hexamer primers were used with a TaqMan reverse transcription reagents kit (Roche) to 
synthesize cDNA. Quantitative PCR was carried out using the LightCycler 480 SYBR Green I master 
kit (Roche) for 45 cycles (5 s at 95°C, 10 s at 60°C, and 20 s at 72°C) on a LightCycler 480 (Roche). 
Resulting Ct values were expressed as fold increase with the value at t = 2 h set as 1.
Viral titer determination. Total virus titers (of intra- and extra-cellular particles) were determined 
by freeze-thaw lysis of infected cells and endpoint titration.
Immunofluorescence microscopy. Cells were fixed with 3% paraformaldehyde and permeabilized 
with PBS containing 0.1% Triton X-100. Cells were then labelled with a mouse monoclonal antibody 
against dsRNA (J2 antibody; English and Scientific Consulting) and secondary Alexa Fluor 
488-conjugated goat-anti-mouse IgG, alongside a nuclear stain (Hoechst 33342). Imaging was 
performed using a widefield DM5500 (Leica) fluorescent microscope.
Electron microscopy
Metabolic labelling and autoradiography. Infected cells were pre-incubated with 10 µg/ml 
dactinomycin for 1 hour to inhibit cellular transcription, then labelled for 45 minutes with tritiated 
uridine ([5-3H], 1 mCi/ml) (Perkin Elmer) also containing dactinomycin. Cells were then washed 
several times to remove unincorporated label and fixed for 1 hour in 1.5% glutaraldehyde in 0.1 M 
cacodylate buffer. Mock-infected control samples were similarly prepared. Post-fixation consisted 
of a 1-hour incubation with 1% osmium tetroxide in 0.1 M cacodylate buffer followed by a 1 hour 
incubation with 1% uranyl acetate solution. Samples were then washed and dehydrated in ethanol 
and infiltrated and embedded in LX 112 resin before polymerisation at 60°C. Sections of 50 nm were 
collected on formvar-coated EM grids and post stained with lead citrate and uranyl acetate, then 
carbon coated and prepared for autoradiography. For this, a thin layer of silver halide photographic 
emulsion (ILFORD L4) was applied in the dark to cell sections prepared for EM. Samples were 
incubated in the dark and developed after several weeks for autoradiography as described in (20). 
During incubation, the radiolabelled uridine incorporated during viral RNA synthesis decays, and 
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small, electron-dense grains dispersed around the original radioactive source that can be visualised 
during EM imaging.
High-pressure freezing and freeze substitution. Cells were high-pressure frozen using an EM 
PACT2 (Leica). Samples were maintained at -90°C in an AFS2 (Leica) freeze substitution device for 
44 h in a solution of 20% H20, 2% osmium tetroxide and 1% anhydrous glutaraldehyde. A high water 
content was used as this was found to improve the contrast of RO membranes. The temperature 
was then raised to 0°C over a period of 22 h through a series of controlled warming phases (identical 
to those described in (21)). Samples were washed with acetone, infiltrated with epoxy resin LX-
112 (Ladd Research) and polymerised at 60°C. Sections of 70 nm were collected on EM grids and 
post-stained with uranyl acetate and lead citrate. For tomography, thicker sections of 200 nm were 
collected. Before post-staining, both sides of the EM grid were incubated with 10 nm colloidal gold 
beads to serve as fiducial makers during tomogram reconstruction.
Electron microscopy imaging. Thin-section (50 or 70 nm) 2D images were collected (binning 
mode 2) on a Tecnai12 BioTWIN or TWIN electron microscope at 120 kV using an Eagle 4k slow-
scan CCD camera (Thermo Fisher Scientific (formerly FEI)) or OneView 4k high frame-rate camera 
(Gatan) respectively. For the semi-automated collection of larger areas, meshes of overlapping 
images were acquired across the entire region of interest and later reconstituted into a single 
composite image (as described in (51)).
Electron tomography. Dual-axis tilt series of 200 nm sections each covering 130-140° around the 
region of interest were collected using an FEI F20 electron microscope at 200kV with zero-loss 
energy filtering using a 2k camera (Gatan) and 1.27 nm pixel size. Automated tilt series acquisition was 
performed using Xplore3DTM software (FEI). Tilt series alignment and tomogram reconstruction 
by weighted back-projection were carried out in IMOD (52) (version 4.7.15). In the process, the 
gold fiducial markers were digitally erased to be eliminated from the final 3D reconstruction. To 
determine the sizes of ROs spanning multiple sections, tilt series of the same region across 2-5 
consecutive sections were collected and combined in IMOD to build tomogram volumes with a 
z-thickness of ~400-1000 nm. The sizes of ROs were estimated by measuring the SMTs, SMVs and 
DMVs within reconstructed volumes in IMOD. The maximum width of SMTs, SMVs and DMVs were 
considered the RO diameters. For all calculations SMTs were approximated to a cylinder, and the 
inner DMV membrane surface area was considered an approximation of the outer.
To generate models of features of interest, image segmentations were made from tomograms 
using Amira 6.0.1 (FEI). Before segmentation, tomograms were post-processed to enhance edges 
by nonlinear anisotropic diffusion filtering (53) as implemented in IMOD using 5 iterations and 
K=1000, and then binned by 2 in x and y. Membranes were selected in manually masked areas 
by thresholding, then refined by removing islands and smoothing. Surfaces that were poorly 
represented (e.g. top and bottom surfaces of vesicles and tubules) due to the missing-wedge 
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S U P P L E M E N TA L  F I G U R E S
Figure S2. The ROs formed by EMCV 3A-A32V are 
indistinguishable from those of wt EMCV. HeLa cells 
infected with EMCV 3A-A32V were frozen at 5 hpi for EM 
processing and 2D cell-section analysis. The virus-induced 
single-membrane and double-membrane structures 
found at earlier (A) and later (B) stages of infection were 
morphologically identical to those formed during wt EMCV 
infection. Double-membrane structures are marked with a 
white asterisk. Scale bars are 5 µm (unboxed images) or 100 
nm (dashed-line boxed images).
A
B
Figure S1. Analysis of the distribution of virus particles shows an association between EMCV virions and ROs. 
Distribution of EMCV virions relative to nearest RO membrane in HeLa cells infected with EMCV at 7 hpi (pooled data 
from two tomograms from two different cells). The distances from the centre of virions to the nearest SMV, SMT 
or DMV RO membrane was measured (n = 183, represented in upper graph). To independently assess whether this 
measured distribution of particles relative to ROs differed from a random distribution, tomograms were populated 
with models of simulated particles by randomly generating co-ordinates within the cytosolic space of the tomogram 
volume. The distances between the centres of these randomly-generated particles and the nearest RO membrane 
was then measured (n = 183, represented in lower graph). The cumulative frequency distributions of the observed and 
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Figure S3. EMCV 3A-A32V dsRNA signal clusters in the perinuclear Golgi region under PI4KA inhibition. HeLa 
cells were infected with EMCV 3A-A32V at an MOI of 75 with or without 10 nM A1 treatment to inhibit PI4KA, and 
fixed at 7. The trans-Golgi network marker TGN46 was labelled with a primary rabbit polyclonal antibody (Novus 
Biologicals) and secondary Alexa Fluor 594-conjugated goat-anti-rabbit IgG for immunofluorescence analysis in a 
Leica SPII confocal microscope. PI4KA inhibition led to clustering of dsRNA signal (green) around the perinuclear 
region in foci that were often proximal to the TGN46 signal (red). Scale bar is 10 µm.
Movie S1. Reconstructed and joined serial tomograms and segmentation of ROs found at early 
stages of EMCV infection. The complete tomogram volume (1 µm x 2.4 µm x 2.4 µm) of the 
region featured in Fig.3A is shown, which represents a typical region in an infected cell at 5 hpi. 
Segmentation of a sub-volume within this data highlights connections between SMTs (blue) or 
SMVs (red) and the endoplasmic reticulum (green).
Movie S2. Reconstructed and joined serial tomograms and segmentation of ROs found at late 
stages of EMCV infection. The complete tomogram volume (0.4 µm x 2.3 µm x 2.3 µm) of the 
region featured in Fig. 4A is shown, which represents a typical region in an infected cell at 7 hpi. 
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T H E  MU LT I FAC E T E D  RO L E  O F  P I 4 P  I N  P I CO R N AV I R U S  I N F E C T I O N 
As obligate intracellular parasites, viruses are dependent on the cells they infect for their propaga-
tion. In addition to hijacking cellular systems like endocytosis for virus entry and the ribosomal ma-
chinery for translation, individual host factors are utilised to support different processes through-
out the virus life cycle.
In uninfected cells PI4P is a lipid with diverse functions, including the mediation of cholesterol ex-
change at the ER-Golgi interface via OSBP. Many of the viruses that utilise PI4P, including enterovi-
ruses and cardioviruses, recruit PI4Ks to sites of replication to increase local PI4P levels (1-4), where 
it facilitates local cholesterol exchange (2, 5-8). A role for PI4P in modulating proteolytic processing 
of the viral polyprotein has also emerged from experiments in poliovirus (9, 10), where PI4P appears 
to mediate cleavage at the 3AB junction. In Chapter 3, we establish that this role is conserved in 
another enterovirus, CVB3. The mechanism underlying this effect in either enterovirus species has 
yet to be determined, but may relate to the influence of lipid composition on the orientation of 3A 
precursors within the membrane. Indeed, PI4KB resistant mutations in both poliovirus (3A-A70T) 
and CVB3 (3A-H57Y) lie within or proximal to the putative membrane-spanning hydrophobic do-
main of the 3A protein (11, 12). Interestingly, OSBP inhibition also impairs 3A-3B cleavage (10), sug-
gesting that this effect could be mediated by low membrane cholesterol levels rather than low PI4P 
levels directly.  In Chapter 3 we also outline a new function of PI4KB. Utilising a CVB3 resistant to 
PI4KB inhibition, low local concentrations of PI4P were found to delay the formation of CVB3 ROs to 
beyond the phase of exponential viral RNA synthesis. ROs that appear to be morphologically typical 
formed only late in infection under PI4KB inhibition, and these structures appeared to be devoid 
of the high levels of PI4P associated with ROs in wt CVB3 infection. Thus, high PI4P levels are not 
strictly required for the development of ROs, but do expedite their formation. Inefficient cleavage 
of viral proteins has been suggested to affect RO formation in HCV (13), as well as in coronaviruses 
(14). However, poor polyprotein processing under low-PI4P conditions did not explain the delay in 
CVB3 RO formation we observed, as polyprotein processing of the PI4KB resistant CVB3 3A-H57Y 
was not impaired under PI4KB inhibition. This suggests that the role of PI4P in polyprotein process-
ing and its role in expediting RO formation are independent in enterovirus-infected cells.
While the mechanism that underlies the role of PI4P in RO formation remains uncertain, it is likely to 
be more nuanced than for other host factors that influence RO development, like the ESCRT pro-
teins and reticulons that shape virus-induced membrane modifications during infections of other 
+RNA viruses (15, 16), and perhaps also of enteroviruses (17). PI4P may in fact have a semi-redundant 
function during RO formation, rather than an intrinsic structural role. This is supported by find-
ings in Chapter 5, in which an analogous PI4KA-resistant cardiovirus, EMCV 3A-A32V, was found to 
produce ROs under PI4KA inhibition at a similar time point post-infection to uninhibited wild-type 
virus. One tantalising possibility is that the effect of PI4P on RO formation stems from its role in 
OSBP-mediated cholesterol recruitment, as cholesterol has a direct effect on the formation of lipid 
domains and on membrane morphology (18-20). Indeed, enteroviruses have been shown to utilise 
other routes for cholesterol recruitment, for instance via endosomal transfer (21). These alternative 
routes may be more effectively harnessed, when PI4P levels are suppressed. However, while cho-
lesterol is essential for replication and, like PI4P, has been shown to be important for polyprotein 
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M E M B R A N E  U T I L I SAT I O N  F O R   RO  F O R M AT I O N  I S  R E M A R K A B LY  F L E X I B L E
While our understanding of the viral and host components that engender enterovirus ROs is broad-
ening, fundamental questions about their origin remain unanswered. Putative donor organelles 
have been identified for many +RNA viruses using electron microscopy, but connections between 
a donor organelle and ROs have been elusive in ultrastructural studies of enterovirus infection. 
Other studies that explore co-localisations between viral and host factors, or hunt for the locations 
of early viral RNA synthesis, have generated a sprawling and at times contradictory picture of where 
the first enterovirus ROs are formed. Much of the available evidence suggests that membranes of 
the Golgi apparatus contribute to enterovirus RO biogenesis (1, 23-25). This idea is supported by 
the chronological correspondence between Golgi apparatus disintegration and RO formation ob-
served in EM (26), and in live-cell imaging data (Chapter 2) of infected cells, and by the association 
of viral replication with the Golgi in the absence of ROs found in Chapter 3. However, alternative 
origins have also been suggested, including the ER and the autophagy pathway (1, 23, 27-29). In-
terpretation of data that suggest potentially conflicting origins is confounded by the differenc-
es in virus species, the times post-infection assessed, and the experimental methodologies used 
across these studies. In Chapter 4 we present compelling evidence that membrane utilisation by 
enteroviruses is diverse, revealing connections between ROs and both ER and Golgi membranes in 
SBF-SEM and TEM data. In addition to uniting disparate ideas about the origins of enterovirus ROs, 
these data highlight the surprising flexibility with which viruses can exploit cellular membranes for 
RO formation. This flexibility may extend to other +RNA viruses, as suggested by key experiments 
using tombusviruses and nodaviruses, where RO formation could be directed to specific organelles 
using localisation signals, or was found to occur at alternative organelles in the absence of the typ-
ical membrane target (30, 31).
Our observations further demonstrate that morphologically similar ROs can be derived from differ-
ent membrane sources. This suggests that the host factors that drive or contribute to enterovirus 
RO biogenesis, and those that have a role in the transformation of single- into double-membrane 
structures, are not specific to the membrane origin, or can be recruited. These criteria are well met 
by PI4P, which is ubiquitous in the cell and produced by kinases that are readily recruited to spe-
cific cellular compartments. In uninfected cells PI4KB is recruited primarily to the Golgi apparatus, 
while PI4KA is responsible for PI4P generation at the plasma membrane and ER (32, 33). While PI4KB 
recruitment to the Golgi apparatus is enhanced during enterovirus infection, where it contributes 
to rapid RO formation (Chapter 3), the role of PI4P in ER-derived RO formation is less clear. PI4P 
production may be stimulated by the selective recruitment of PI4KB to the ER, else existing ER 
pools of PI4P generated by PI4KA may be sufficient (e.g. at ER exit sites (34)). Another possibility is 
that ROs of ER origin form independently of PI4P. Live-cell imaging data (Chapter 3) suggest that, 
under PI4KB inhibition, the 3A protein accumulates almost exclusively in the Golgi region rather 
than first forming in peripheral/ER-associated clusters, pointing to a role for PI4KB in ER-derived 
RO formation.
In Chapter 5 this idea that characteristic picornavirus RO morphologies are not tied to a specific 
membrane origin was reinforced following the characterisation of the 3D morphology and devel-
opment of EMCV ROs. Despite significant differences in cardiovirus and enterovirus host factor 
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those of enteroviruses, producing initially single-membrane structures that developed into DMVs. 
Connections between endomembranes and early ROs were readily found during EMCV infection, 
suggesting that the ER is the exclusive donor organelle for cardiovirus ROs. Together with the re-
sults in Chapter 4, these data suggest that the donor organelle is not deterministic of the resulting 
RO morphology for enteroviruses and cardioviruses, and perhaps picornaviruses more generally. 
While studies in tombusviruses (35, 36) provide evidence that the viral replication machinery can 
be successfully diverted to different organelles, it is unclear whether virus-induced membrane re-
arrangements form at these sites and, if so, whether these structures have typical morphologies.
While viruses appear to target specific membrane compartments upon infection, these findings 
altogether raise the question of what defines an appropriate membrane platform for replication, or 
an appropriate membrane donor for RO formation. While viruses have typical membrane targets 
from which they derive ROs for genome replication, it is clear that the core requirements for rep-
lication are not tied to specific membrane compartments in all cases. Membrane utilisation may 
instead be decided by the localisation and dynamics of early replication events, the requirements 
for protein folding and processing, or be the result of favourable positioning or proximity to aux-
iliary organelles utilised during but not essential for replication, like lipid droplets or endosomes.
T H E  S I T E S  O F  R N A  SY N T H E S I S  R E P R E S E N T  A  N E W  R O  P H E N OT Y P E
The archetypal RO morphologies produced by +RNA viruses are broadly characterised as forming 
secluded compartments; the spherules of FHV (37), Zika virus (38), and DENV (39, 40) and the DMVs 
of SARS- and MERS- coronaviruses (41, 42), EAV (43), HCV (44), CVB3 (26), PV (25) and EMCV (Chap-
ter 5). However, our findings from studies of EMCV (Chapter 5) and similar data from enterovirus 
studies ((25, 26), Chapter 3) suggest that, for the picornaviruses, the primary sites of RNA synthesis 
are single-membrane ROs with positive curvature. While the 3D structures of other picornavirus 
ROs remain to be explored, the 2D profiles found in EM cell-sections of other genera, like the aph-
thoviruses, also resemble those of the enteroviruses and cardioviruses (45). While putative DMVs 
identified in FMDV-infected cells could be found at the mid-point of infection, the predominant 
ROs at early and intermediate points in infection were single-membrane structures. Rather than 
the DMVs then, it is single-membrane structures that appear to be the primary support for picor-
navirus RNA synthesis. For this reason, single-membrane structures with positive curvature must 
be considered a third archetypal RO morphology produced by +RNA viruses. Unlike the spherules 
and DMVs utilised for genome replication in other +RNA virus families, these single-membrane 
tubule ROs of picornaviruses do not enclose cytosolic space.
T H E  A DVA N TAG E S  O F  G E N E R AT I N G  RO S  F O R  P I C O R N AV I R U S  I N F E C T I O N
In Chapter 3 we present an example of +RNA virus replication at a morphologically intact cellu-
lar organelle. These data effectively demonstrate that ROs are not strictly required for sustained 
enterovirus RNA synthesis, raising questions over the advantages of RO formation during replica-
tion. While a causative relationship between the delayed enterovirus RO formation and reduced 
replicative efficiency observed under PI4KB inhibition has not been established, this observation 
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effective RNA synthesis. The advantages conferred by RO formation in this regard may include the 
expansion of suitable membranes for genome replication, or the provision of an optimal environ-
ment for the RNA replication machinery to assemble and function. For FHV (46), poliovirus (47) 
and SARS-coronavirus (48) there is evidence to suggest that intact membranes are required for 
efficient viral RNA synthesis, supporting this notion. 
Intact membranes may also prove beneficial by protecting viral RNA from sensors of the innate 
immune system. In vitro studies of FHV (46), and poliovirus (49) show a link between (intact) RO 
membranes and RNAse access to RO-associated viral RNA. Given that enterovirus replication com-
plexes are thought to reside on the cytosolic face of ROs (28), this apparent protective function 
could serve to shield viral replication intermediates from cellular innate immune sensors in vivo. 
Another +RNA virus, HCV, appears to have developed an alternative or additional mechanism to 
shield viral RNA species from cellular sensors, by integrating nucleoporins into its membranous 
web to regulate protein access (50). It should be noted that, while these studies show that intact 
membranes confer protection, it remains unknown whether this effect is dependent upon specific 
ROs morphologies. For spherule-forming viruses, the morphology of ROs may provide a straight-
forward shielding mechanism. Given that only a small, neck-like opening bridges the space be-
tween cytosol and spherule interior, these compartments are relatively isolated from the remain-
der of the cytosol, limiting the availability of viral products for detection by cellular sensors. Unlike 
spherules, the tubules and vesicles produced by picornaviruses, and (if their outer membrane is 
utilised for genome replication) the DMVs generated by nidoviruses and flaviviruses replication, 
represent a large, exposed surface area vulnerable to sensing. For these viruses, the concept that 
the morphology of their ROs is adapted to shield RNA is less intuitive. In fact, an absence of ROs at 
the peak of RNA synthesis in CVB3 3A-H57Y infection was found to have no significant impact on 
the measured IFN-b response across infection, or the state of the innate immune sensors MAVS 
and PKR, as described in Chapter 3. While it remains to be established whether viral RNA is also 
physically shielded (e.g. from RNases) in these conditions, these data could suggest that any pro-
tective function is unrelated to RO morphology, and that replication at a morphologically intact 
Golgi apparatus is similarly protective to replication at ROs. Protection could feasibly be conferred 
by the viral replication machinery within the replication membrane. Viral dsRNA must be available 
to the C terminus and helicase domain of the RIG-I-like receptor MDA5 for its activation (51), and 
the juxtaposition of membrane and replicating RNA, or the viral machinery surrounding it, may 
limit accessibility. It may also be that membranes, morphology-dependent or otherwise, serve at 
best a semi-redundant function in innate immune evasion, given the efficacy of viral proteases that 
cleave innate immunity recognition and signalling molecules (52, 53).
ROs may also facilitate other processes during infection, by co-ordinating different events during 
the viral life cycle. For enteroviruses, genome replication at ROs is directly coupled to genome 
encapsidation (54, 55). This mechanism may have developed as a means of increasing the efficacy 
of nascent virion production by eliminating the need for RNA diffusion ahead of packaging. If RO 
membranes represent a protective environment for viral products, then diffusion of ssRNA away 
from ROs would also expose the virus to cellular innate immune proteins like RNAse L (56) in virus-
es like CVB3 whose genomes are vulnerable to its endonuclease activity (57). The direct coupling 
of viral genome synthesis and encapsidation also ensures specificity of RNA packaging, and rep-
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replication and packaging of viral genome (58). That these processes are coupled implies that virus 
particles also assemble at ROs, and may in some way utilise the membrane platform they provide to 
co-ordinate assembly. Alternatively, particles may assemble in the cytosol and aggregate at ROs. In 
accordance with these possibilities, a striking spatial proximity between ROs and virus particles was 
observed in EMCV-infected cells in Chapter 5, which could reflect a similar association between 
RNA synthesis and virion packaging in cardioviruses. 
T H E  R O L E  O F  D MV S  I N  P I CO R N AV I RU S  R E P L I C AT I O N
Enteroviruses DMVs have also been reported to serve as vehicles for the en bloc transfer of mature 
virions (59-61), which may increase the likelihood of a viable infection if complementary viral qua-
sispecies are exported together. However, the analysis of EMCV virion distribution in Chapter 5 
demonstrated that only a small fraction of DMVs contain virus particles. While this does not exclude 
the possibility that these DMVs are exported, it suggests that en bloc transfer is not a prominent 
mechanism of viral export in cardioviruses. 
A clear role for DMVs in picornavirus replication has yet to be identified. The peak of viral RNA 
synthesis in enteroviruses and cardioviruses (Chapters 4 and 5) occurs when single-membrane 
structures predominate, ahead of their transformation into DMVs, raising the question of why 
this transformation occurs. One possibility is that DMV formation, by enwrapping small volumes 
of cytosol, is a mechanism to shield a proportion of the RNA replication machinery or replicative 
products from innate immune sensors. This could be advantageous particularly at late stages of 
infection, when other viral mechanisms to evade the cellular innate immune system, like the viral 
protease-mediated cleavage of cellular sensors, may be overburdened. Evidence for the accumu-
lation of viral RNA within DMVs has been found in nidoviruses (41, 43), although it remains unclear 
whether the inner membrane of nidovirus DMVs, which do not have openings connecting the DMV 
interior to the cytosol, are the primary site of nidovirus RNA synthesis. A small proportion of en-
terovirus and cardiovirus DMVs were found in a vase-like configuration that connected the DMV 
interior and the cytosol ((26), Chapter 5). It is unclear whether these openings represent (semi-)
stable structures found in a low percentage of DMVs, or a transient late stage of DMV formation. 
Given that picornavirus RNA synthesis continues following the transformation of tubules into 
DMVs, open DMVs could represent a shielded environment for late-stage viral genome replication. 
Indeed, given the evidence for coupled genome replication and virion packaging, those DMVs that 
contain openings may correspond to those that accumulate nascent virions, perhaps ahead of pore 
fusion and en bloc transfer.
R E T H I N K I N G  T H E  V I R A L  R E P L I C AT I O N  M E M B R A N E
While categorisations based on morphology are contextually useful, archetypal RO morphologies 
are an incomplete picture of how viral replication membranes develop throughout infection. In-
deed, prior to the accumulation of RO-forming viral proteins, viral genome replication may occur 
at largely unmodified membranes.
It is also significant that, while the vast majority of viral RNA synthesis occurs at ROs under typical 
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In Chapter 3, extended enterovirus RNA synthesis was shown to occur at a morphologically intact 
Golgi apparatus under low PI4P conditions, without any apparent penalty to innate immune eva-
sion, but with a corresponding drop in RNA replication efficiency. In this case it is unclear whether 
low replication efficiency results directly from a lack of archetypal enterovirus ROs, or indirectly 
from (the incomplete rescue of) defects in polyprotein processing. Other evidence suggests that 
RO morphology can be dispensed without a cost to fitness. Manipulating the relative levels of the 
BMV 1a and 2a polymerase shifted the BMV replication membrane morphology from archetypal 
spherules to flat membrane sheets, without a reduction to replicative efficiency (62). This high-
lights again the surprising flexibility with which viruses can use membranes, and emphasises the 
pitfalls of defining the membranes utilised for replication by their morphology. Indeed, the evi-
dence thus far aligns with a scenario where specific membrane morphologies may be secondary 
for viral RNA synthesis. A holistic approach is required to understand the membrane composition 
that underlies the efficient, sustained viral RNA synthesis that is typically associated with ROs. Im-
proved procedures for the isolation and lipidomic or proteomic analysis of replication membrane 
fractions will allow for a more comprehensive understanding of the changing compositions of rep-
lication membranes at different stages of infection. This information can be coupled with powerful 
techniques to visualise native-state RO structures by cryo-electron microscopy, which can inform 
us regarding the conformation of intact replication complexes, and demonstrate how these as-
semble and function on the surface of replication membranes with changing compositions. The 
mechanism that drives the development of archetypal RO morphologies may well emerge from 
this enhanced understanding of their composition. It is this mechanism that lies at the heart of the 
question of RO function, and whether the morphologies that arise during infection represent the 
result of, or a prerequisite to, effective replication.
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N E D E R L A N D S E  SA M E N VAT T I N G
In dit proefschrift worden verschillende aspecten van replicatie organellen (RO’s), die tijdens 
een picornavirus infectie in de cel ontstaan, onderzocht. Hoofdstuk 1 bevat een inleiding over 
de rol en het belang van deze picornavirus RO’s. Ook komen er belangrijke vraagstukken die nog 
opgehelderd moeten worden aan bod, zoals wat de oorsprong van RO’s is, wat de vereisten zijn 
voor het ontstaan ervan, en welke functies de RO’s hebben. De verschillende methodes die worden 
gebruikt om deze vragen te beantwoorden worden tevens uitgelegd, met name de voordelen van 
“Serial Block-Face Scanning Electron Microscopy” (SFB-SEM). Deze techniek maakt het mogelijk 
om, in tegenstelling tot conventionele Electronen Microscopie (EM), gehele cellen te bestuderen, 
hetgeen ongekende contextuele informatie oplevert. De technieken en methoden die tijdens dit 
werk zijn ontwikkeld en gebruikt bieden nieuwe mogelijkheden voor vervolg studies naar vorm en 
functie van RO’s.
In Hoofdstuk 2 wordt de constructie en toepassing besproken van een enterovirus dat een 
zogeheten split-GFP-tag draagt in zijn genoom. Deze kleine split-GFP-tag wordt geïntroduceerd in 
het RO-geassocieerde 3A eiwit en zal ervoor zorgen dat de enterovirus RO’s groen zullen oplichten 
tijdens infectie. De implementatie en validatie van dit split-GFP virus komen achtereenvolgens 
aan bod. Als eerste wordt aangetoond dat de introductie van de split-GFP-tag in het enterovirale 
3A eiwit geen nadelige gevolgen heeft voor de bekende functies van dit eiwit. Vervolgens wordt 
met Correlatieve Licht en Electronen Microscopie (CLEM) bewezen dat de RO’s geïnduceerd door 
het split-GFP virus inderdaad groen oplichten en een morfologie hebben die karakteristiek is voor 
enterovirus RO’s. Tot slot wordt in levende cellen onderzocht wat de ruimtelijke en chronologische 
relatie is tussen de vorming van enterovirus RO’s en het uiteenvallen van het Golgi apparaat. Dit 
split-GFP virus omzeilt de beperkingen van het gebruik van grote fluorescerende eiwitten, die niet 
worden getolereerd in het enterovirale genoom, en is een elegant antwoord op het ontbreken van 
de mogelijkheid om enterovirale RO’s in levende, geinfecteerde cellen te bestuderen.
De split-GFP methodologie die gepresenteerd is in Hoofdstuk 2 wordt in Hoofdstuk 3 gebruikt 
om de rol van PI4P lipides tijdens enterovirus infectie te bestuderen. Dit maal wordt de split-
GFP-tag geïntroduceerd in het 3A eiwit van een mutant enterovirus. Dit mutante enterovirus is in 
staat om zichzelf te vermenigvuldigen wanneer de activiteit van PI4KB, een kinase dat PI4P lipides 
synthetiseert, wordt geremd. Hiermee zijn de effecten van lage PI4P concentraties op de vorming 
van enterovirus RO’s bestudeerd. Eerst wordt met Transmissie Electronen Microscopie (TEM) 
aangetoond dat er geen RO’s aanwezig zijn in cellen die geïnfecteerd zijn met het mutante virus in 
aanwezigheid van de PI4KB remmer. Dit resultaat is het eerste bewijs dat langdurige replicatie van 
het enterovirale genome kan plaatsvinden in afwezigheid van RO’s of andere modificaties van de 
intracellulaire membranen. Met CLEM is gevonden dat de genoom replicatie onder deze condities 
daarentegen plaatsvindt op een schijnbaar intact Golgi apparaat. Deze bevinding wordt bevestigd 
met autoradiografie studies, die direct bewijs leveren voor viraal genoom synthese op het Golgi 
laat in infectie. Deze resultaten samen suggereren dat PI4P lipides een belangrijke rol spelen in het 
uiteen vallen van het Golgi apparaat en vervolgens tijdens de vorming van enterovirus RO’s. Om dit 
verder te onderzoeken is een replicatie-onafhankelijk systeem opgezet, waarmee wordt bevestigd 
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dat de aanwezigheid van PI4P lipides het ontstaan van RO’s versnelt, maar niet strikt noodzakelijk 
is voor RO vorming. Deze rol van PI4P lipides blijkt niet verweven te zijn met de rol tijdens de 
proteolytische digestie van het enterovirale “polyprotein”. De intrigerende eigenschap van dit 
mutante enterovirus om zichzelf te vermenigvuldigen in de afwezigheid van RO’s is vervolgens 
benut om de functies van RO’s verder te onderzoeken. Replicatie in afwezigheid van RO’s blijkt 
geen zichtbare effecten te hebben op interferon beta levels, hetgeen vraagtekens zet bij de notie 
dat RO’s een cruciale rol spelen in het ontwijken van de aangeboren afweer tegen virale infecties.
In Hoofdstuk 4 worden de donor organellen die gekaapt worden voor de vorming van enterovirus 
RO’s opgehelderd. Dit is bewerkstelligd door het vastleggen van het moment van ontstaan van 
RO’s uit het donor organel met behulp van het split-GFP virus, dat in Hoofdstuk 2 is beschreven, en 
de SBF-SEM techniek. Hiervoor zijn levende, geïnfecteerde cellen gemonitord en gefixeerd op het 
moment dat de eerste groene RO’s verschenen. Deze gefixeerde cellen zijn onderworpen aan SBF-
SEM om zo CLEM informatie van de gehele cel te verkrijgen. Verrassend genoeg is gevonden dat de 
eerste RO’s ontstaan uit het endoplasmatisch reticulum en wat later in infectie uit het trans-Golgi 
netwerk. Dit suggereert dat beide organellen het ontstaan van enterovirus RO’s ondersteunen, 
waardoor schijnbaar conflicterende hypotheses over de oorsprong van RO’s worden verenigd. 
Daarnaast zijn in deze data fysieke connecties tussen RO’s en “lipid droplets” gedetecteerd, die 
mogelijk wijzen op een route voor lipide uitwisseling tussen beide die belangrijk is voor replicatie 
van het enterovirale genoom. Deze rijke dataset illustreert de voordelen van de SBF-SEM techniek 
gecombineerd met fluorescentie, waarmee contextuele informatie van de gehele cel kan worden 
vastgesteld.
In Hoofdstuk 5 worden de RO’s van een ander picornavirus bestudeerd, te weten een cardiovirus. 
Electronen Tomografie wordt toepast om de driedimensionale morfologie van de cardiovirus 
RO’s op verschillende tijdstippen van infectie op te helderen. Deze studie toont aan dat sferische 
cardiovirus RO’s met een enkelvoudig membraan ontspringen uit het endoplasmatisch reticulum 
en vervolgens transformeren in blaasjes met een dubbelvoudige membraan naarmate de 
infectie vordert. Daarnaast wordt aangetoond met een cardiovirus mutant, die zichzelf kan 
vermenigvuldigen bij lage concentraties van PI4P lipides, dat PI4P lipides een belangrijke rol spelen 
bij de vorming van cardiovirus RO’s. Deze overeenkomsten en de verschillen met enterovirussen 
wordt besproken in de context van de gelijkenissen tussen verschillende picornavirussen.
Hoofdstuk 6 bevat een algemene disccusie van de verschillende hoofdstukken, waarbij de 
belangrijkste bevindingen worden gebruikt om nieuwe thema’s in het onderzoek naar positief-
strengs RNA virussen uit te lichten. De belangrijke rol van PI4P lipides voor verschillende aspecten 
van picornavirus replicatie wordt besproken. Mogelijke functies van picornavirus RO’s, in het 
bijzonder die van de blaasjes met een dubbelvoudige membraan die later in infectie ontstaan, 
worden bediscusieerd. Het zichtbare gemak waarmee sommige picornavirussen verschillende 
organellen en intracellulaire membranen kunnen benutten voor de vorming van RO’s benadrukt 
dat niet zozeer de oorsprong of morfologie van RO’s, maar juist de specifieke functionele vereisten 
van het replicatie membraan cruciaal zijn voor picornavirus replicatie.
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S H O RT L I S T  O F  F R E Q U E N T LY  U S E D  A B B R E V I AT I O N S
TEM  Transmission electron microscopy
SEM  Scanning electron microscopy
SBF-SEM  Serial block-face scanning electron microscopy
ET  Electron tomography
CLEM  Correlative light and electron microscopy
RO(s)  Replication organelle(s)
DMV  Double-membrane vesicle
SMV/T  Single-membrane vesicle/tubule
CVB3  Coxsackievirus 3B
EMCV  Encephalomyocarditis virus
PI4P  Phosphatidylinositol-4 phosphate
PI4KB  Phosphatidylinositol-4 kinase 3 beta
LD(s)  Lipid droplet(s)
IFN  Interferon
PKR  Protein kinase R
MAVS  Mitochondrial antiviral-signaling protein
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Endomembrane mutiny
How picornaviruses hijack host organelles 
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